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Preface
Cataract surgery is one of the most frequently performed surgical procedures in
the world. Intraocular lens (IOL), as an integral part of ocular refractive system
reconstruction, is playing a more and more important role in cataract surgery. 
Moreover, with the development of IOL technology and patients’ increasing 
demands of postoperative visual quality, different kinds of premium IOLs, 
such as the toric IOL, multifocal IOL, trifocal IOL, accommodating IOL, and 
extended depth of focus IOL, are widely used in ophthalmology. The careful and 
exact understanding of the optical physical properties of each type of IOL, their
advantages and disadvantages, and biocompatibilities is essential.
This book is fortunate to have outstanding contributors from different countries. 
We believe that IOL content has a practical and clinical interest for clinical 
ophthalmology. Moreover, we hope that this book provides a timely answer to a
current clinical need.
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This chapter will explain the materials used in making intraocular lenses. 
Rigid IOL’s made of PMMA have now given way to foldable silicone and acrylic 
lenses. This chapter will also throw light on the indications and contraindica-
tions for using each of the IOL’s. The composition of each of the lenses, their 
water content, mechanical properties and their special ultraviolet absorbing 
features will be discussed in detail. The mechanism by which hydrophilic lenses 
are inserted through small incisions during cataract surgery will need a special 
mention. The problems with use of different types of intraocular lenses will also 
be dealt with.
Keywords: intraocular lens, material, PMMA, acrylic, silicone
1. Introduction
Cataract surgery is being carried out for over more than 3000 years. What began 
as simply dislodging the cataractous lens posteriorly into the vitreous, also known 
as couching, got the ball rolling. And now we have advanced surgical techniques 
with minimal incision size and excellent visual prognosis due to the recent advances 
in intraocular lenses (IOL) [1].
In November, 1949, Dr. Harold Ridley implanted the first intraocular 
lens after extracapsular cataract extraction (ECCE) in a 45 year old female 
at St. Thomas Hospital, London [2]. This IOL was made of a material called 
Polymethylmethacrylate (PMMA).
After a lot of clinical trials and initial disapproval, it wasn’t until 1970, that IOL 
implantation became a well accepted procedure. And hence began a revolution in 
the field of cataract management. Over the past 5 decades there have been monu-
mental breakthroughs and various IOLs of finest elements are now routinely being 
implanted (Figure 1).
An intraocular lens can be described on the basis of certain properties possessed 
by the material it is made up of. These properties include the following:
1. Affinity for water
2. Refractive index








This chapter will explain the materials used in making intraocular lenses. 
Rigid IOL’s made of PMMA have now given way to foldable silicone and acrylic 
lenses. This chapter will also throw light on the indications and contraindica-
tions for using each of the IOL’s. The composition of each of the lenses, their 
water content, mechanical properties and their special ultraviolet absorbing 
features will be discussed in detail. The mechanism by which hydrophilic lenses 
are inserted through small incisions during cataract surgery will need a special 
mention. The problems with use of different types of intraocular lenses will also 
be dealt with.
Keywords: intraocular lens, material, PMMA, acrylic, silicone
1. Introduction
Cataract surgery is being carried out for over more than 3000 years. What began 
as simply dislodging the cataractous lens posteriorly into the vitreous, also known 
as couching, got the ball rolling. And now we have advanced surgical techniques 
with minimal incision size and excellent visual prognosis due to the recent advances 
in intraocular lenses (IOL) [1].
In November, 1949, Dr. Harold Ridley implanted the first intraocular 
lens after extracapsular cataract extraction (ECCE) in a 45 year old female 
at St. Thomas Hospital, London [2]. This IOL was made of a material called 
Polymethylmethacrylate (PMMA).
After a lot of clinical trials and initial disapproval, it wasn’t until 1970, that IOL 
implantation became a well accepted procedure. And hence began a revolution in 
the field of cataract management. Over the past 5 decades there have been monu-
mental breakthroughs and various IOLs of finest elements are now routinely being 
implanted (Figure 1).
An intraocular lens can be described on the basis of certain properties possessed 
by the material it is made up of. These properties include the following:
1. Affinity for water
2. Refractive index




5. Presence or absence of glistening phenomenon
6. Prevention of posterior capsular opacification (PCO)
7. IOL design
1.1 Affinity for water
IOL materials are defined hydrophobic or hydrophilic according to the angle a 
drop of water makes with respect to the material surface. The more acute this angle 
is, the more hydrophilic the material is defined and vice versa.
1.2 Refractive index
Refractive index of a material refers to ratio of velocity of light in vacuum to 
velocity of light in that medium. It is a measure of bending of light rays when they 
travel through a particular medium. The refractive index and thickness of the IOL 
are inversely proportional.
1.3 Size
The optic diameter and the length of the haptics are taken into consideration 
when the size of the IOL is to be measured. The size of the incision, the type of 
injector and methods of introducing the IOL are all based on the size of the IOL.
1.4 Adhesiveness
Adhesiveness is a property by which the IOL fuses with anterior and posterior 
capsule and hence reduces the risk of decentration. This property becomes essential 
in toric IOLs.
1.5 Glistening phenomenon
Penetration by aqueous humor has been noted to cause small vacuoles within the 
lens optic. This phenomenon is called ‘glistening phenomenon’.
Figure 1. 
Contact angles of water on hydrophobic and hydrophilic surfaces. (a) Contact angle is >900 on hydrophobic 
surface (b) contact angle is <900 on hydrophilic surface.
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1.6 Prevention of PCO
The properties of the IOL such as affinity for water, adhesiveness and presence 
of square edge contribute in prevention of opacification of posterior capsule after 
cataract surgery.
1.7 IOL design
The structure and design of IOL contributes to its ability to remain centered in 
the capsular bag. The shape and length of haptics and the optical diameter are taken 
into consideration in designing an intraocular lens.
2. Classification






One of the first materials to be used for the purpose of intraocular lenses, 
polymethyl methacrylate (PMMA) is a rigid, non-foldable, hydrophobic material 
(Figure 2). Hydrophobic nature of PMMA lenses makes them more likely to adhere 
to corneal endothelial cells during insertion, thus causing potential endothelial loss. 
The refractive index is 1.49 and the usual optic diameter is 5–7 mm. They are usually 
single piece and have low memory haptics.
Due to their property of rigidity, a large incision is required for its implantation. 
An incision size of about 5.5–6 mm or a large corneoscleral tunnel is required for its 
Figure 2. 
(a) MMA (methyl methacrylate) forms the basis for acrylic IOLs. (b) Poly(methyl methacrylate) (PMMA) 
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implantation. Large sized incisions are associated with delayed healing and astig-
matic refractive errors. Hence PMMA is seldom used today except in developing 
countries due to economic reasons.
One piece variant of PMMA lens means that optics and haptics are made from a 
single mold of the same material. It is said to be three piece when the optics and the 
haptics are made from different materials and are attached together (Figure 3).
Penetration by aqueous humor has been noted to cause small vacuoles within the 
lens optic. This “glistening” phenomenon is rarely seen with PMMA.
After the advent of phacoemulsification in 1967, by Charles Kelman, the size of 
the incision did decrease significantly. However, the incision still had to be extended 
for implantation of the rigid IOL. The obligation of downsized incision was still 
amateur. This made way for the flexible and foldable breed of IOLs.
2.2 Silicone
Since 1950s, silicone has been used in a variety of medical device applications 
including contact and intraocular lenses. The malleable nature of silicone makes 
it chemically stable as well as imparts diverse mechanical properties. Also, due to 
its excellent biocompatibility and versatile properties, desired optical clarity and 
specific viscosity can be attained.
The first foldable silicone IOL was implanted in human eyes in the 1978 by 
Kai-yi Zhou. Silicone is hydrophobic, that is, it makes a contact angle of 990 with 
the water droplet on its material surface and therefore must be handled dry before 
implantation. This property allows a smaller incision than the IOL size. The refrac-
tive index of silicone lens is between 1.41 and 1.46 and the optic diameter is 5.5–
6.5 mm. Because of the low refractive index, the optics are rather thick especially 
for high refractive powers. Such lenses may require an incision of size up to 3.2 mm. 
Although there are injectors available for safe and dry handling of silicone lenses, 
premature and abrupt opening of the lenses remains a dispute for most surgeons.
After implantation, the anterior capsule rim opacifies quickly, while the 
posterior capsule may remain clear for many years. Despite the low posterior 
capsular opacification (PCO) rate and the good resistance to Nd:YAG laser shots, 
silicone is less used today because it is not suitable for micro incision cataract 
surgery (MICS).
Adhesiveness is a property by which the IOL fuses with anterior and posterior 
capsule and hence reduces the risk of decentration. An important point about 
silicone lenses is that it has poor adhesive property and it is kept in place by the 
virtue of its haptics and capsule coalescence. The character of “glistening” is seen in 
silicone lenses as well.
Figure 3. 
(a) Polydimethylsiloxane and (b) polydimethyldiphenylsiloxane.
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Silicone lenses are available in two variants depending on the type of haptics. 
The two kinds of haptics include modified C loop and plate haptics. Of these, the 
plate haptics have a higher tendency to decenter in eyes with defective anterior 
capsule [3].
Silicone is a synthetic polymer made up of periodically repeated silicon-oxygen-
groups (siloxane). This structure is the backbone for a polymer, which is identical 
for all silicone IOLs. Bound to the silicon atom are side chains, which influence the 
properties of the material.
2.3 Acrylic
The rigid PMMA lens is acrylic in nature. However the side chain molecules 
attached to the main polymer confer certain properties to the IOL. So, substituting 
the side chains in PMMA to hydroxyethyl or polyethyl groups alters the rigidity of 
the material. The newly formed polymers are now flexible and clear and this is the 
material that makes newer generation IOLs foldable. Furthermore, depending on 
the side-chain chemistry, the flexible acrylic material can be made to be hydrophilic 
or hydrophobic.
Most hydrophilic IOLs utilize the same material as contact lenses: hydroxyeth-
ylmethacrylate (HEMA) (Figure 4). Poly HEMA containing IOLs are also called 
hydrogels. With a water content of approximately 38%, they are flexible. Because 
of the high water content, they have a low refractive index. These lenses are highly 
foldable and can be injected through incisions approximately 1.8 mm in length or 
smaller, allowing for microincision cataract surgery (MICS). Because of hydrophilic 
nature of hydrogels, they are flexible and inert. Hydrophobic lenses have a low 
water content (<1%) and they carry a lesser risk of posterior capsule opacification. 
Higher uveal biocompatibility was achieved with the modern hydrophilic acrylic 
IOLs than with the hydrophobic acrylic IOL [4].
A salient property of these acrylic materials is glass transition temperature or 
Tg. It is essentially the temperature at which the material changes its rigidity and 
becomes more flexible. Tg is different for different acrylic materials depending on 
its side chain molecule.
Foldable acrylic lenses tend to be more robust than their silicone equivalents. 
They undergo less post-implantation decentration or rotation. If posterior segment 
surgery is likely to be necessary at a later date, they are a better choice, as silicone 
oil – which would ruin silicone-based IOLs – can be used. However, this comes at the 
cost of a slightly larger incision size being necessary for implantation.
The three piece hydrophobic acrylic foldable intraocular lens consists of a 
truncated hydrophobic optic and polymethylmethacrylate (PMMA) haptics. The 
single piece IOL is a new version of the hydrophobic acrylic foldable IOL, with both 
Figure 4. 
Flexible acrylic lenses can be made from (a) HEMA – (hydroxyethyl) methacrylate, (b) PEMA – (polyethyl) 
methacrylate, and (c) PEA – poly(ethyl acrylate).
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the optic and haptics consisting of a foldable acrylic material. The table below gives 
a comparison based on their different properties [5, 6]:
2.4 Collamer
Another subset of hydrophilic foldable acrylics is the Collamer lens. This Collamer 
material is a patented copolymer of hydrophilic acrylic and porcine collagen (<0.1%) 
hydroxyethyl methacrylate copolymer with a UV absorbing chromophore. In theory, 
the porcine collagen improves the biocompatibility of the lens when implanted in 
human eyes. It is a foldable phakic IOL consisting of a plate haptic with a central 
convex/concave optical zone and a forward vault to reduce the contact with the lens.
3. Ultraviolet absorbing intraocular lenses
The crystalline lens absorbs ultraviolet radiation between 300 and 400 nm and 
protects the retina from photochemical damage [7]. This protective phenomenon 
is lost when the lens is removed during cataract surgery, but it can be restored by 
the implanting a UV-absorbing polymethylmethacrylate IOL. Implantation of a 
UV absorbing IOL results in cyanopsia or blue tinted vision. However it helps in 
preventing age related macular degeneration, improving contrast sensitivity and 
Properties Single piece acrylic Three piece acrylic
Visual acuity Same Same
Refractive stability Same Same
Centration Same Same
SPCO formation More Less
Anterior capsule opacification Less More
Dysphotopsias Less More
PMMA Silicone Acrylic
Size 5–7 mm 5.5–6.5 mm Foldable (minimum 1.8 mm)
Rigidity Rigid Flexible Foldable
Affinity to water hydrophobic hydrophobic Hydrophilic/hydrophobic
Refractive index 1.49 1.41–1.46 1.39–1.42
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reducing glare in mesopic and photopic conditions. There are various UV-absorbing 
IOLs but they are not equally effective in absorbing UV radiation (Figure 5). To 
prevent the toxic effects of short wavelength light, IOL’s have been developed that 
only block UV light but also reduce transmission of violet and blue wavelengths. 
The yellow pigment containing IOL’s were first developed by Hoya in Japan followed 
by Menicon Co. Ltd. The first foldable IOL was developed by Alcon Laboratories.
4. Future aspects
The incidence of endophthalmitis following cataract surgery has reduced sig-
nificantly over the last few decades but it is still a nightmare for every eye surgeon. 
Post-operative instillation of topical antibiotics and antiinflammatory is the rule. 
However, recent studies show that delivery of these drugs intraocularly released from 
the IOL material may reduce the need for postoperative medication and thereby may 
further reduce the incidence of endophthalmitis. A combination of moxifloxacin and 
ketorolac is better than a combination of moxifloxacin with diclofenac [10]. Its effec-
tive against Staph. aureus and Staph. epidermidis for about 15 days. Further studies 
should be aimed at such modern dual drug delivery incorporated in the IOL.
5. Summary
Right from couching and rendering the patient aphakic, science has come a 
long way to manufacturing intraocular lens. The different materials have their own 
advantages and pitfalls owing to their chemical structure and inherent properties. 
UV absorbing and dual drug delivery systems are the future.
Figure 5. 
Comparison of transmission spectra of UV transmitting, UV blocking, violet light-filtering and blue  
light-filtering IOLs [8, 9].
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Abstract
In 1949, first intraocular lens (IOL) insertion after cataract surgery was per-
formed by Sir Harold Ridley, in London. Only in the 1970s, the IOL insertion after 
cataract surgery began to be a standard procedure. The material the first IOL-s were 
composed of was polymethyl methacrylate (PMMA). The PMMA is a rigid material 
and the corneal incision had to be at least as big as the IOLs optic and it became 
its biggest disadvantage in the cataract surgery. The main goal of modern cataract 
surgery is as smallest incision possible, so the IOL-s had to be flexible and therefore 
foldable. This goal was achieved by improvements in the IOL design and materials 
that made them foldable. First foldable IOL-s were made of hydrogel but they were 
unstable and the development of the first silicone IOL-s overcame that problem. 
Foldable silicone IOL-s were first implanted in 1978 by Kai-yi Zhou. Foldable 
IOL’s benefits are its compatibility with a small incision surgery that is self-sealing 
procedure and the possibility of insertion by a single-use applicators that made 
the surgery safer. In the future, we can expect some new, different and innovative 
approaches in the IOL design and materials.
1. Introduction
Intraocular lenses (IOL) are implanted in the eye in order to treat refractive 
errors produced by extraction of the lens as a standard procedure in cataract 
surgery.
IOL is designed and composed of optic—central part, and the haptics—side 
structures that keep the lens inside the capsular bag.
The first intraocular lens was inserted in 1949 after cataract surgery by Sir 
Harold Ridley in St Thomas Hospital in London [1]. The material the first IOLs were 
composed of was polymethyl methacrylate (PMMA). It was a rigid nonfoldable 
material making the placement of the IOL challenging [2]. In the 1970s, the new 
lighter posterior chamber IOLs were designed and had propylene haptics for better 
stabilization and ciliary sulcus fixation and the IOL insertion after cataract surgery 
began to be a standard procedure.
In the early 1980s, Epstein began to use lenses made of silicone with the inten-
tion to make them foldable. That way they could be inserted into the eye through 
the small incisions of 3 mm and less compared to 5–7 mm incisions needed for 
nonfoldable IOLs insertion [3, 4]. The practice of IOL implantation was revolution-
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Current materials used for IOL optics are of two types—acrylic and silicone. 
Acrylic materials can be rigid (PMMA) and foldable made of hydrophobic acrylic 
materials (AcrySof - Alcon Laboratories, Sensar – Advanced Medical Optics –
AMO) and hydrophilic acrylics (Centerflex, Akreos).
Each foldable acrylic lens design is made from a different copolymer acrylic with 
a different refractive index, glass transition temperature, water content, mechanical 
properties and other attributes.
Hydrophobic acrylic lenses and silicone lenses have very low water content (less 
than 1%). But there are hydrophobic acrylic materials with higher water content 
about 4% also available. Hydrophilic acrylic lenses are made from copolymers with 
higher water content ranging from 18 to 38%.
The first silicone material that was used in the industry of IOLs was polydimeth-
ylsiloxane, with refractive index of 1.41 while the new silicone materials have higher 
refractive indexes.
Refractive index in foldable acrylics is 1.47 or greater, and for silicone lenses is 
lower—1.41 and higher. Therefore acrylic lenses are thinner than silicone ones with 
the same refractive power.
2. Materials
2.1 Biocompatibility
The biocompatibility of a material is dependent of a biological response to a 
foreign body material and it depends on the design and the material of the implant. 
The material should be chemically inert, physically stable, noncarcinogenic, non-
allergenic, capable of fabrication in the required form, and have no foreign body 
reaction [6]. Materials used in ophthalmology should also be optically transparent 
for long period of time, have a high resolving power or refractive index, and should 
block ultraviolet rays.
The reaction of lens epithelial cells and the capsule to IOL material and design is 
capsular biocompatibility. The uvea’s reaction to the IOL is uveal biocompatibility 
[7]. During cataract surgery the blood-aqueous barrier is disrupted and proteins 
and cells are released in the aqueous humor. Proteins then adsorb on the IOL surface 
and this will influence subsequent cellular reactions on the IOL [8].
3. Glistenings
Glistenings are a phenomenon caused by penetration of aqueous humor into the 
IOL material causing vacuole formation in the IOLs optic [9].
Glistenings are fluid-filled microvacuoles that form within the IOL optic when 
the lens is in an aqueous environment. They can be observed with any type of IOL 
more often in association with hydrophobic acrylic lenses.
Factors that may influence the formation of glistenings include IOL material, 
manufacturing technique and packaging and also the associated conditions of the 
eye-glaucoma, conditions leading to breakdown of the blood-aqueous barrier and 
use of ocular medications.
Some theories refer glistenings as a cavitation within the IOL from slow moving 
hydrophilic impurities within the IOL. An osmotic pressure difference between 
the aqueous solution within a cavity and the external media in which the lens is 
immersed leads to growth of the cavity [10].
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Glistening develop over time and indicate a dynamic process within the lens/eye 
system. Causes and long-term outcomes are not entirely clear [11].
Hydrophobic acrylic IOL have the highest degree of lens glistening in com-
parison to the silicone and the HSM-PMMA IOL 11.3–13.4 years after surgery. The 
HSM-PMMA IOL had almost no lens glistenings. Lens glistening do not interfere 
with the dioptric power of the hydrophobic acrylic lens IOL [12].
4. Hydrophobicity and hygroscopy
Hydrophobicity is a measure of material’s tendency to separate itself from water. 
Every material has its measurable hydrophobicity that is graded using contact-angle 
measurements and it is a surface property [13–15]. It ranges from only a few degrees 
for almost perfectly hydrophilic surfaces, such as bare silica glass prepared with 
dangling hydroxyl groups [16] to almost 180° for super-hydrophobic surfaces [14].
Hydrophobicity is highly dependent of the material’s chemistry since the oxygen–
hydrogen bonds in water are highly polar. Partial electric charges on the atoms tend 
to be attracted to opposite charges. That way water dissolves salts and is attracted 
to materials that also have partially charged bonds. Polymers consist primarily of 
nonpolar carbon–carbon and carbon–hydrogen bonds, which is why they are not 
generally hydrophilic and is attracted to materials with partially charged bonds.
Hygroscopy explains a material’s tendency to absorb and hold water. A highly 
hygroscopic material draws water into itself. In ophthalmology the hydrophobicity 
has been used to describe both the surface and interior of IOLs. The interaction of 
an IOL’s surface with water is a measure of hydrophobicity and the ability of IOLs to 
draw water into their interior a hygroscopy.
5. Polymethyl methacrylate
The first IOL, implanted in 1949, was made of PMMA. There have been reports 
of original lenses implanted by Ridley remaining perfectly clear and centered for 
more than 28 years [3]. There were also reports of some spontaneous dislocations 
into the vitreous [5].
It is a rigid, nonfoldable material with less than 1% water content and therefore 
hydrophobic. PMMA IOLs are usually single pieced, large and therefore nowadays 
rarely used. They have a refractive index of 1.49 and usual optic diameter 5–7 mm. 
They are s too rigid to fold and therefore the lens cannot pass through the small inci-
sions used phacoemulsification.
6. Silicone
Silicon IOLs were designed to allow implanting through the incision smaller than 
the optics diameter. Implantation of silicone IOLs was introduced in 1984 [17]. Silicone 
is a hydrophobic material of refractive index 1.41–1.46 and the optic diameter of 
5.5–6.5 mm. Models are three-piece design with PMMA, polyvinyl difluoride (PVDF) 
and polyamide haptics. The problem with silicone is an abrupt opening in the anterior 
chamber following implantation which may cause rupture of the posterior capsule.
Silicone IOL-s suspected to favor bacterial adhesion and therefore having the 
higher risk of postoperative infections [18]. Silicone oil droplets adhere well to 
silicone IOL in patients with silicone oil tamponade used in retinal detachment or 
Intraocular Lens
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diabetic retinopathy surgery [19]. Therefore silicon IOL should not be implanted in 
highly myopic eyes in risk of retinal detachment.
Nowadays the silicone IOLs are less frequently used because they are not suitable 
for microincision cataract surgery (MICS).
There are also a light adjustable lens-two component silicone IOL where power is 
adjusted after implantation with UV-exposure in use [20, 21].
Glistenings can happen with silicone optics while the aqueous humor can 
penetrate the silicon material [12].
7. Hydrophobic foldable acrylic
Acrylic hydrophobic IOLs are modern foldable IOLs most widely used nowadays. 
They are designed of copolymers of acrylate and methacrylate derived from PMMA. The 
intention of the new design is to make the IOL foldable. They can be manipulated during 
the surgery and always turning back to its original shape [22] in a short period of time. 
First implanted IOL was in year 1993. Hydrophobic Foldable Acrylic can be of three 
piece and one piece design, with optic diameter 5.5–7 mm, and overall length 12–13 mm, 
transparent or colored—yellow. Refractive index can be 1.44–1.55.
Single and multi-piece hydrophobic IOLs can be implanted through small inci-
sion, not lover than 2.2 mm and have to be positioned properly since they have low 
self-centering ability. PCO is significantly lower than in PMMA IOLs but generally a 
bit higher for hydrophobic acrylic lenses compared with silicone [23].
They have higher incidence of photopsias than other acrylic IOLs because of 
high refractive index and low anterior curvatures and some of them develop glisten-
ings since some are easily penetrated by aqueous humor but are not always clini-
cally relevant unless when are dense or multifocal [24]. New materials of IOLs are 
prehydrated to equilibrium and will not accept further water, they are hydrophobic 
with the contact angle with water that of hydrophobic acrylic and are packaged in 
BSS to absorb the eventual water content before implantation [25].
8. Hydrophilic foldable acrylic
Hydrophilic foldable acrylic is a combination of hydroxyethylmethacrylate 
(polyHEMA) and hydrophilic acrylic monomer [26] material and it was introduced 
in 1980 with several modifications since. The IOLs made of this materials are usu-
ally single pieced and designed for capsular bag implantation. Refractive index of 
the material is 1.43, with water content ranging from 18 to 34% [27, 28].
They are soft, compressible with excellent biocompatibility for its hydrophilic 
surface. They can be implanted through a small incisions, lower than 2 mm and 
therefore ideal for MICS [29]. The folding of poly-HEMA chains depends on the 
level of hydration, and so the physical and optical properties of the polymer change 
as a function of water content. As the lenses hydrate, they absorb water and become 
soft and transparent.
The main disadvantage is the higher rate of optic opacification than in other 
materials and lower resistance for capsular bag contraction [30, 31].
9. The future of IOL s materials and designs
Considering the new knowledge and technological improvements and achieve-
ments, we can expect the new materials and designs of IOLs. In order to improve 
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biocompatibility and refractive quality we expect some changes in shape of the IOLs 
(discoid, plate-lamellar, ball shaped) and therefore some novelties in implantation 
possibilities. The new neuro-ophthalmological knowledge and knowledge about 
adaptation and perception, industries based on robotic approach and innovations 
give us the right to expect some new and completely different IOLs in their shape, 
materials and functioning principle [32, 33]. In conclusion, in the future, we can 
expect some new, different and innovative approaches in the IOLs design and 
materials and refractive ophthalmology.
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Abstract
The shape of the normal human cornea induces positive spherical aberration
(SA) which causes image blur. In the young phakic eye, the crystalline lens com-
pensates for a certain amount of this corneal aberration. However, the compensa-
tion slowly decreases with the aging lens and is fully lost after cataract extraction
and implantation of a standard intraocular lens (IOL). Conventional spherical IOLs
add their intrinsic positive SA to the positive SA of the cornea increasing the image
blur. As a useful side effect, this also increases the depth of focus—often referred
to as pseudo-accommodation. Aspheric intraocular lenses have been introduced
to be either neutral to SA or to compensate for a certain amount of corneal SA.
A customized correction for the individual eye seems to be the most promising solu-
tion for tailored correction of SA. In this chapter we will provide detailed informa-
tion on the various concepts of aspheric intraocular lenses to elucidate that the term
“aspheric intraocular lens” is being used for a large amount of different lens designs.
Keywords: spherical aberration, aspheric surface, customized intraocular lens,
decentration, tilt
1. Introduction
The disease pattern of cataract comprises pathologic conditions of the human
eye resulting from an opacification of the crystalline lens. The most frequent causes
for the development of cataract are age-related transformation processes. Although
research on pharmacologic treatment of cataract has been in focus for many years,
the surgical extraction of the cloudy crystalline lens and implantation of an artificial
intraocular lens (IOL)—referred to as cataract surgery—represent the only avail-
able treatment. Cataract surgery is one of the most frequently performed surgical
procedures with several million surgeries being performed worldwide each year.
First IOL developments were primarily targeted on biocompatible materials and
new fixation techniques rather than on correction of ocular aberrations other than
defocus and astigmatism. First lens implants were made from polymethyl methac-
rylate, therefore being rigid and requiring large incisions for implantation. Further-
more, the optimum site of implantation (anterior chamber, iris, ciliary sulcus, or
capsular bag) still had to be found, and adequate haptics for proper fixation had to
be developed. Surgical results were therefore less predictable [1, 2].
In the early 1980s, foldable silicone materials and later acrylic materials allowed
implantation through smaller ports and therefore caused less damage to the corneal
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1. Introduction
The disease pattern of cataract comprises pathologic conditions of the human
eye resulting from an opacification of the crystalline lens. The most frequent causes
for the development of cataract are age-related transformation processes. Although
research on pharmacologic treatment of cataract has been in focus for many years,
the surgical extraction of the cloudy crystalline lens and implantation of an artificial
intraocular lens (IOL)—referred to as cataract surgery—represent the only avail-
able treatment. Cataract surgery is one of the most frequently performed surgical
procedures with several million surgeries being performed worldwide each year.
First IOL developments were primarily targeted on biocompatible materials and
new fixation techniques rather than on correction of ocular aberrations other than
defocus and astigmatism. First lens implants were made from polymethyl methac-
rylate, therefore being rigid and requiring large incisions for implantation. Further-
more, the optimum site of implantation (anterior chamber, iris, ciliary sulcus, or
capsular bag) still had to be found, and adequate haptics for proper fixation had to
be developed. Surgical results were therefore less predictable [1, 2].
In the early 1980s, foldable silicone materials and later acrylic materials allowed
implantation through smaller ports and therefore caused less damage to the corneal
structure allowing a faster rehabilitation. This finally facilitated ambulant cataract
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surgery. In the following years, the capsular bag was identified as the optimum
position for an IOLs, and the development of new lens power calculation formulas
dramatically increased the predictability of the refractive outcome [1].
2. Aspheric lenses
With the improvement in IOL power calculation, the goal of cataract surgery
became predictable; the focus of cataract surgery shifted from “restoration of
vision” to “refractive surgery.” Manufacturers started optimizing the IOL optic
from an equiconvex spherical lens design to different aspheric surface profiles and
finally multifocal and free-form surface designs. The buzzword of those days was
“spherical aberration” (SA) which should be eliminated to improve contrast sensi-
tivity and visual acuity. Spherical aberration is one of the monochromatic aberra-
tions that is caused by the difference in focal length (or optical power) for varying
aperture diameter of a lens. For positive spherical aberration, the optical power
increases from the lens center to the periphery, and rays far from the optical axis
will intersect the optical axis in front of the paraxial focus (Figure 1).
Any spherical optical surface causes SA. To achieve an equal distribution of
optical power across the lens diameter, the optical surfaces have to be tailored
accordingly. SA can only be reduced by varying the spherical radii of curvature of
anterior and posterior surface yielding a so called best-form lens, but it cannot be
eliminated. This can be achieved by implementing aspheric surfaces. There are
basically two types of aspheric surfaces that have been described in the literature, the










a2n � ρ2n þ X (1)
Figure 1.




where z is the height of the surface from the apex (= 0 mm), r is the radius of
curvature, and ρ is the radial coordinate from the center to the periphery. Q is called
“asphericity” [3], and a2n are higher-order aspheric coefficients. X is a placeholder
for additional polynomials, such as Zernike polynomials, which can be used to
define additional surface shapes. From this equation numerous aspheric surface
profiles can be generated (Figure 2), and most of current aspheric intraocular
lens designs are based on the formula above. Equation (1) can be expanded to
represent toric and biconic surfaces as well. The asphericity Q is identical to the
conic constant κ (often used in optical design software) and can be transformed
from other shape definitions for the aspheric surface such as the eccentricity e or
the index of eccentricity e2 [3]:
Q ¼ �e2 (2)
The second type of aspherical surfaces, called “zonal asphere,” is constructed
from a set of annular rings with varying radius of curvature and asphericity. For a
detailed description of these surfaces, please refer to the literature [5, 6].
By modulating radius of curvature, asphericity, and aspheric coefficients, the
SA induced by the surface can be customized. Additional polynomials can be added
on top to create non-rotationally symmetric aspheric surfaces to compensate for
higher-order errors such as coma or trefoil. For example, one alternate way to
compensate for spherical aberration would be to modulate the aspherical surface
with a linear combination of Zernike polynomials representing various orders of
spherical aberration:
X ¼ C11 � Z04 þ C22 � Z06 þ C37 � Z08 þ⋯ (3)


















Q-asphere with 4th and 6th order coefficients
non-Q-asphere with 2nd to 6th order coefficients
Q-asphere with up to 14th order coefficients
Figure 2.
Variation of optical surface section with increasing number of coefficients. z is the elevation relative to the
surface apex. All curves are derived from intraocular lens designs for an average power (20 to 22 D) lens.
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surgery. In the following years, the capsular bag was identified as the optimum
position for an IOLs, and the development of new lens power calculation formulas
dramatically increased the predictability of the refractive outcome [1].
2. Aspheric lenses
With the improvement in IOL power calculation, the goal of cataract surgery
became predictable; the focus of cataract surgery shifted from “restoration of
vision” to “refractive surgery.” Manufacturers started optimizing the IOL optic
from an equiconvex spherical lens design to different aspheric surface profiles and
finally multifocal and free-form surface designs. The buzzword of those days was
“spherical aberration” (SA) which should be eliminated to improve contrast sensi-
tivity and visual acuity. Spherical aberration is one of the monochromatic aberra-
tions that is caused by the difference in focal length (or optical power) for varying
aperture diameter of a lens. For positive spherical aberration, the optical power
increases from the lens center to the periphery, and rays far from the optical axis
will intersect the optical axis in front of the paraxial focus (Figure 1).
Any spherical optical surface causes SA. To achieve an equal distribution of
optical power across the lens diameter, the optical surfaces have to be tailored
accordingly. SA can only be reduced by varying the spherical radii of curvature of
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Q-asphere with 4th and 6th order coefficients
non-Q-asphere with 2nd to 6th order coefficients
Q-asphere with up to 14th order coefficients
Figure 2.
Variation of optical surface section with increasing number of coefficients. z is the elevation relative to the
surface apex. All curves are derived from intraocular lens designs for an average power (20 to 22 D) lens.
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3. Corneal spherical aberration
As mentioned above, the average human cornea induces a significant portion of
positive SA, which is typically being described by the Zernike coefficient Z04
(spherical aberration) on a diameter of 6.0 mm at corneal plane. The amount of
SA can be calculated from the corneal surface shape by optical ray tracing.
A method to do so was described by Norrby et al. providing a reference value for
the Liou-Brennan model eye [7, 8]. Calossi provided an overview of SA values for a
limited set of variables [3].
Depending on the underlying database, various authors reported different
values for the average corneal SA. Holladay et al. reported that the average SA of the
human cornea is about +0.27  0.20 μm (value misprinted in the original publica-
tion [9] and corrected by Norrby et al. [7]). Similar values were found by Beiko and
Haigis (+0.274  0.089 μm) [10]. The widely spread Liou-Brennan model eye pro-
vides about +0.258 μm of spherical aberration being close to the reported average
clinical values [7, 8]. De Sanctis et al. found higher values in their patients
(+0.328  0.132 μm) [11], while Shimozono et al. found lower values
(0.203  0.100 μm) [12].
4. Correction of spherical aberration with IOLs
Aberration correction could be best described as a superposition of wave fronts
as outlined in Figure 3.
During cataract surgery the corneal SA is typically increased by the likewise
positive spherical aberration of a spherical IOL. Therefore, lens designers at first
created the “aberration-free” or “aberration-neutral” lens concept, a lens design that
was meant to eliminate its intrinsic spherical aberration and thus being neutral to the
eye’s overall SA [13]. However, the amount of SA is highly depending on the vergence
of the incident rays. Therefore, there are differences in the design of “aberration-
neutral” lenses: some of them are designed to be neutral to SA in a collimated beam,
e.g., a beam as such could be used in measurement instrumentation. Others are
designed to be neutral to SA behind some generic model cornea (in a converging
beam). Both of them will exhibit a considerable amount of SA when implanted in a
real eye; the first will provide a small correction for SA, while the latter may provide
+ =0 µm
+0.27 µm -0.27 µm
Figure 3.
Simplified sketch of the principle of aberration correction: An impinging plane wave front (collimated beam) is
refracted by the cornea and affected by spherical aberration (red); the intraocular lens (yellow) compensates for
the same amount of spherical aberration (green) resulting in a perfect wave front at the focus plane. Note: The
plotted wave fronts do not account for the defocus.
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negligible change to the corneal SA. When being analyzed on an optical bench (in a
collimated beam), both lenses will show the opposite characteristics [4].
Aberration-correcting designs evolved subsequently, providing compensation to
a fixed amount of corneal SA. One of the first aberration-correcting lenses was
presented by Holladay et al. providing a correction of 0.27 μm and thus targeting
on the average SA found in human eyes [9].
Today, surgeons may choose from a variety of aspheric IOLs with different
amount of compensation for SA (Table 1). Theoretically, one could choose the IOL
providing the optimum correction for an eye. This would require preoperative
examination of corneal topography and analysis of corneal aberrations. Diagnostic
instrumentation for the anterior segment such as the Pentacam (Oculus Optikgeräte
GmbH, Wetzlar, Germany) or the CASIA2 (Tomey Corp., Nagoya, Japan) allow
direct readout of the SA amount over 6 mm diameter. The SA value calculated from
corneal tomographic data could then be used to select an IOL model that provides
best correction. Still, since the range of IOLs with different SA corrections is lim-
ited, not every eye could be supplied with optimum correction. Clinical results with
this “selection method” are controversial but indicate the potential for improve-
ment [14–16]. Piers et al. found that contrast sensitivity peaks with 0 μm of SA [17].
On the contrary, other investigators found that a residual SA of about +0.1 μm may
be beneficial for visual performance [18–20]. Manzanera and Artal argued that
changes in SA between 0.17 and + 0.2 μm are merely noticeable by patients [21].
This may be an explanation why the differences in visual performance between
aberration-free and aberration-correcting lenses are usually small.
The next logical step is a compensation procedure based on the true individual
SA, rather than on average values. Wang et al. found that not only SA should be
considered but the full spectrum of corneal aberrations [22–24]. Especially eyes
with high amounts of spherical aberration such as eyes after laser refractive surgery
or eyes with forme fruste keratoconus could benefit more from customized correc-
tion of SA [22, 23, 25] than normal eyes, if centration of the implant can be kept
within strict limits. Therefore, an optimum solution could be the customization of
intraocular lenses [26, 27]. Several researchers provided theoretical basics and the-
oretical results showing the potential of customized intraocular lenses [28–31]. The
design process of such IOLs requires the implementation of customized model eyes
based on biometric data and the use of ray tracing technology [28, 32–36]. The first
clinical results with this method have recently been published showing promising
results [37].
Manufacturer Product SA correction
Johnson & Johnson Vision, Groningen, The Netherlands TECNIS 0.27 μm [9]
HOYA, Nagoya, Japan Vivinex XC1 0.18 μm [17, 18]
Carl Zeiss Meditec, Berlin, Germany CT ASPHINA 509MP 0.18 μm [18]
Alcon Laboratories, Forth Worth, TX, USA AcrySof IQ SN60WF 0.17 μm [17]
Bausch + Lomb, Rochester, NY, USA EyeCee One 0.14 μm [18]
Quatrix Evolutive 0.1 μm [18]
PhysIOL, Liege, Belgium PODeye 0.11 μm [18]
Kowa Pharmaceuticals, Düsseldorf, Germany AvanSee 0.04 [18]
Table 1.
List of selected intraocular lens models providing correction of spherical aberration.
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negligible change to the corneal SA. When being analyzed on an optical bench (in a
collimated beam), both lenses will show the opposite characteristics [4].
Aberration-correcting designs evolved subsequently, providing compensation to
a fixed amount of corneal SA. One of the first aberration-correcting lenses was
presented by Holladay et al. providing a correction of 0.27 μm and thus targeting
on the average SA found in human eyes [9].
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examination of corneal topography and analysis of corneal aberrations. Diagnostic
instrumentation for the anterior segment such as the Pentacam (Oculus Optikgeräte
GmbH, Wetzlar, Germany) or the CASIA2 (Tomey Corp., Nagoya, Japan) allow
direct readout of the SA amount over 6 mm diameter. The SA value calculated from
corneal tomographic data could then be used to select an IOL model that provides
best correction. Still, since the range of IOLs with different SA corrections is lim-
ited, not every eye could be supplied with optimum correction. Clinical results with
this “selection method” are controversial but indicate the potential for improve-
ment [14–16]. Piers et al. found that contrast sensitivity peaks with 0 μm of SA [17].
On the contrary, other investigators found that a residual SA of about +0.1 μm may
be beneficial for visual performance [18–20]. Manzanera and Artal argued that
changes in SA between 0.17 and + 0.2 μm are merely noticeable by patients [21].
This may be an explanation why the differences in visual performance between
aberration-free and aberration-correcting lenses are usually small.
The next logical step is a compensation procedure based on the true individual
SA, rather than on average values. Wang et al. found that not only SA should be
considered but the full spectrum of corneal aberrations [22–24]. Especially eyes
with high amounts of spherical aberration such as eyes after laser refractive surgery
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tion of SA [22, 23, 25] than normal eyes, if centration of the implant can be kept
within strict limits. Therefore, an optimum solution could be the customization of
intraocular lenses [26, 27]. Several researchers provided theoretical basics and the-
oretical results showing the potential of customized intraocular lenses [28–31]. The
design process of such IOLs requires the implementation of customized model eyes
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results [37].
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5. Limitations of aberration-correcting lenses
A major limitation for the selection of the appropriate IOL is the accuracy and
repeatability of the preoperative corneal topography. The calculation of corneal SA
requires highest precision of corneal topography in the periphery, since the differ-
ence in elevation between an aspheric corneal surface and a spherical surface is only
some microns (Figure 4). Schröder et al. investigated the measurement repeatabil-
ity and precision of several corneal topographers and tomographers and found that
the repeatability of these devices is decreasing from the center to the periphery and
may not be sufficient to detect small changes in corneal asphericity [38].
Another limitation arises from the concept of aberration correction itself. As
outlined in Figure 3, the method requires the alignment of the IOL in relation to the
cornea to be as perfect as possible. But even if an ideal positioning of the IOL is
achieved intraoperatively, the risk of decentration or tilt remains in the postopera-
tive course.
Altmann et al., Eppig et al., and others analyzed the effects of decentration and
tilt of spherical and aspherical IOLs on the image quality and found that it is more
affected by decentration than by tilt and that the susceptibility of lens misalignment
increases with the amount of SA to be corrected [9, 39–46]. Some authors defined
that a range of decentration within a SA-correcting IOL would perform better or
equal than a standard spherical IOL. This range was reported to be between 0.0
and 0.3–0.8 mm, depending on the design of the lens and simulation conditions
[9, 40–42]. In a previous publication, we summarized the data on the IOL
decentration from various sources and found that the clinically observed decentra-
tion is between 0 and 1 mm but most frequently about 0.3 mm [33, 40, 47–56].
Others showed that there is a tendency for IOLs decentering and tilting into nasal
direction with mirror symmetry between both eyes [51].
Gillner et al. showed in a previous publication that IOL designs with a more
conservative correction of SA may provide a larger range of tolerance to
decentration [41]. Examples thereof are the ZO/ASPHINA design (Carl Zeiss
Meditec AG, Berlin, Germany) and the Aspheric Balanced Curve Design (ABCD)
(Hoya Corporation, Tokyo, Japan). Both designs are based on higher-order
Figure 4.
Difference in corneal elevation for three surfaces with R = 7.77 mm radius of curvature and several values of Q
compared to a sphere.
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aspherics including coefficients a4 and higher (see Eq. 1) and were specifically
designed considering some reasonable amount of IOL decentration. The effect of
decentration on image performance of some selected IOL designs is shown in
Figures 5 and 6. The graphs exhibit a drop of the image quality with aspheric lenses
below the image quality of a spherical IOL when decentration exceeds 0.4 and
0.3 mm, respectively.





























aberration correction approx. -0.18 µm
aberration correcting approx. -0.27 µm
Figure 5.
Simulation of modulation transfer function at 30 cycles per degree for four different intraocular lenses and a
pupil diameter of 3.0 mm in the Liou-Brennan model eye as a function of decentration [40, 41, 57].
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aberration correcting approx. -0.27 µm
Figure 6.
Simulation of modulation transfer function at 30 cycles per degree for four different intraocular lenses and a
pupil diameter of 4.5 mm in the Liou-Brennan model eye as a function of decentration [40, 41].
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6. Conclusions
Correcting the spherical aberration of the cornea by intraocular lenses may
improve the visual outcome compared to standard spherical lenses. Especially
patients with high aberrations after corneal refractive surgery may benefit from a
reduction of the overall aberrations. However, the prospects for a 100% correction
of SA or aiming to a residual SA of +0.1 μm are limited with respect to an ideal and
stable IOL. Therefore, any generic or customized IOL concept pursuing an aberra-
tion correction of aberrations, such as astigmatism, spherical aberration, coma, etc.
must be designed with a tolerance according to the average expected misalignment
in normal eyes (approximately 0–0.3 mm decentration and 0–3 degrees of tilt)
[40, 57]. Consequently, this likewise limits the correctability of some higher-order
aberrations. Eyes after corneal refractive surgery usually show very high values of
SA and require special attention in the planning of cataract surgery. While eyes
after myopic refractive procedures might benefit from a negative SA IOL [22], eyes
after hyperopic refractive procedures often show high-negative SA and would
require an IOL with positive SA for compensation [23]. Due to the high variability
of SA in cataract patients, the “one-size-fits-all” approach may only provide opti-
mum correction for a small amount of patients. Therefore, customized intraocular
lenses tailored to correct for the individual spherical aberration may provide a
better solution for a wide range of patients.
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This chapter described a short history about the toric intraocular lenses (IOLs)
and then discussed some interesting topics such as the measurement of (front and
posterior) corneal astigmatism and surgically induced astigmatism; the manual
marking techniques and image-guided systems and intraoperative aberrometry-
based methods; the new toric lens calculation calculators and toric IOLs formulas;
the post operation care of toric IOLs and re-rotation of misaligned toric IOLs; and
some relevant issues on multifocal toric intraocular lens. Meanwhile, this chapter
also discussed toric IOL in some special cases like keratoconus corneal ectatic
disorders, post-refractive surgery and post-keratoplasty, etc.
Keywords: astigmatism, cataract, toric IOL
1. Introduction
Up to more than one-third of cataract patients have preoperative corneal astig-
matism of more than 1.0 diopter (D) [1], while 26.2% have more than 1.5 D [2, 3],
8–14.9% have more than 2.0 [1, 3], and 2.6–7.4% have more than 3.0 D [1, 3].
Astigmatism is one of the most important factors that affect postoperative vision
quality. More than 0.5 D of residual astigmatism can reduce visual performance and
patient satisfaction [4–6]. Currently, implanting a toric lens is recognized as the
most accurate form of astigmatic correction during cataract surgery, especially
astigmatism of more than 1 D [7]. Actually, toric IOLs correct preexisting regular
corneal astigmatism usually ranging from 0.75 to 4.75 D [8]. However, the out-
comes after toric IOL implantation are still influenced by many factors including
accurate preoperative measurement of corneal astigmatism, IOL selection, marking
techniques, intraoperative alignment and postoperative care, etc.
2. A short history and clinical outcomes of toric IOLs
The first article reporting a toric IOL (Nidek NT -98B) was published in 1994
[9], which had a cylinder power of 2.00 or 3.00 D. In the study, Shimizu et al. had
relatively positive results, although some negative results still occurred in some eyes
of which the lens axis rotated more than 30° [9]. Ever since then, with the predict-
ability increasing and the safety enhancing, toric IOLs have definitely become a
considerable option to correct significant astigmatism when undergoing cataract
surgery [10, 11]. At present, standard toric IOLs are available in cylinder powers of
1.0 to 6.0 D, while higher cylinder powers are also available (see Table 1).
Toric IOL had achieved increasingly great visual outcomes. An uncorrected
distance visual acuity (UDVA) of 20/40 or better is achieved in more than 70% of
35
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This chapter described a short history about the toric intraocular lenses (IOLs)
and then discussed some interesting topics such as the measurement of (front and
posterior) corneal astigmatism and surgically induced astigmatism; the manual
marking techniques and image-guided systems and intraoperative aberrometry-
based methods; the new toric lens calculation calculators and toric IOLs formulas;
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1. Introduction
Up to more than one-third of cataract patients have preoperative corneal astig-
matism of more than 1.0 diopter (D) [1], while 26.2% have more than 1.5 D [2, 3],
8–14.9% have more than 2.0 [1, 3], and 2.6–7.4% have more than 3.0 D [1, 3].
Astigmatism is one of the most important factors that affect postoperative vision
quality. More than 0.5 D of residual astigmatism can reduce visual performance and
patient satisfaction [4–6]. Currently, implanting a toric lens is recognized as the
most accurate form of astigmatic correction during cataract surgery, especially
astigmatism of more than 1 D [7]. Actually, toric IOLs correct preexisting regular
corneal astigmatism usually ranging from 0.75 to 4.75 D [8]. However, the out-
comes after toric IOL implantation are still influenced by many factors including
accurate preoperative measurement of corneal astigmatism, IOL selection, marking
techniques, intraoperative alignment and postoperative care, etc.
2. A short history and clinical outcomes of toric IOLs
The first article reporting a toric IOL (Nidek NT -98B) was published in 1994
[9], which had a cylinder power of 2.00 or 3.00 D. In the study, Shimizu et al. had
relatively positive results, although some negative results still occurred in some eyes
of which the lens axis rotated more than 30° [9]. Ever since then, with the predict-
ability increasing and the safety enhancing, toric IOLs have definitely become a
considerable option to correct significant astigmatism when undergoing cataract
surgery [10, 11]. At present, standard toric IOLs are available in cylinder powers of
1.0 to 6.0 D, while higher cylinder powers are also available (see Table 1).
Toric IOL had achieved increasingly great visual outcomes. An uncorrected
distance visual acuity (UDVA) of 20/40 or better is achieved in more than 70% of
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the cases, and spectacle independence has been reported in more than 60% of the
patients in previous studies [12, 13, 15–23, 25–30], which is significantly increased
compared with nontoric monofocal IOLs [31, 32]. A randomized controlled trial
(RCT) compared the outcomes of AcrySof toric IOLs with conventional spherical
IOLs and observed a UDVA of 20/40 or better in 92.2% of cases undergoing toric
IOL implantation, with 63.4% having a UDVA of 20/25 or better. In contrast, only
81.4% of cases undergoing nontoric IOL implantation had a UDVA of 20/40 or
































































































































































Summary of commercially available toric IOLs.
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better and 41.4% had a UDVA of 20/25 or better [9]. Similar results were found in
another high-quality RCT [29].
Compared with incisional astigmatic keratotomy, toric IOLs offered better pre-
dictability and stability of correction [17], especially in moderate to high astigma-
tism [30]. In a recent meta-analysis (including 13 RCTs with 707 eyes), toric IOLs
provided better distance visual acuity and lower amounts of residual astigmatism,
combined with greater spectacle independence, than nontoric IOLs even when
relaxing incisions were used [33].
From a social cost-effectiveness perspective, toric IOLs were inferior to
monofocal IOLs in a recent prospective study [34], which should be noted in health-
care decision-making.
3. The measurement of astigmatism
For a toric IOL, the keratometric astigmatism (both axis and magnitude) of the
cornea must be accurately measured.
3.1 Anterior corneal curvature
Traditionally, keratometry and topography take into account only the anterior
corneal curvature [35]. However, nomograms predict total corneal astigmatism
based on the power and axis of the anterior corneal astigmatism, assuming a fixed
ratio between the anterior and posterior curvature [36]. These methods obviously
cannot take outliers and irregularities into account (e.g., post-refractive surgery
eyes) [35], thus leading to significant postoperative and/or overcorrection. However,
if the agreement of measurement of astigmatism between instruments of different
kinds is poor (more than 10°), the selection of toric IOLs requires extra care.
3.2 Posterior corneal curvature
The astigmatism of posterior cornea is generally minus lens of against-the-rule.
As mentioned above, ignoring effects of actual posterior corneal curvature may lead
to inaccuracies in total astigmatism estimation in some eyes. In a recent study [36],
for those eyes who received IOLs with 2 diopters of cylinder or less, a coefficient of
adjustment of 0.75 for with-the-rule astigmatism and 1.41 for against-the-rule
astigmatism can be applied to the corneal astigmatism power value to calculate a
more appropriate IOL cylinder power than that be calculated by using unadjusted
anterior corneal curvature measurements.
Since minimizing the residual refractive error is especially critical in toric
multifocal IOLs [37], imaging systems that measure posterior corneal curvature, as
well as the new algorithm that incorporates the effect of posterior corneal astigma-
tism, are increasingly being invented. For example, the Scheimpflug imaging sys-
tems, slit scanning systems, and OCT systems could measure posterior corneal
curvature, besides the anterior curvature. In a comparative study [35] including a
Scheimpflug tomography (OCULUS Pentacam), a Placido topographer (Tomey
TMS-5 in Placido mode), a swept source/Fourier domain OCT (CASIA SS-1000), an
autokeratometer (Haag-Streit Lenstar), and a hybrid topographer (Tomey TMS-5),
the OCULUS Pentacam has the disadvantage of high measuring noise on posterior
corneal curvature. Meanwhile, the highest precision for planning toric IOL power
and axis was achieved by combining the keratometry and OCT data. In a recent
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eyes) [35], thus leading to significant postoperative and/or overcorrection. However,
if the agreement of measurement of astigmatism between instruments of different
kinds is poor (more than 10°), the selection of toric IOLs requires extra care.
3.2 Posterior corneal curvature
The astigmatism of posterior cornea is generally minus lens of against-the-rule.
As mentioned above, ignoring effects of actual posterior corneal curvature may lead
to inaccuracies in total astigmatism estimation in some eyes. In a recent study [36],
for those eyes who received IOLs with 2 diopters of cylinder or less, a coefficient of
adjustment of 0.75 for with-the-rule astigmatism and 1.41 for against-the-rule
astigmatism can be applied to the corneal astigmatism power value to calculate a
more appropriate IOL cylinder power than that be calculated by using unadjusted
anterior corneal curvature measurements.
Since minimizing the residual refractive error is especially critical in toric
multifocal IOLs [37], imaging systems that measure posterior corneal curvature, as
well as the new algorithm that incorporates the effect of posterior corneal astigma-
tism, are increasingly being invented. For example, the Scheimpflug imaging sys-
tems, slit scanning systems, and OCT systems could measure posterior corneal
curvature, besides the anterior curvature. In a comparative study [35] including a
Scheimpflug tomography (OCULUS Pentacam), a Placido topographer (Tomey
TMS-5 in Placido mode), a swept source/Fourier domain OCT (CASIA SS-1000), an
autokeratometer (Haag-Streit Lenstar), and a hybrid topographer (Tomey TMS-5),
the OCULUS Pentacam has the disadvantage of high measuring noise on posterior
corneal curvature. Meanwhile, the highest precision for planning toric IOL power
and axis was achieved by combining the keratometry and OCT data. In a recent




could provide high repeatable measurements in (both anterior and posterior) cor-
neal power and astigmatism [38].
3.3 Surgically induced astigmatism
Besides naturally occurring astigmatism, the surgically induced astigmatism
(SIA) is also an important factor for the appropriate option of a toric IOL. The SIA
could be influenced by position and length of incisions [39]. Meanwhile, to achieve
minimum residual refractive astigmatism for specific patients, the incisions could
be determined by the magnitude and axis of preoperative keratometric astigmatism
[4]. The application of femtosecond laser-assisted cataract surgery (FLACS) could
minimize SIA.
4. IOL power calculation
An accurate biometry is a precondition not only for toric IOLs but also for
regular IOL power calculation. The axial length may be measured by either ultra-
sonic biometry or optical systems, and SRK/T, Holladay 2, Hoffer Q, and Barrett
formula are recommended to be used to calculate sphere power. Nguyen et al.
adjusted the power of an existing hydrophobic acrylic IOL by a femtosecond laser
[40], which is definitely a promising idea.
There are several toric calculators available for surgical planning that have been
developed to predict postoperative cylinder power, such as Barrett toric calculator
[41], Holladay toric calculator, and Alcon toric calculator(the revised Alcon toric
calculator is a derivation of the Barrett calculator). In general, an ideal IOL power
calculation formula should take into account the posterior corneal curvature, the
effective lens position (ELP), as well as the SIA. And there are a few formulas
available such as Abulafia-Koch linear regression formula [42], Baylor nomogram
(a method from Koch) [43], Barrett formula, Abulafia-Koch formula, etc.
4.1 IOL power calculation considering posterior cornea
A few online toric IOL calculators have been revised to take into account the
contribution of the posterior cornea in IOL power calculation, but it proved itself
valuable. The Baylor nomogram which incorporates the posterior corneal curvature
has been observed to be more precise than traditional Alcon and Holladay toric
calculator without posterior corneal astigmatism compensation [44]. However, the
revised AcrySof toric calculator incorporates the Barrett toric algorithm, which
takes into account both the ELP and the posterior corneal astigmatism, and had
better predictability than the Baylor nomogram as well as Holladay and traditional
Alcon toric calculator [44]. Other toric IOL calculators such as TECNIS calculator
also incorporate posterior corneal astigmatism compensation.
4.2 IOL power calculation considering ELP
Failing to consider the anterior chamber depth and cornea thickness may result
in inaccurate calculations, especially in eyes with extremes of axial lengths [45]. As
mentioned above, the revised AcrySof online toric calculator and iTrace toric plan-
ner takes into account the ELP [14, 46]. The TECNIS calculator incorporates the
anterior chamber depth based on the axial length and keratometry values [46], and
the Holladay formula incorporates the ELP in its calculations.
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4.3 Intraoperative wavefront aberrometry
Intraoperative wavefront aberrometry is increasingly being used to estimate the
toric IOL power and axis of placement based on the aphakic refraction, especially in
post-refractive surgery cases. A recent study reported only a mean error of
0.43  0.33 D with Optiwave Refractive Analysis (ORA; WaveTec Vision Systems
Inc., CA, USA) in post laser-assisted in situ keratomileusis (LASIK) cases undergo-
ing toric IOL implantation, which were more accurate than those obtained by the
standard SRK/T formula and the online ASCRS calculator.
5. Surgery techniques
Many issues, such as accurate marking technique, clear corneal incisions,
intraoperative alignment of the toric IOL, capsulorhexis, and IOL centration, play a
significant role in achieving optimal outcomes.
5.1 Marking techniques
Preoperative reference and axis marking techniques could be broadly catego-
rized as manual methods, image-guided systems, and intraoperative aberrometry-
based methods.
The three-step manual technique is at present most commonly used [47], which
is fairly accurate [48]. The first step is preoperative marking of the reference axis,
which is commonly placed in the horizontal 3’o and 9’o clock positions. The second
step is intraoperative alignment of the reference mark. The marking may be
performed with a skin marking pen or needle. The patient should be sitting erect in
a straight-ahead gaze while marking the reference axis. A change in patient position
from sitting to supine may induce significant cyclotorsion; studies reported up to
28° of cyclotorsion in 68% of cases [49]. The manual marking methods have been
limited by smudging of the dye, irregular, and broad marks.
Image-guided systems and intraoperative aberrometry have advantages com-
pared with manual marking. The image-guided system based on the concept of
landmarks to place the axis marks [50], which could be iris crypts, nevi, brush
fields, etc. The systems capture a preoperative reference image and calculated the
location of these marks and their distance in degrees from the target IOL axis. Then
the system generated a final plan which provides simple angular directions from
each reference mark to the planned axis of IOL placement.
There are a few image-guided systems at present such as CALLISTO Eye and Z
Align (Carl Zeiss Meditec, Jena, Germany), VERION (Alcon, Fort Worth, Texas),
TrueGuide (TrueVision 3D Surgical System, Santa Barbara, Calif), Osher Toric
Alignment System (OTAS, Haag-Streit, Koeniz, Switzerland), and iTrace System
(Tracey Technologies, Houston, Tx). Besides alignment, image-guided systems also
contribute to planning the incisions, capsulorhexis size, and optimal IOL centration.
5.2 Intraoperative toric IOL alignment
Intraoperative IOL positioning is the key procedure to sustain rotation stability.
During IOL alignment, the IOL should be left about 3–5° anticlockwise of the final
desired lens position, followed by complete OVD removal and hydration of the
wounds. Most open-loop IOLs can be rotated only clockwise, and a complete re-
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During IOL alignment, the IOL should be left about 3–5° anticlockwise of the final
desired lens position, followed by complete OVD removal and hydration of the
wounds. Most open-loop IOLs can be rotated only clockwise, and a complete re-




The image-guided systems and intraoperative aberrometry could be definitely
more useful than manual alignment. As mentioned above, the image-guided sys-
tems capture a preoperative reference image and an intraoperative image and then
match the two images with respect to each other using landmarks. During the
operation, a graphic overlay is then superimposed on the surgical field along the
target axis, which provides a guide for toric IOL alignment. The image-guided
systems and intraoperative aberrometry have improved the precision of toric IOL
alignment, with <5° of deviation from the intended axis in the majority of cases.
Compared with manual marking, Elhofi et al. had observed more precise align-
ment with VERION image-guided system [51], which offers comprehensive astig-
matism management, the incision location optimization, toric IOL power
calculation, as well as decreasing SIA.
However, Solomon et al. claimed that, compared with the surgeon’s standard of
care, the use of the VERION combined with intraoperative aberrometry (Optiwave
Refractive Analysis system with VerifEye) did not significantly optimize the out-
comes [52]. The accuracy of CALLISTO Eye is also very effective [53], and it also
assists in planning the position of limbal relaxing incisions.
6. Complications
Postoperative toric IOL misalignment is the major complication after toric IOL
implantation. Toric IOL misalignment could harm visual quality. In a recent exper-
imental study, 5° IOL axis rotation from the intended position determined a decay
in the image quality of 7.03%, 10° of IOL rotation caused 11.09% decay, and 30°
rotation caused 45.85% decay [54].
Toric IOL misalignment may be attributed to three factors: (1) inaccurate preop-
erative prediction of the axis of IOL alignment; (2) inaccurate intraoperative align-
ment; and (3) postoperative IOL rotation. IOL rotation may be observed as early as
1 hour after surgery, and a majority of rotations occur within the initial 10 days [18].
Early IOL rotation likely results from incomplete OVD removal, whereas late post-
operative rotation is influenced by the IOL architecture, design, and axial length. In a
recently published case report, the toric IOL was rotated more than 115° shortly after
a neodymium: YAG (Nd:YAG) laser posterior capsulotomy [55].
Rotational stability of the IOL varies with design and material and strength of
IOL capsular bag adhesions. Maximum rotational stability has been observed with
hydrophobic acrylic lenses, followed by Hydrophobic acrylic, hydrophilic acrylic,
PMMA and silicone. Loop haptic IOLs are better than plate-haptic IOLs on postop-
erative rotation stability when using silicone IOL, but they are similar when using
acrylic IOL. A study of AT TORBI 709 M, which had one-piece hydrophilic acrylic
with hydrophobic surface and a supporting four-haptic design, had rotation of more
than 5° in 10% cases in 6 months [56]. Another study of AT TORBI 709 M reported
13% eyes had rotation of more than 10° [57], while another study reported 100%
rotation of more than 10° [58]. Scialdone et al. found similar results in rotation
stability between AT TORBI 709 M and AcrySof toric IOLs [59]. A long-term of
2-year study of AcrySof toric IOLs (hydrophobic acrylic IOL with Flexible loop
haptic) reported postoperative rotation of more than 10° in 1.68% eyes, more
than 5° in 23.3% eyes [18]. A recent cohort study [60] of 1273 eyes showed that
AcrySof toric IOL was less likely to rotate, with 91.9% of eyes rotated 5° in AcrySof
toric IOL eyes compared with 81.8% in TECNIS Toric IOL eyes (P < 0.0001);
rotation 10° (97.8% Acrysof vs. 93.2% TECNIS, P = 0.0002) and 15° (98.6% Acrysof
vs. 96.4% TECNIS, P = 0.02). Furthermore, a hydrophilic IOL with C-flex design
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(Rayner 600S IOL) was reported to have excellent rotational stability: average
1.83°  1.44° at 6 months and no lens rotated more than 5° [61].
In cases with more than 10° of rotation, realignment of the toric IOL is needed
[62]. In a study by Oshika et al., 6431 eyes are implanted with toric IOLs, and
realignment was performed in 0.653% of cases [63]. An early repositioning
performed after 1 week of primary cataract surgery had optical outcomes.
IOL tilt could also induce astigmatism: tilting toric IOLs aligned at 180° would
decrease with-the-rule astigmatism, bringing in undercorrection, while aligned at
90° increased against-the-rule astigmatism, bringing in overcorrection [64].
Meanwhile, LASIK, customized surface ablation, or femtosecond laser-assisted
intrastromal keratotomies could also be used to correct residual astigmatism [65].
Some toric rotation check, such as https://www.astigmatismfix.com/, could help
determine the amount of IOL rotation, and the expected residual refraction. When
the large residual cylinder not amenable to correction by rotation alone or refractive
surgery, an IOL exchange, piggyback IOLs procedures may be considered.
7. Multifocal toric IOLs
Toric designs are even more required in multifocal IOLs [66] because patients
undergoing multifocal IOLs may not tolerate residual astigmatism of <1 D,
and multifocal IOLs without toric design perform best with less than 0.75 D of
cylinder [67].
In previous studies [68–72], toric multifocal IOLs achieved good visual perfor-
mance, with UDVA better than 20/40 in more than 97% of patients, uncorrected
near visual acuity better than 20/40 in 100% of patients, spectacle independence in
more than 80% of patients, and residual refractive astigmatism lower than 0.50 D in
38–79% of patients. Toric trifocal IOLs such as a trifocal spherical hydrophilic IOL
(FineVision POD F) [73] also showed great performance.
But on the other hand, the selection of multifocal toric IOLs should be more
restricted than monofocal toric IOLs, especially for the following candidates: (1)
patients who had unrealistic expectations of visual quality when having related
ocular comorbidities; (2) patients who may not tolerate dysphoric symptoms such
as glare and halos; and (3) patients who had specific contraindications for
multifocal IOLs, such as abnormal κ or α angle, etc. Thus, a comprehensive ocular
examination should be undertaken to rule out any ocular comorbidities that may
interfere with the postoperative outcomes.
8. Special cases
Normally, cases with irregular astigmatism, corneal ectatic disorders, post-
refractive surgery, post-keratoplasty, and high myopia are not ideal candidates for
toric IOL implantation, partly because they are unlikely to achieve complete refrac-
tive correction with toric IOLs. However, the amount of astigmatism may be partly
reduced, decreasing spectacle dependence. And such cases may be considered for
surgery after adequate counseling. As a consequence, the applications of toric IOLs
are expanding to include special cases such as pellucid marginal degeneration
[74, 75], mild keratoconus with cataract [76], astigmatism after keratoplasty
[77–80], and high astigmatism [81]; even toric trifocal IOLs were used in high
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The outcomes after toric IOL implantation are influenced by a few factors:
accurate astigmatism measurement, marking techniques, intraoperative alignment,
and postoperative care. The importance of posterior corneal curvature is increas-
ingly being recognized, and advanced toric calculators and fumulars that account
for both the anterior and posterior corneal power are becoming the standard of care.
The image-guided systems and intraoperative aberrometry could provide a
markless IOL alignment and optimize incisions, capsulorhexis size, and optimal IOL
centration. New toric IOLs with superior design are still being looked forward
although they have already achieved great performance.
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Pseudophakic dysphotopsia is an unwanted entoptic phenomenon caused by 
intraocular lenses. Dysphotopsias have been classified as positive (brightness, 
streaks, haze, or glare) and negative (temporal arc or half-moon crescent) in the 
visual field. These visual phenomena seem to be well tolerated cause in the case 
of positive dysphotopsia, but not as well in the negative cases that sometimes 
discomfort to the patient. The incidence of dysphotopsia ranges from 20% to 
77.7%, and the prevalence seems not to be altered by the type of intraocular 
lens. Pseudophakic dysphotopsia continues to be enigmatic over time; however, 
many efforts are being made in order to resolve the mystery. In this chapter, the 
evolution of the dysphotopsia, possible causes, and proposed treatments will be 
described.
Keywords: pseudophakic dysphotopsia, negative dysphotopsia,  
positive dysphotopsia, dysphotopsia, half-moon crescent
1. Introduction
Cataract surgery has been one of the great ophthalmological contributions to the 
worldwide prevention and treatment of blindness.
The first cataract surgery was performed by an Indian surgeon, Sushruta, in the 
fifth century BC. [1–3]. Over time, improvements in cataract surgery led to many 
advances, such as the replacement of the opaque crystalline lens with an intraocular 
lens (IOL). The first IOL implant was performed by Sir Harold Ridley on November 
29, 1949, at St. Thomas Hospital, London [4, 5]. Thanks to the contributions of 
many scientists and surgeons, techniques improved as well as IOL design. However, 
with the use of new technologies, complications or unwanted side effects may also 
arise. Dysphotopsia secondary to IOL [6, 7], is the reason for this chapter.
2. Pseudophakic dysphotopsia
Dysphotopsias are visual phenomena caused by light in phakic and pseudo-
phakic patients. The term was introduced by Tester et al. [6] in the year 2000, and 
included all entoptic phenomena triggered by light (glare, halos, and dark arc). 
These phenomena frequently bother the patient, producing a certain degree of 
dissatisfaction, even in circumstances where there is good visual acuity (20/20 or 
better).
Dysphotopsia in phakic patients may improve with correction of the refrac-
tive error [8], special lenses [9], sunglasses [10], lenses with filters [11] and 
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1. Introduction
Cataract surgery has been one of the great ophthalmological contributions to the 
worldwide prevention and treatment of blindness.
The first cataract surgery was performed by an Indian surgeon, Sushruta, in the 
fifth century BC. [1–3]. Over time, improvements in cataract surgery led to many 
advances, such as the replacement of the opaque crystalline lens with an intraocular 
lens (IOL). The first IOL implant was performed by Sir Harold Ridley on November 
29, 1949, at St. Thomas Hospital, London [4, 5]. Thanks to the contributions of 
many scientists and surgeons, techniques improved as well as IOL design. However, 
with the use of new technologies, complications or unwanted side effects may also 
arise. Dysphotopsia secondary to IOL [6, 7], is the reason for this chapter.
2. Pseudophakic dysphotopsia
Dysphotopsias are visual phenomena caused by light in phakic and pseudo-
phakic patients. The term was introduced by Tester et al. [6] in the year 2000, and 
included all entoptic phenomena triggered by light (glare, halos, and dark arc). 
These phenomena frequently bother the patient, producing a certain degree of 
dissatisfaction, even in circumstances where there is good visual acuity (20/20 or 
better).
Dysphotopsia in phakic patients may improve with correction of the refrac-
tive error [8], special lenses [9], sunglasses [10], lenses with filters [11] and 
other techniques. In patients with significant cataracts, surgery is the option [6]. 
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Before the advent of IOLs, aphakic patients (without IOL) who were placed in 
contact lenses reported glare phenomena [11]. The first report was by Koetting 
and Von Gunten in 1969 [12]. Subsequently, with the emergence of IOLs, patients 
with pseudophakia began to experience visual phenomena more emphatically 
than they did before surgery [13]. However, the benefit of improvement in visual 
acuity generally compensated for problems with dysphotopsia. A number of cli-
nicians and researchers have tried to determine the causes of dysphotopsia [13].
Initial reports considered causes including the pupil, the intraocular lens, and 
the posterior capsule. This is reflected in one of the initial publications by Doden in 
1984 [14]. This author studied the pupillary changes observed in 2500 eyes oper-
ated on cataract by extra capsular technique and phacoemulsification. He associ-
ated glare with the optical irregularity caused by the pseudophakia “per-se” or the 
opacities affecting the posterior capsule. Subsequently, sophisticated techniques 
were employed, refining the studies and reducing the number of causative factors 
to IOL as well as opacity of the posterior capsule [1, 12, 13, 15].
Between 1994 and 1995, the 6 mm and 5.5 mm acrylic IOL were introduced, 
which allowed patients to have calm eyes in the postoperative period, that is, 
with less chance of developing anterior uveitis and cystoid macular edema. They 
also found that these lenses caused less fibrosis and opacities of the posterior 
capsule, with lower capsular contraction, reduction of optical precipitates, and 
good optical centering [16]. Based on this, it was postulated that the square edge 
of the intraocular lens was the primary reason for the above findings [15, 17, 
18]. In the laboratory, Nishi [15] confirmed that the edge of the IOL acted as a 
barrier to cell migration within the posterior capsule independent of the mate-
rial. Unfortunately, the edge also caused a new undesirable visual phenomenon 
resulting from internal reflection due to the angle of incidence of oblique light. 
This was often referred to by the patient as a dark shadow in a half moon shape 
or an arc in the temporal field. The effect was more annoying than previously 
reported, proving even difficult to predict which patient could develop this 
symptomatology [15, 17, 19, 20].
Pseudophakic dysphotopsia was presented for the first time by Olson, MD, at 
the XVIth Congress of the European Society of Cataract & Refractive Surgeons, in 
Nice, France, on September 1998 [7]. Initially, it was thought that this visual phe-
nomenon was transitory. Overtime the visual effect persisted as a souce of visual 
compliants, resulting in a number of procedures to attempt to reduce or solve the 
problem. In 2000, Davidson [7] divided these dysphotopsia phenomena according 
to the symptoms into positive and negative.
3. Dysphotopsia classification
3.1 Positive dysphotopsia
Positive dysphotopsia refers to the brilliant, lines or = stripes that emanate from 
a central point of a light source sometimes creating diffusion and strong glare, 
described by the author as “hazy glare.”
Few reports exist regarding positive dysphotopsia. Shambhu et al. [11] used 
a questionnaire to compare three different types of acrylic IOLs. In this study, 
15 patients with severe dysphotopsia (negative and positive) were reported, but 
apparently, positive dysphotopsia (particularly the glare phenomena) was not 
severe enough to require the change of IOL. In a study conducted by Radford et al. 




found that dysphotopsia declined by 8 weeks in 31.3% for positive dysphotopsia and 
20.7% for negative ones.
Recently, publications showed in vitro evaluations that IOL designs with round 
optic edge curvature and full functional optics demonstrated the lowest level of 
glare-type photic phenomena. Clinical studies are necessary to demonstrate this 
observation [22].
My personal opinion is that positive dysphotopsia is caused by the wavelength of 
light as it interacts with the pseudophakic lens. Intraocular lens still permits sig-
nificant transmission between 350 and 400 nm. Most intraocular lenses provide a 
reasonable imitation of the spectral characteristics of the natural lens, but probably, 
the exact balance to the natural lens has not been achieved [23, 24].
In relation to the type of dysphotopsia, it seems that positive dysphotopsias are 
better tolerated than negative ones; the reason is for this unknown. That’s why conser-
vative treatment or observation is generally recommended. However, some authors 
recommend correcting the refractive error with conventional or contact lenses, while 
also treating coexisting ocular pathology such as the opacity of the posterior capsule 
requiring it, and intraocular lens decentralization or large pupil size [25].
Chandramani A et al. relate positive dysphotopsia with the square edge of 
IOL. The authors reported that a patient with previous refractive surgery and 
persistent positive dysphotopsia after the insertion of a square-edge IOL responded 
well when they inserted a zero-power 3-piece silicone IOL in the sulcus, in order to 
maintain the refractive efficacy of the original IOL. It was thought that the symp-
toms decreased because the rounded edge of the silicone optic masked the aberrant 
reflections and refractions of the square edge of the acrylic IOL [25].
3.2 Negative dysphotopsia
Negative dysphotopsia is characterized by an arc-shaped shadow, usually located 
in the temporal field. Visible with or without frame lenses, the problem can be mon-
ocular or binocular and may affect near and far vision as well as occur in internal or 
external environments (lighting or gloom), mobile or not. Negative dysphotopsia 
generally appears 1-2 days postoperatively. Over time, some of them disappear and 
in others remain.
Various approaches to negative dysphotopsia were made in search for possible 
solutions [7, 13, 19, 20, 26–33] as reflected below:
1. Related to the intraocular lens:
• Anterior and posterior lens surface
 ○ Reflections associated with the anterior and posterior surface of the lens 
due to the high refractive index of the lens material
 ○ Reflections generated by the high index of the bright optical edge 
material
• Intraocular lens edge
 ○ Straight or round
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found that dysphotopsia declined by 8 weeks in 31.3% for positive dysphotopsia and 
20.7% for negative ones.
Recently, publications showed in vitro evaluations that IOL designs with round 
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also treating coexisting ocular pathology such as the opacity of the posterior capsule 
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IOL. The authors reported that a patient with previous refractive surgery and 
persistent positive dysphotopsia after the insertion of a square-edge IOL responded 
well when they inserted a zero-power 3-piece silicone IOL in the sulcus, in order to 
maintain the refractive efficacy of the original IOL. It was thought that the symp-
toms decreased because the rounded edge of the silicone optic masked the aberrant 
reflections and refractions of the square edge of the acrylic IOL [25].
3.2 Negative dysphotopsia
Negative dysphotopsia is characterized by an arc-shaped shadow, usually located 
in the temporal field. Visible with or without frame lenses, the problem can be mon-
ocular or binocular and may affect near and far vision as well as occur in internal or 
external environments (lighting or gloom), mobile or not. Negative dysphotopsia 
generally appears 1-2 days postoperatively. Over time, some of them disappear and 
in others remain.
Various approaches to negative dysphotopsia were made in search for possible 
solutions [7, 13, 19, 20, 26–33] as reflected below:
1. Related to the intraocular lens:
• Anterior and posterior lens surface
 ○ Reflections associated with the anterior and posterior surface of the lens 
due to the high refractive index of the lens material
 ○ Reflections generated by the high index of the bright optical edge 
material
• Intraocular lens edge
 ○ Straight or round





• Number of lens parts
 ○ One to three pieces
2. Manufacturing:
• Optical defect during the manufacturing process
• Central optical defect during the folding process
3. Surgeon:
• Incomplete capsulorhexis with optical overlap
• Reflection of the capsulotomy of the anterior border projected into the 
nasal peripheral retina
• Temporal clear corneal incision
4. Patient: visual system or psychological factors:





• Post negative image phenomenon
• Neural adaptation
A program with a three-dimensional model eye was used to study the edges 
(straight or truncated and/or round) of IOL, through an analysis of ray tracing 
emanating from the light. The rays that reach the straight edge cause reflection 
of the light at an angle greater than 30 to 40–90° or more, maximizing the inten-
sity of the reflexes, since they reach very close to each other and reflect on the 
opposite side of the peripheral retina as a dark shadow described by the patients 
as an arch or crescent (negative dysphotopsia). At the round edges, the rays cause 
significant dispersion and are reflected before 30°, not causing this temporary 
penumbra [7, 19, 20, 33].
It was shown that the round edge decreased the image in the form of an arc 
(negative dysphotopsia) by 87–91% in relation to the square edge [19]. Additional 
evidence of absence of positive dysphotopsia phenomena (light flashes) but not 
negative when the edges were compared with opaque lens was also found. Lenses 
with textured or opaque edges as a replacement or as a primary lens in the second eye 
suppose a decrease in the occurrence of positive and negative dysphotopsias. This 
type of design (textured or opaque border) creates the same type of light scattering 




light from the straight edge by scattering, but still allows the presence of positive 
dysphotopsia and does not make the negative ones disappear [16, 30, 34].
The opaque edges of the AcrySof SA30 IOL were compared with the bright edges 
in the AcrySof MA30 BA (Alcon) and AcrySof MA60BM (Alcon) intraocular lens 
models [7], but the negative dysphotopsia did not disappear.
The diameter of the IOL does not significantly reduce the occurrence of dyspho-
topsia as Davidson reported when two types of lens diameters of 5.5 and 3.60 mm 
were compared; the occurrence of negative dysphotopsia was similar (80%) in both 
groups [7].
In relation with the lens material, Tester et al. compared two types of acrylic 
intraocular lenses of different diameters (5.5 and 6 mm) with a control group (no 
acrylic IOL); the authors found that acrylic lenses produce more dysphotopsia than 
nonacrylic IOL. The authors concluded that patients who received an acrylic IOL 
with flattened edges were at increased risk of experiencing images associated with 
edge reflections [6]. Holladay et al. found that only the square-edged design con-
centrated the light into a well-formed arc on the retina. Round-edge designs tended 
to disperse the stray light over a much larger portion of the retina, suggesting that 
its visual consequences fall below a perceptible threshold [13, 19].
Radford et al. compared two types of acrylic IOL (AcrySof SN60-AT IOL 
(Alcon) and the Akreos Adapt (Bausch & Lomb) IOL. The results of this study 
showed that patients with SN60-AT IOL reported more undesired images than 
patients with the Akreos Adapt IOL. It was more significant during the first week 
postsurgery, but at 8 weeks, the incidence of this negative dysphotopsia decreased 
in 20.7%; the cause of this phenomenon was not clarified by the authors [21].
The anterior surface of the AcrySof MA30 BA and AcrySof MA60 BA lenses 
with a 5.5 D curve was studied; the remaining power was found on the posterior 
surface. Because these surfaces are highly reflective, it could make lenticular 
reflections complex enough to cause negative dysphotopsia. The optical inversion or 
reversion of the anterior-posterior diopter surface (posterior surface flatter than the 
previous one) as observed in the AcrySof MA30 AA and AcrySof SA30 AL lenses 
did not solve the problem [7].
The incision in the temporal area of clear cornea has been implicated by Osher 
[35] as a cause of transient negative dysphotopsia due to a broad clear base and 
incisional edema in the cornea that interferes with the oblique light projected into 
the distant peripheral field; however, it does not explain permanent dysphotopsia. 
Nasal, upper, and lower incisions and scleral tunnel showed no difference between 
the presence of transient and permanent negative dysphotopsia [36].
One-piece lenses in a posterior chamber with horizontally placed haptics make 
the edge of the lens more peripheral when the “shoulder” of the haptic is inserted 
into the optics; this would imply that the “shadow” would move more previously, 
reflecting with less amplitude, but this proposal would have to be supported by the 
ray tracing program [29, 37, 38].
A manufacturing defect should be evident in other intraocular lenses of the 
same batch used in patients, but this did not occur [7].
The central optics could be altered by folding; when folding forceps are used, an 
irregular line is formed temporarily, since it disappears after the operation. However, 
if it persists permanently, it can create defects, but they do not specifically produce 
negative dysphotopsia. Nowadays, with the injectors used for lens folding, no altera-
tions have been demonstrated, even when they have been studied due to intraocular 
lens change [7]. Incomplete capsulorhexis with its superimposition variable is quite 
common; this would not explain a temporary defect of the visual field [29, 34].
Individual predisposition with a certain constellation of factors in relation to 
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into the optics; this would imply that the “shadow” would move more previously, 
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irregular line is formed temporarily, since it disappears after the operation. However, 
if it persists permanently, it can create defects, but they do not specifically produce 
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lens change [7]. Incomplete capsulorhexis with its superimposition variable is quite 
common; this would not explain a temporary defect of the visual field [29, 34].
Individual predisposition with a certain constellation of factors in relation to 
ocular anatomy, including corneal curvature, new pseudophakic state, anterior 
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chamber depth, axial length, and intraocular lens power, can be particularly 
vulnerable, also be sensitive to aberration, and produce dysphotopsia. This peculiar 
interaction seems to vary from patient to patient [16, 33, 38].
Of all these studies, the design of the intraocular lens, specifically the edge, 
proved to be the source of negative pseudophakic dysphotopsia. The explanation 
of this enigmatic phenomenon has not been elucidated despite so many investiga-
tions [7, 34, 38].
In 2014, the author reported that the negative dysphotopsia was caused by 
a stimulation of the unpaired temporary crescent or “half moon” because the 
incidence of rays on the edge of the intraocular lenses refracts on the peripheral 
nasal retina outside 30° (location area of the temporary flood). The fact that some 
patients have it at 30° and others between 60 and 90° would explain why some 
patients may present them and others not, as well as unilateral or bilateral [39].
The disappearance or transientness of the negative dysphotopsia was explained 
by the opacification or translucency of the nasal sector of the capsule, later acting as a 
diffuser of the rays, in the first week or months following the surgery. The opacity of 
the posterior capsule causes diffusion of light and reduces contrast and retinal sensitiv-
ity. The anterior axial movement of the intraocular lens by contraction of the capsular 
bag maybe is another explanation that decreases the occurrence over time, since it 
reduces the axial space under the iris to 0.06 mm or less, causing a myopic change that 
is extremely rare. However, this has not made dysphotopsia disappear [38].
In relation to a persistent visual phenomenon, possible therapeutics arise such as 
the use of miotics [6, 21, 23, 29] but, contrary to expectations, it increases the prob-
lem and the pharmacological dilation seems to reduce it [34], anterior and posterior 
capsulotomies [6, 24, 34, 39, 40], smaller capsulorhexis [6, 31, 37], modifications 
of the intraocular lens [11, 30, 32, 34], change of intraocular lens [6, 13, 37, 40] do 
not solve the problem. The placement of another intraocular lens on the primary 
or “piggy bag” [29, 38] and reverse optical capture of the lens [34, 38] had partial 
or complete resolution of symptoms. The suture of the IOL-capsule complex iris 
bag [38] can decrease the visual phenomenon. The author used prism in the eye of 
dysphotopsia causing a displacement of the temporal crescent outside the visual 
field, with the disappearance of symptoms [39].
Henderson et al. [40] reported a 2.3-fold decrease in negative dysphotopsia 
symptoms early after cataract surgery when the nasal optic–haptic junction was 
oriented slightly super nasally (30° from horizontal) when compared with the 
haptic junction being oriented vertically. Henderson hypothesized that when the 
haptic junction was placed vertically, it exposed the nasal optic edge to reflections 
from temporal light. By placing the haptic junction relatively horizontal, the junc-
tion would then “block the light,” and the intraocular lens edge reflections and the 
resultant temporal negative dysphotopsia shadow would be avoided.
Erie et al. [41] with a ray-tracing software demonstrated how the horizontal 
haptic junction minimizes negative dysphotopsia.
The incidence of dysphotopsia phenomena in pseudophakic patients after 
uncomplicated cataract surgery varies, ranging from 20 to 77.7%, since there are 
only isolated reports as can be seen in the literature [6, 11, 30, 39, 42–49]; however, 
the prevalence does not seem to be altered with the type of intraocular lens [28].
4. Conclusions
Pseudophakic dysphotopsia is an entoptic phenomenon induced by intraocular 
lenses that cause discomfort to patients. Positive dysphotopsia manifested as 




incorporation of intraocular lenses with square edges is a source of dissatisfaction 
in pseudophakia patients despite good visual acuity. After evaluating the different 
factors that could be responsible for it from the intraocular lens, manufacturing, 
surgical technique, surgeon, and patient, it was concluded that the square edge of the 
intraocular lens is responsible for the undesirable phenomenon. Multiple therapeu-
tics have been proposed in order to solve the problem such as the use of miotic drops, 
piggy back, intraocular lens replacement textured or freezing lenses, etc. without 
finding the appropriate therapy. Additional studies with software or intraocular lens 
design program on schematic eye will be necessary to solve the problem.
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Pathologic Myopia: Complications 
and Visual Rehabilitation
Enzo Maria Vingolo, Giuseppe Napolitano  
and Lorenzo Casillo
Abstract
High myopia, defined as refractive error of at least −6.00D or an axial length of 
26.5 mm or more, can induce many modifications in eye’s anatomy that can lead to 
complications. When high myopia is able to decrease best corrected visual acuity 
(BCVA) due to its complications, it is called pathologic myopia. Pathologic myopia is 
one of the major causes of blindness, and it represents a serious issue, since incidence 
of myopia and high myopia is constantly rising. For educational purposes, in this 
chapter, complications of pathologic myopia will be divided into anterior (when struc-
tures external to the globe or anterior to the ora serrata are involved, such as motility 
disturbances and cataract) and posterior (when structures posterior to the ora serrata 
are involved, such as lacquer cracks, chorioretinal atrophy, Fuchs maculopathy, myopic 
choroidal neovascularization, and retinal detachment). Many treatments are avail-
able for pathologic myopia complications depending on their type, such as vascular 
endothelial growth factor (anti-VEGF) injections and surgery. We will focus on visual 
rehabilitation interventions, such as visual biofeedback and visual aids that in many 
cases are the only chance that the ophthalmologist has in order to help patients suffer-
ing from pathologic myopia to use at their maximum their residual vision.
Keywords: visual rehabilitation, low-vision aids, microperimetry, high myopia,  
pathologic myopia complications
1. Introduction
Many modifications in normal eye anatomy and structure occur in high myopic 
patients. Sclera is the most external layer of the eye. In normal nonelongated eyes, 
scleral thickness decreases from the limbus to the equator, then increasing again to the 
posterior part of the eye. Normal sclera has also well-known tensile and elastic proper-
ties. In highly myopic eyes, these properties are altered with tensile strength reduced 
and augmented elasticity especially at the posterior pole of the globe. The reason can be 
searched in the alteration of its ultrastructure (which is more layered and lamellar com-
pared to the normal sclera), in thinning and decreased diameter of the collagen fibers, 
and also in configuration and conformation of the collagen fibrils. In highly myopic 
eyes, also a remodeling of the extracellular matrix is observed during the extension of 
the eyeball, even if its mechanisms are not fully understood. These modifications lead 
to the fact that in highly myopic eyes, sclera is thinner in the part that goes posterior 
to the equator, while the anterior part does not show any significative difference with 
normal eyes. This kind of modification can contribute to the development of many 
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complications that will be discussed in this chapter. Corneal modifications in high 
myopic patients are still under debate; some studies reported modifications in corneal 
biomechanical properties in high myopic patients, such as lower hysteresis. According 
to some studies [1], highly myopic patients had flatter curvature, modifications in 
corneal thickness, and decreased endothelial density, while other studies did not report 
any statistical difference in central corneal thickness (CCT) in various ranges of myopia 
[2]. Choroid’s thickness is significantly reduced in highly elongated eyes; its thickness in 
foveal and parafoveal portions showed to be inversely proportional to parameters such 
as patient’s age, myopic sferic equivalent, and axial length of the globe, with this last 
parameter showing to be the most consistently related. Also, distribution of choroidal 
thickness is altered in these eyes, with temporal and superior regions far from the fovea 
that show to be thicker than foveal region. Another strong predictor for choroidal 
thinning in high myopic patients is the presence of a posterior scleral staphyloma [3]. 
Furthermore, this thinning in choroidal tissue has a negative impact on retinal tro-
phism. With regard to choroidal flow in highly myopic eyes, studies are controversial; 
for some of them, blood flow in choriocapillaris is augmented, while for others not. It is 
possible to find differences between high myopic patients and emmetropic ones even in 
retinal blood flow. Density of the superficial and deep plexus is significatively reduced 
in high myopic subjects, and the magnitude of this phenomenon is negatively related 
to axial length and myopic refraction. It is possible to postulate that increasing of the 
axial length on this eyes can lead to mechanical stretching of ocular structures, leading 
to damage to retinal pigmented epithelium (RPE), retinal microvascular network, and 
endothelial cells. Furthermore, in highly myopic eyes, excessive elongation of the globe 
and tilting of the optic disc can lead to posterior staphylomas formation and the tilting 
of the optic disc could lead to alterations in macular and foveal morphology, leading to a 
change in foveal position that can be found moved mainly in the vertical direction. High 
axial length is associated with many morphologic changes in the optic nerve and peri-
papillary region. The axial elongation is associated with the enlargement of the optic 
nerve head and of the peripapillary scleral tissue. The scleral flange is strongly adherent 
to the lamina cribrosa and axial-elongation-induced scleral enlargement during eye 
movements. This condition may lead to thinning of the lamina cribrosa, and it may 
also be associated with the formation of peripapillary choroidal cavitation. Thinning 
of lamina cribrosa leads to an alteration between intraocular pressure (optic nerve 
tissue pressure and cerebrospinal fluid pressure) with a steepening of the translamina 
cribrosa pressure gradient; this may play a role in the development of the glaucomatous 
optic neuropathy.
2. Anterior complications in pathologic myopia
2.1 Cataract and pathologic myopia
Three main studies have investigated the connection between cataract forma-
tion and high myopia: the Blue Mountains Eye Study and the Beaver Dam study. In 
the first one, researchers found that there may be a strong connection between the 
development of posterior polar cataract and myopia that appeared before 20 years. 
Furthermore, they found a correlation between the level of myopia and posterior 
subcapsular cataract. High myopia, however, was linked to the formation of all the 
three types of cataract known [4]. In the Beaver Dam study, researchers confirmed the 
connection highlighted in other studies between myopia and nuclear cataract [5].  
Unlikely, the connection between myopia and age-related cataract is not fully con-
firmed, while the incidence of PSC and nuclear cataract in myopic eyes appears well 
established. Also, the distribution of the type of cataract in relation to the axial length 
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of the eye has been investigated; some studies found no connection, while others 
found a significative direct correlation between AL and the severity of the lens opacity 
[6]. Eventually, the mechanism that underlies this condition is not fully understood.
2.2 Motility and globe position alterations in high and pathologic myopic patients
High myopia is one of the clinical entities that cause a unilateral proptosis [7], 
leading to poor cosmesis, motility alterations, and pain. Furthermore, chronic 
exposition of anterior surface may cause exposition keratopathy. The mechanics of 
the relationship between axial elongation and myopic proptosis is complex; in its 
elongation process, the eyeball tends to expand backward and proptosis forward [8].
There is also evidence of a linear correlation between sferic equivalent and 
proptosis grade. It has been observed that in patients that suffer from strabismus 
related to high myopia, there is a displacement of the globe from the muscle cone in 
the space that forms between superior and lateral rectus muscles [9]. Lateral rectus 
is also inferiorly displaced.
Alterations in motility alterations can also be observed in high myopic eyes; the 
range of these alterations goes from small angle esotropia with mild reduction of abduc-
tion to strabismus fixus. Exotropia and hypotropia can also be seen in these patients. 
Exodeviations due to a lesser accommodative work are relatively common in myopes.
Strabismus fixus is the latest stage of the abovementioned spectrum; the eye 
appears fixed in esotropic and hypotropic position; even passive movements 
in other positions of gaze are impossible. Many theories for that phenomenon 
have been proposed; one of them is that the displacement of the eyeball already 
described causes a compression of lateral rectus muscle against the orbital wall. 
According to other authors, not only lateral rectus muscle can experience this 
compression, but also superior and medial rectus.
To prove this hypothesis, many MRI studies of the orbit have been performed; 
some found a displacement of the abovementioned muscles, while others demon-
strated a superotemporal prolapse of the elongated posterior portion of the globe, 
which displaces lateral and superior rectus [10]. High myopic patients with time can 
also develop diplopia, which is due to esotropia, and hypotropia that is accompanied 
by limitation of abduction and elevation [11].
Patients that suffer from alterations in motility and position of the globe often 
have an axial length that is more than 30 mm.
3. Posterior complications in pathologic myopia
3.1 Lacquer cracks
Lacquer cracks are linear breaks of the Bruch’s membrane-choriocapillaris 
complex, which can be found in 4% of subjects with high myopia [12]. The main 
pathogenetic mechanism is the mechanical stretching of the chorioretinal struc-
tures due to scleral elongation [12]. However, according to other studies, their 
formation could be associated with near vessels perforating the sclera causing the 
expansion of surrounding scleral tissue [13].
The first clinical presentation usually consists in subretinal hemorrhage, which 
is a potential sight-threatening condition. Fluoro angiography and indocyanine 
angiography are important for differential diagnosis with myopic choroidal neovas-
cularization. At the fundus examination, lacquer cracks appear as yellowish-white 
linear lesions, rarely starry or mixed shapes. Usually, they are located at the poste-
rior pole, and their peripheral formation is unusual [14].
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complications that will be discussed in this chapter. Corneal modifications in high 
myopic patients are still under debate; some studies reported modifications in corneal 
biomechanical properties in high myopic patients, such as lower hysteresis. According 
to some studies [1], highly myopic patients had flatter curvature, modifications in 
corneal thickness, and decreased endothelial density, while other studies did not report 
any statistical difference in central corneal thickness (CCT) in various ranges of myopia 
[2]. Choroid’s thickness is significantly reduced in highly elongated eyes; its thickness in 
foveal and parafoveal portions showed to be inversely proportional to parameters such 
as patient’s age, myopic sferic equivalent, and axial length of the globe, with this last 
parameter showing to be the most consistently related. Also, distribution of choroidal 
thickness is altered in these eyes, with temporal and superior regions far from the fovea 
that show to be thicker than foveal region. Another strong predictor for choroidal 
thinning in high myopic patients is the presence of a posterior scleral staphyloma [3]. 
Furthermore, this thinning in choroidal tissue has a negative impact on retinal tro-
phism. With regard to choroidal flow in highly myopic eyes, studies are controversial; 
for some of them, blood flow in choriocapillaris is augmented, while for others not. It is 
possible to find differences between high myopic patients and emmetropic ones even in 
retinal blood flow. Density of the superficial and deep plexus is significatively reduced 
in high myopic subjects, and the magnitude of this phenomenon is negatively related 
to axial length and myopic refraction. It is possible to postulate that increasing of the 
axial length on this eyes can lead to mechanical stretching of ocular structures, leading 
to damage to retinal pigmented epithelium (RPE), retinal microvascular network, and 
endothelial cells. Furthermore, in highly myopic eyes, excessive elongation of the globe 
and tilting of the optic disc can lead to posterior staphylomas formation and the tilting 
of the optic disc could lead to alterations in macular and foveal morphology, leading to a 
change in foveal position that can be found moved mainly in the vertical direction. High 
axial length is associated with many morphologic changes in the optic nerve and peri-
papillary region. The axial elongation is associated with the enlargement of the optic 
nerve head and of the peripapillary scleral tissue. The scleral flange is strongly adherent 
to the lamina cribrosa and axial-elongation-induced scleral enlargement during eye 
movements. This condition may lead to thinning of the lamina cribrosa, and it may 
also be associated with the formation of peripapillary choroidal cavitation. Thinning 
of lamina cribrosa leads to an alteration between intraocular pressure (optic nerve 
tissue pressure and cerebrospinal fluid pressure) with a steepening of the translamina 
cribrosa pressure gradient; this may play a role in the development of the glaucomatous 
optic neuropathy.
2. Anterior complications in pathologic myopia
2.1 Cataract and pathologic myopia
Three main studies have investigated the connection between cataract forma-
tion and high myopia: the Blue Mountains Eye Study and the Beaver Dam study. In 
the first one, researchers found that there may be a strong connection between the 
development of posterior polar cataract and myopia that appeared before 20 years. 
Furthermore, they found a correlation between the level of myopia and posterior 
subcapsular cataract. High myopia, however, was linked to the formation of all the 
three types of cataract known [4]. In the Beaver Dam study, researchers confirmed the 
connection highlighted in other studies between myopia and nuclear cataract [5].  
Unlikely, the connection between myopia and age-related cataract is not fully con-
firmed, while the incidence of PSC and nuclear cataract in myopic eyes appears well 
established. Also, the distribution of the type of cataract in relation to the axial length 
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formation could be associated with near vessels perforating the sclera causing the 
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An OCT scan overlying an area of chorioretinal atrophy: a myopic CNV is also present.
In autofluorescence exam, they appear ipoautofluorescent. Spectral domain optical 
coherence tomography (SD-OCT) allows studying RPE and Bruch’s membrane breaks; 
“en face” OCT angiography shows avascular bands in choriocapillaris segmentation [12].
Break of Bruch’s-choriocapillaris complex leads to near RPE atrophy and fibrotic 
degeneration. Thus, fluoro angiography shows window-effect hyperfluorescence 
with no leakage; staining can appear during late phases, especially in fibrotic-evo-
luted breaks. In those cases, indocyanine angiography shows linear ipocyanescent 
lesions, which extension results longer than the one appreciable in fluoro angiogra-
phy exam. Therefore, indocyanine angiography results in a most accurate examina-
tion in lacquer crack detection. Breaks on Bruch’s-choriocapillaris complex lead to 
RPE damage and subsequent retina-epithelial “patchy atrophies” and, in 30% of 
cases, choroidal neovascularization (CNV) [19].
3.2 Chorioretinal atrophy (tessellation, patchy, diffuse)
Choroid thinning and subsequent retinal involvement are typical findings in patho-
logic myopia. Retinal remodellation seems to be associated with choroidal hypoperfu-
sion due to vascular axial stretching. There are three main atrophy morphologies.
Tessellated fundus is the most common. It consists in multiple linear choroid-RPE 
thinning, making fundus appear as tiger streaked. Tessellated fundus is a very early 
manifestation of myopic retinal changes, and it can evolve in other more severe lesions. 
In fact, it is associated to lacquer crack formation and myopic chorioretinal atrophies.
Patchy atrophy appears as a gray-white lesion with well-defined edges; they 
can be found on staphyloma edges, near lacquer cracks, or as CNV evolution [15]. 
Coalescent patchy atrophies can lead to diffuse atrophy; furthermore, they have 
been described as very important risk factor in CNV formation (20%).
Diffuse atrophy, instead, is a large yellowish-white lesion with no well-defined 
edges. Usually, it is located in peripapillary zone and its correlation with CNV 
formation is rare (3.7%). RPE atrophy, patchy ore diffuse, leads to photoreceptor 
atrophy and their loss of function. Thus, macular or foveal atrophy is responsible of 
important and irreversible central vision loss. Fluorescein and indocyanine angi-
ographies show hyperfluorescence and hypercyanescence due to window effect. In 
autofluorescence, atrophy is hypoautofluorescent with mild hyperautofluorescent 
edges, especially in patchy atrophy.
SD-OCT allows the operator to study the retinal structures involved, measuring 
progression of lesions over time (Figure 1).
The process that can lead to complications due to myopic chorioretinal atrophies 
is resumed in Figure 2.
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3.3 Fuchs’ spots
Fuchs’ spots are patch-like whitish retinal lesions characterized by a dark 
pigmented central formation. They are the result of previous myopic CNV and 
their atrophic evolution with subretinal and intraretinal pigment dispersion. As 
for patchy atrophies, multiple Fuchs’ spots can coalesce forming macular atrophy. 
Presence of Fuchs’ spots in a myopic eye is very important to understand the history 
of the pathology and its future prognosis [16].
3.4 Myopic CNV
Myopic CNV (mCNV) is found in 5–10% of high myopic eyes. Over time, many 
environmental and genetic risk factors have been detected. Among the main ones, 
lacquer cracks (29%), patchy atrophy (20%), female gender, and genetic pro-
inflammatory protein expression are important to remember. However, the most 
important one is history of myopic CNV in the other eye (34%). Very often, mCNVs 
grow between RPE and neuroepithelium (CNV type 2 or “classic CNV”) [17] in 
the macular region and precisely: 58% foveal and 23% juxtafoveal. Only 19% of 
mCNVs have extramacular location on the edges of a peripapillary diffuse atrophy 
(periconus-CNV).
The pathogenesis of mCNVs is still controversial. Their subretinal growth 
associated to underlying RPE atrophy (75–94% of mCNVs occur on lacquer cracks), 
together with strong association of choroidal thinning, suggests that an angiogenic 
stimulus due to choroidal hypoxia could be a plausible pathogenic mechanism, 
when RPE barrier breaks are present (patchy atrophies and lacquer cracks). Axial 
length and refractive error, if considered by themselves, do not represent risk 
factors for mCNVs development [18]. mCNVs growth is asymptomatic until the 
activation, which leads to rapid reduction of visual acuity with metamorphopsia 
and scotoma.
On the funduscopic examination, they appear as small grayish spots with 
pigmented edges; subretinal hemorrhages’ and intraretinal exudation are modest.
Fluoro angiography remains the benchmark test for early diagnosis of myopic CNVs, 
presenting a higher sensitivity than SD-OCT in the detection of early active forms [19].
These lesions appear as hyperfluorescence in the early phases. When active, 
they show late fluorescein leakage, which is modest when compared to CNV in 
Figure 2. 
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age-related macular degeneration (AMD). Furthermore, fluoro angiography, when 
a subretinal hemorrhage occurred, is a fundamental tool in the differential diagno-
sis between mCNV and Lacquer crack, which typically does not show fluorescein 
leakage. However, factors such as staining of dye in fibrotic tissue and hemorrhagic 
blocking defect may reduce the reliability of fluoro angiography exam.
Indocyanine angiography has a better penetration through bleeding, pig-
ment, and exudates; it also allows a more accurate visualization of lacquer cracks. 
However, sensitivity in identifying CNVs is lower than fluoro angiography. 
Neovascularizations are shown as inconstant hypercyanescent lesions, sometimes 
surrounded by a hypocyanescent halo. For these reasons, indocyanine angiography 
is used only in case of extensive macular hemorrhages and in case of doubtful fluoro 
angiographic results.
SD-OCT exam is a primary, rapid, and noninvasive test in the diagnosis and 
follow-up of myopic CNV (Figure 3). However, modest exudation and bleed-
ing of active mCNVs can sometimes lead to misdiagnosis on OCT examination. 
They appear as hyperreflective subretinal formations; signs of exudation (such as 
intraretinal fluid, retinal thickening, and outer limiting membrane interruption) 
can be detected only in 48% of cases, while fluorescein leakage is found in 82%. A 
multimodal approach, combining OCT and fluoro angiography, allows reaching 
high sensitivity in the diagnosis of myopic CNVs [20].
Overmore, implementation with OCT angiography function allowed us to study 
the retinal flow in the single tomographic segmentation of the retina, managing 
to identify 94.1% of mCNVs with a specificity of 93.75%. In “en face” visualiza-
tion, active CNVs appear as vascular organizations in a typical lacy wheel shape 
or glomerular pattern, with many anastomoses and thin capillaries, in addition to 
the typical perilesional dark halo. In the quiescent phase, instead, they assumed 
the typical aspects of mature neovessels: large caliber and linear course, without 
anastomosis, with a filiform aspect, or dead tree appearance.
The most effective treatments to date are intravitreal injections of anti-VEGF 
drugs. While bevacizumab and ranibizumab demonstrated a comparable efficacy, 
aflibercept allowed the resolution of the CNV with a single administration in 55% of 
cases, resulting in the best medication for the “result/number of injection” ratio [21].
Photodynamic treatment has been shown to be less effective than ranibizumab; 
therefore, it is considered as a second choice treatment [22]. Natural evolution of 
mCNVs consists in a remodellation of the neuroepithelial and pigmented epithelial 
tissues, leading to the formation of typical Fuchs’ spots and patchy atrophies with 
loss of function of involved retina.
Figure 3. 
An OCT scan of a myopic patient showing active myopic CNV.
73
Pathologic Myopia: Complications and Visual Rehabilitation
DOI: http://dx.doi.org/10.5772/intechopen.85871
3.5  Myopic tractional maculopathy (VMT, foveoschisis, macular hole, macular 
detachment)
The definition of “myopic tractional maculopathy” includes a wide range of 
pathologies: vitreomacular traction, foveoschisis, and macular hole.
High myopic eyes, with a posterior pole staphyloma, undergo tractional phe-
nomena between stretchable structures and nonelastic structures. To understand 
the biomechanics underlying these modifications, it is important to consider the 
physiological adherence of posterior vitreous cortex on the fovea. Furthermore, 
inner limiting membrane (ILM) and retinal vessels showed a reduced stretching 
capability compared to choroidal and scleral structures.
The extreme bulbar elongation caused by staphylomas creates axial vitreo-
macular traction with increased macular thickness; it is usually an asymptomatic 
condition, or it may lead to metamorphopsia, with preserved or mild altered 
visual acuity. Axial traction may result in alterations of vitreous body, such as 
cortical vitreoschisis or posterior vitreous detachment (PVD) (43.2%) with sub-
sequent cellular proliferation and increased risk of epiretinal membrane (ERM) 
formation.
Progression of staphylomatous bulbar elongation comes up against lower 
elasticity of retinal internal structures (ILM, retinal vessels, incomplete PVD with 
vitreoretinal adhesion, ERM), causing an intraretinal cleavage and configuring 
a foveoschisis (9%) [23]. Cleavage can occur in the inner, outer, or both retinal 
layers, but more often, it affects the inner limiting membrane. This condition has a 
variable progression, and some studies demonstrate its stability in 88.4% of cases. 
However, further progression of axial traction may lead to a detachment of the 
macular neuroepithelium.
The alteration of posterior pole profile due to the staphyloma, the presence 
of an ERM, and the incomplete PVD are factors that can lead to the development 
of tangential traction forces, which, combined with axial traction, can make the 
foveoschisis evolve into lamellar or full thickness macular holes with important 
visual acuity impairment. Furthermore, a full-thickness macular hole may cause 
a rhegmatogenous retinal detachment that can be confined to the macula or also 
involve the peripheral retina.
Diagnostic strategy of all the clinical presentation analyzed is based on fundus 
examination and, above all, on the SD-OCT exam. The latter allows a precise 
characterization of the single vitreoretinal structures involved, through a tomo-
graphic study of the bulbar structures. OCT exams also make an accurate, rapid, 
and noninvasive follow-up possible (Figure 4) [24].
Figure 4. 
An OCT of a myopic patient showing a macular pucker and a foveoschisis.
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The therapy of myopic tractional maculopathies varies depending on the type 
of lesion or their combination (foveoschisis, macular hole, macular detachment). 
Description of surgical procedures is not pertinence of this chapter. In a general way, 
surgery is the only possible choice and aims at reducing axial and tangential stretch-
ing forces. The peeling of ILM and ERM via Pars plana vitrectomy (PPV) is the basis 
of the resolution of foveoschisis and macular holes [25]. However, sometimes, this 
approach is not enough, especially if a macular detachment occurred. In these cases, 
it may be necessary to perform a macular buckle combined or not with PPV.
The pathogenetic process that can lead to the abovementioned complications is 
resumed in Figure 5.
3.6 Retinal detachment
High myopia is the main risk factor for rhegmatogenous retinal detachment; 
50% of which, according to some estimates, occurs in myopic patients [26].
Rhegmatogenous retinal detachment is defined as the separation of retinal 
neuroepithelium from the retinal pigment epithelium following the infiltration of 
liquefied vitreous material through a full-thickness retinal rupture (tears or holes).
Early vitreal degenerative phenomena leading to syneresis show a peak at 
young age. Those changes can culminate in a PVD and vitreous liquefaction. This 
mechanism, typical of myopic eyes, could underlie the higher retinal detachment 
prevalence. Furthermore, numerous studies have shown a strong association of 
axial bulbar elongation with various peripheral retinal degenerations, especially 
with lattice degenerations. These consist in retinal thinning spots with strong vit-
reous adhesion on the edges, which can exert traction, especially in the presence 
of PVD. Usually, the vitreous detaches from the retina without causing problems. 
But, sometimes, the vitreous pulls hard enough to tear the retina in one or more 
places. Retinal tears can have different shapes and locations. Typically, they are 
located between equatorial zone and ora-serrata, especially in the upper-temporal 
quadrant; in over 50% of cases, they appear as circular or oval tears (retinal 
holes); in the remaining 50%, there are multiple microtears, horseshoe-shaped, 
and operculated tears [27].
Giant retinal tears are rare and usually associated with bulbar traumas and 
vitreoretinal proliferation. Overmore, the already mentioned full thickness macular 
holes can lead to a total retinal detachment in some cases.
Figure 5. 
Myopic tractional maculopathy and complications.
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Diagnosis of tears and retinal detachment is based on the history and the exami-
nation of the fundus oculi. Color peripheral fundus camera and SD-OCT macular 
scans are often very useful tools. Patients may be asymptomatic or complain of 
phosphenes and miodesopsias. Standard treatment for retinal tears and lattice 
degeneration without retinal detachment is argon laser barrage, which has shown to 
be a very effective prophylactic solution for retinal detachment.
If retinal detachment has already occurred; however, the only therapy is surgery. 
Ab interno and ab externo approaches are options, but the treatment is delegated to 
specialistic texts.
3.7 Dome-shaped macula
Features of dome-shaped macula (DMS) are an abnormal profile of the macula 
that appears convex with an anterior protrusion. Three types of DSM have been 
described in literature [28]:
• horizontal oval-shaped dome
• vertical oval-shaped dome
• round dome.
DMS can occur in eyes with or without staphyloma and appears related to a 
localized thinning of the sclera under the dome-shaped macula [29]. This condition 
can lead to formation of subretinal fluid (SRF) and choroidal neovascularization 
(CNV). Based on last evidences, the pathologic mechanisms of formation of SRF 
and CNV could be linked to a similarity of choroid’s features between CSCR and 
only choroid’s portion located above the DMS area in high myopic eyes [30]. One of 
the complications that can occur in eyes with dome-shaped macula is CNV forma-
tion, and the types of CNV mostly related to DMS are either typical myopic CNV 
(i.e., type 2 CNV) or pachychoroid-associated CNV (i.e., type 1 CNV). Another 
kind of complication related to DMS is the presence of subretinal fluid that causes 
a chronic serous retinal detachment, which not seems to impair visual function 
in majority of cases and also shows a certain stability over time. OCT is a crucial 
technique to observe this condition, because it is almost impossible to detect on 
standard fundus examination (Figure 6). Furthermore, it is crucial to detect 
the presence of SRF and CNV. Up to date, many treatment approaches such as 
Figure 6. 
An OCT of a myopic patient showing a dome-shaped macula.
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intravitreal aflibercept, subthreshold laser treatment, PDT, and antimineralocorti-
coids have been tried to treat SRF associated with DSM, but there is no a definitive 
one. While representing a potential problem in high myopic eyes, some authors 
found DMS to be a protective factor for visual function after cataract surgery [31].
3.8 Posterior staphyloma
Posterior staphyloma is defined as “an outpouching of the wall of the eye that 
has a radius of curvature that is less than the surrounding curvature of the wall of 
the eye” [32].
Some authors argue that pathologic myopia should not be defined based on axial 
length but on the presence of staphyloma. An increased presence of staphyloma in 
eyes exhibits a longer axial length.
According to Curtin, there are many types of staphylomas [33] that can be clas-
sified into 10 subcategories. However, also, other classifications have been proposed 
recently [34]. Methods for detecting staphylomas are OCT, fundus imaging, B mode 
echography, and 3D magnetic resonance imaging (MRI). Among all, OCT offers 
the possibility to detect the posterior staphyloma and also to study the morphology 
of the retinal layers. Interpreting an OCT exam in these cases, it is crucial not to 
confuse a real staphyloma with a simple scleral backward bowing due to elongation 
of the eyeball, which is a relatively common finding in high myopic patients. 3D MRI 
in T2-weighted acquisition perfectly delineates the presence and the type of staphy-
loma. However, this is not a routine technique and its limits are that it is expensive 
and that this is not widespread. The presence of a posterior staphyloma can have neg-
ative implications on visual outcome, and is also linked to an augmented incidence 
of other complications such as myopic CNV, myopic macular retinoschisis, and high 
myopia-associated glaucoma-like defects or glaucomatous optic neuropathy.
4. Low-vision rehabilitation
In many cases, pathologic myopia patients experience an irreversible and deep 
loss of vision. In such cases, low-vision interventions are useful to allow patients to 
continue or to improve daily living tasks, independency, and quality of life. Many 
devices and trainings are available to achieve this goal.
This is an important tool to use in high myopic patients with visual field defects 
that impair vision, because this is a particularly favorable condition for low-vision 
correction, mainly because they are used to read at close range of distance.
Low-vision rehabilitation can be approached by many techniques that can be 
subdivided in two main categories:
a. stimulation techniques (such as visual biofeedback)
b. low-vision aids.
4.1 Stimulation techniques
In general terms, biofeedback is a technique that is used to learn how to control a 
body function that normally is not under patient’s control.
Visual biofeedback can be accomplished by many techniques; in our experience, 
acoustic biofeedback visual training provides to be the most effective. First of all, 
it is useful to evaluate patient’s retinal sensibility and fixation stability by making 
a microperimetry (Figure 7); this exam allows the examiner to evaluate retinal 
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sensitivity in each and every single point of the strategy chosen in a very accurate 
manner, because the machine presents the light stimulus only when it is perfectly 
lined with the point to examine by simultaneously analyzing the matching between 
two or more region of interests (ROIs) chosen by the examiner and the fundus 
image at that exact moment. This technology, also defined as “fundus-related 
perimetry,” overcomes the main limit of the traditional perimetry: the perfect 
matching between the stimulus and the point to be stimulated. Then, a fixation 
stability study using bivariate contour analysis area (BCEA) can be performed. The 
most important thing in follow-up is to evaluate the fixation stability always in the 
same manner, since there may be some differences between the one evaluated dur-
ing microperimetry exam and the one using fixation stability tool, maybe because 
of the difference in duration between the two exams.
Acoustic visual biofeedback patient is usually done by putting the patient in front 
of a machine (a microperimeter). The ophthalmologist chooses a point external to 
the central scotoma to be stimulated and to become a pseudofovea (or stimulates the 
natural fovea in cases of peripheral visual defects in case of poor fixation stability).
This point is chosen evaluating:
• patient’s attitudes and necessities
• retinal sensitivity by means of a microperimetric map
• fixation stability and distribution (bivariate contour ellipse analysis or BCEA)
• distance from the natural fovea.
Figure 7. 
A microperimetry exam of a high myopic patient who suffered from multiple areas of retinal atrophy and 
who underwent surgery for retinal detachment, exam prior of acoustic biofeedback training. A threshold of 4-2 
strategy with a Goldmann III stimulus was used to perform this exam. An unstable fixation was shown in this 
patient by means of FUJI classification provided by the machine.
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Regarding last point, it is important to understand that more the distance of the point 
chosen for stimulation from the natural fovea, the lesser is the outcome to be expected. 
When the most favorable point to be stimulated is chosen, the patient is asked to firmly 
look with one eye at a time (in case of rehabilitation of both eyes) to a fixation target 
inside the microperimeter with the point chosen to be stimulated; during the session, 
the lesser the distance between the target and the new fixation point chosen, the more 
continuous the sound emitted by the instrument will be, hence giving the patient a 
constant control of the retinal point fixing the target. After a training period (usually 10 
sessions of 10 min each per eye), the goal is to achieve a constant and stable fixation with 
the most favorable (in terms of position and residual sensitivity) retinal point other than 
the fovea previously chosen (Figure 8) [35], which is also called pseudofovea, in case of 
a central scotoma or to achieve a more stable fixation in case of a peripheral defect with a 
poor fixation stability. All these aspects lead to a better reading performance.
In case of a lesion that leads to a central scotoma, patient’s neurovisual system 
automatically chooses a preferred retinal locus (PRL also known as pseudofovea), 
which is defined as “one or more circumscribed regions of functioning retina, 
repeatedly aligned with a visual target for a specified task that may also be used for 
attention deployment and as the oculomotor reference” [36]. It is also possible to 
develop two or more PRLs that change accordingly to different tasks. If the ophthal-
mologist decides to move this PRL using visual biofeedback to a point other than the 
one automatically set by the patient’s brain because he thinks it may be more favor-
able, it is possible to call it trained retinal locus (TRL). Before starting the treatment, 
it is absolutely mandatory that the patient has already developed a PRL by itself.
The improvements in fixation stability and PRL relocation observed using acoustic 
biofeedback technique suggest that a mechanism of cortical reorganization and corti-
cal plasticity may underline those changes [37]. In case of the presence of peripheral 
visual field defects, a perimetry using 30-2 strategy is useful and can be added to a 
microperimetry in order to have a more precise evaluation of patient’s residual vision.
As already said before, there are two main categories of visual defects that high 
myopic patients can develop [38]:
• central scotoma (variable in depth, extension, position)
• glaucomatous (if glaucoma develops) or glaucoma-like defects (central and 
peripheral defects variable in depth, extension, position).
Figure 8. 
The fixation stability study (BCEA) of a high myopic patient suffering from a small absolute central scotoma. 
On the left: before the treatment with acoustic biofeedback; on the right: changes in fixation stability after 
two treatment of acoustic biofeedback, each of 10 sessions of 10 min. It is possible to appreciate the drastic 
improvement in fixation stability by means of bivariate contour ellipse analysis.
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It is well known that patients affected by absolute central scotoma from other 
kinds of maculopathies may benefit from visual biofeedback training. Highly myopic 
patients develop macular complications that can lead to this kind of defect, hence 
making this kind of therapy beneficial also to those patients. Due to the risk of devel-
oping glaucoma and/or glaucoma-like defects as mentioned above, acoustic biofeed-
back can be a useful technique in the visual rehabilitation of those patients. Many 
studies proved the efficacy of this technique in advanced glaucomatous damage in 
improving fixation stability and visual performances in patients with glaucoma.
4.2 Visual aids
Visual aids are tools (optical or technological) that may improve visual perfor-
mances in low-vision patients such as high myopic patient in which visual defects 
have already developed.
For didactic purposes, we will divide them into three main categories:
a. for distance and intermediate vision
b. for near vision and reading
c. field enhancement.
4.2.1 For distance and intermediate vision
Telescopic systems are the hallmark of this category, and they work by producing 
magnification. There are two main kinds of telescopes: the Galilean and the Keplerian 
ones. A Galilean telescope works by coupling a convex lens (object) and a concave 
lens (ocular) [39]; the image produced is real and erect. A Keplerian telescope is made 
by the combination of two lenses: a convex lens, which is closest to the object (the 
ocular lens) and a convex lens (the objective lens), which is closest to the eye and 
has less dioptric power than the first one. The distance between the two lenses is the 
result of the sum of their focal length. Since the image produced is inverted, a prism is 
required in order to reverse it. This kind of telescope has more wide field of view, less 
aberrations, and a better image quality than Galilean ones, but they are a little bit less 
comfortable since they are heavier and often more expensive. In contrast, Galilean tele-
scope is lighter, cheaper, and shorter, making them handier for the patient. Telescopes 
are very effective for distance tasks, but they present some problems. They have a 
steep learning curve because of the restricted field of view, and the learning process 
is a struggle because of the distortion provided on space and objects. Telescopes are 
available in many forms such as hand held, spectacle mounted (Figure 9), and clip-on. 
They may also have fixed or variable focus. Spectacle mounted is obtained by cutting 
an hole in the spectacle lenses and inserting the telescope; this one can be placed at the 
center of the lens or higher than the center; this position is particularly useful since 
the patient uses the center of his lens for most of the time and can look through the 
telescope placed in the upper part of his spectacles only when he needs to magnify 
some distant object (such as, for example, traffic signs) [40].
4.2.2 For near vision and reading
Microscopic systems are high dioptric positive power lens that work by reducing 
focal length. There are many solutions that use this technology. Handheld magnifiers 
are variable positive power lens with handle, aspheric or biconvex, in various dioptric 
power and magnification, whether illuminated or not. High positive power lens are 
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available also as pocket magnifiers. Bar magnifiers are variable length bars able to 
magnify a text by sliding upon it. They are available in different dioptric powers (hence 
different magnification) and can be illuminated or not. Another option is high posi-
tive dioptric power lens spectacle mounted. However, they pose some struggling: the 
higher the power, the lesser the distance between the text/object and lens; the higher 
the power the, higher the convergence required to the patient. Binocular microscopic 
systems (also known as prismatic hypercorrective) are spectacle-mounted hypercor-
rective lens, which consist in two positive lenses and two prisms that are calculated 
based on the power of the positive lens; this kind of glass is found in various amount 
of magnification and dioptric power (usually from +3.00 to 16.00 dpt). The higher the 
magnification, the higher the difficulty of the patient to adapt to this kind of low-
vision aid. The aim of the use of the prisms is to reduce the amount of the convergence 
required to the patient due to the use of the reduced working distance, hence reducing 
discomfort from prolonged tasks as for example reading a book. As we said before, one 
of the key mechanisms to improve reading performance in low vision is magnifica-
tion [41]. Many electronical devices exist to accomplish this job; one of them is closed 
circuit television (CCTV). These systems are often reserved to visually impaired 
people with severe low vision in which the magnification needed to be able to read or to 
do it more fluently should be as high that optic systems would not be comfortable and 
usable [42] to. These are called CCTV to differentiate them from broadcast television. 
This system can also be useful for writing. Behind the lens of the CCTV camera, there 
is an image sensor, which is equivalent to a retina. This lens system refracts light beams 
reflected from an object and focuses them on the plate to become an image.
Based on information sheets of American Foundation for the Blind (AFB), a 
CCTV (Figure 10) must have these characteristics:
• video camera mounted on a fixed stand (some models have optics able to 
provide zoom while others not; some have autofocus while others not)
• TV or monitor from 5″ to 20″
• positive magnification from 2× to 60× (but also even more)
• polarity inversion (from black-white to white-black)
Figure 9. 
A patient driving using binocular telescopes mounted on top of the spectacle lenses.
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• focus, contrast, and brightness controls
• table that moves on an X-Y direction.
Many kinds of CCTV systems are available in the market; the main difference is 
between portable CCTV and table-mounted systems. The first one is extremely use-
ful for children with low vision, because they can be used at home and at school, for 
leisure and for studying. Recently, there has been some evidence that these kinds of 
devices may be more effective than optical devices in improving reading speed [43].
Portable systems are usually composed by a camera with optics able to provide 
a variable amount of zoom and hence magnification, an LCD screen (usually 
small and in most cases within 10″), and an handle to be held by the patient. They 
are designed to be portable: in most cases, they can be placed in the pocket, or in 
the case of largest ones in a bag. They are useful in daily activities such as drugs 
assumption, reading letters, buying products in drugstore, etc. In our experience, 
however, they are most useful in case of low-vision patients with a nonsevere low 
vision that allows the patients a certain level of self-sufficiency. Also, portable video 
magnifiers without screen included exist.
An example of this technology is the mouse video magnifier. It consists in a cam-
era mounted on a mouse that slides above the text, which is projected on a screen. 
The screen is not included; this device must be connected to a monitor, a PC, or a 
TV to be used. In some cases, these products are provided with computer software 
that allows capture of images on the patient’s PC.
4.2.3 Other kinds of devices
Many braille systems exist on the market. One of them is the braille printer, 
which works like a normal printer with the difference that it prints braille text onto 
a thick paper. Those devices are usually linked to a computer equipped with braille 
Figure 10. 
A CCTV used for writing.
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leisure and for studying. Recently, there has been some evidence that these kinds of 
devices may be more effective than optical devices in improving reading speed [43].
Portable systems are usually composed by a camera with optics able to provide 
a variable amount of zoom and hence magnification, an LCD screen (usually 
small and in most cases within 10″), and an handle to be held by the patient. They 
are designed to be portable: in most cases, they can be placed in the pocket, or in 
the case of largest ones in a bag. They are useful in daily activities such as drugs 
assumption, reading letters, buying products in drugstore, etc. In our experience, 
however, they are most useful in case of low-vision patients with a nonsevere low 
vision that allows the patients a certain level of self-sufficiency. Also, portable video 
magnifiers without screen included exist.
An example of this technology is the mouse video magnifier. It consists in a cam-
era mounted on a mouse that slides above the text, which is projected on a screen. 
The screen is not included; this device must be connected to a monitor, a PC, or a 
TV to be used. In some cases, these products are provided with computer software 
that allows capture of images on the patient’s PC.
4.2.3 Other kinds of devices
Many braille systems exist on the market. One of them is the braille printer, 
which works like a normal printer with the difference that it prints braille text onto 
a thick paper. Those devices are usually linked to a computer equipped with braille 
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translator software that converts a text from a language into a braille text. This text 
is then embossed into a thick paper with a braille printer [44].
Braille displays (Figure 11) are special displays made of special materials (metals 
or plastics). They instantly translate the text into braille that is appearing on the 
computer, and they change with the scrolling of the text on the PC screen. They 
are usually placed under the PC keyboard. Also portable note takers exit, making 
patients able to take notes via a keyboard in braille; the system is then able to recall 
and read them via voice activation. A braille writer is very similar to a standard 
typewriter, with the difference that its keyboard is made in braille. It instantly 
embosses letters on a thick paper. System based on optical character recognition 
(OCR) is made of a camera, which scans the text; this is then read by the system 
itself via a synthetized voice. Many OCR systems offer special features such as stor-
age of the texts acquired, research of words, and chapters of the text. The advantage 
of these systems is that they are not dependent on a PC for working. Many OCR 
apps are now available, hence making this technology more widespread [45].
Audiobooks are another useful option in low-vision patients of pathologic 
myopia. Almost any of the best-known novels can be found in audiobook format, 
in which a voice reads the texts for the listeners. Many low-vision societies make 
audiobooks available and also apps for new devices such as that found in tablets.
4.2.4 Household, personal, and other independent living products
In this category, all the devices that improve patient’s self-sufficiency, safety, 
and quality of life are included. As many of them exist, we will cite only the best 
known: vibrating-, braille and talking watches, talking blood pressure- and glucose 
meters, talking thermometers, weighted eating utensil fork, talking kitchen scale, 
cut-resistant gloves, talking microwave, labeling systems, object locators, etc.
4.2.5 Field enhancement
As we already said, pathologic myopic patients are at risk to develop glaucoma 
and optic neuropathies. Patients can also develop ring-shaped scotomas even if the 
patient is not affected by glaucoma. However, when this pathology is present, one 
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is the restriction of the peripheral visual field up to the development of a tubular 
field of view. In the abovementioned cases, field enhancers are useful. There are 
many tools that can act as field expanders such as reverse telescopes, minifiers, and 
prisms. Minifiers act by “miniaturizing the space” in order to maximize the portion 
of this one that can be seen into a tubular visual field. There are many powers of 
miniaturization on the market; best known are 0.25× and 0.5×. They can be found 
as handheld, clip-on, or spectacle mounted. Reverse telescopes are Galilean or 
Keplerian telescopes used by the object lens and not by the ocular lens; in this way, 
a minification of the space is obtained in order to fit a restricted visual field and the 
power of minification is equal to the power of the telescope [46].
Minification devices are a useful help only in static situation, because patient 
is not able to use them while walking since he perceives many aberrations and a 
very restricted visual field. Prisms combined in a field expanding channel lens are 
also an option in such cases [47]. This spectacle lens is made of two lateral prisms 
of 12 pd and an inferior one of 8 pd; a central nonprismatic lens, which has the 
dioptric power of the distance vision prescription, is also present. Prisms work only 
in position of gaze different than the primary. This lens can be built and used for 
peripheral defects even more than 20°.
5. Conclusions
High myopia, defined as refractive error of at least −6.00D and/or an axial length of 
26.5 mm or more, can lead to many morphological changes in the eyeball that can cause 
development of complications. World is facing a rapid rise in high myopia and patho-
logic myopia incidence, and some areas of the globe show a more rapid increase in this 
trend than other ones, such as Asian regions. In such areas, the incidence rate can also 
reach 80–90% of children and young adults in school age. Major risk factors in myopia 
progression are intensive education and limited time outdoors. It is estimated that this 
percentage and the magnitude of myopic shift will rise in the future because of the 
rising educational pressure and needs especially in developing countries. The constant 
rising in the amount of time spent using high-tech devices worldwide such as tablets 
and smartphone and its use by children represents an adjunctive risk factor. These 
evidences produce a worrying outline for the future, because early onset of myopia 
in childhood is associated with high myopia in adult life. Prevention in such cases can 
count on interventions on school system, favoring open air activities if possible, and 
children’s lifestyle modifications [48], spending more time outside and reducing the 
time spent with electronic devices. Recently, many clinical trials investigated the role 
of pharmacologic therapy with atropine 0.01% eye drops and orthokeratology [49] in 
slowing the progression of myopia in children and young individuals with good results.
Studies estimated that by 2050, half of the global population (5 billion people) 
would be myopic and 25% of those (1 billion) would be considered highly myopic 
(>−5D), making it a serious problem for healthcare systems and governments 
facing the rise in healthcare expenditure, because such patients have a greater need 
of care and assistive devices, low-vision interventions, and a greater impact of the 
disease on their work productivity, eventually quitting work and hence increasing 
the costs of this pathology. In our opinion, prevention of high myopia by reducing 
near work when possible and stimulating open-air activities for children is essen-
tial; we also think that atropine drops will be an useful tool for reducing the rising 
in incidence of myopia in children. For senior individuals affected by high myopia, 
a comprehensive ophthalmologic assessment with OCT exam, each 6–12 months, 
depending on the degree of myopia, is in our opinion crucial to be able to act 
promptly in case of onset of complications related to high myopia.
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of this one that can be seen into a tubular visual field. There are many powers of 
miniaturization on the market; best known are 0.25× and 0.5×. They can be found 
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a minification of the space is obtained in order to fit a restricted visual field and the 
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slowing the progression of myopia in children and young individuals with good results.
Studies estimated that by 2050, half of the global population (5 billion people) 
would be myopic and 25% of those (1 billion) would be considered highly myopic 
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facing the rise in healthcare expenditure, because such patients have a greater need 
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disease on their work productivity, eventually quitting work and hence increasing 
the costs of this pathology. In our opinion, prevention of high myopia by reducing 
near work when possible and stimulating open-air activities for children is essen-
tial; we also think that atropine drops will be an useful tool for reducing the rising 
in incidence of myopia in children. For senior individuals affected by high myopia, 
a comprehensive ophthalmologic assessment with OCT exam, each 6–12 months, 
depending on the degree of myopia, is in our opinion crucial to be able to act 
promptly in case of onset of complications related to high myopia.
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As above mentioned, when complications due to high myopia occur, we talk 
about pathologic myopia. Many complications can develop, and their treatment 
can count mainly on surgery and anti-VEGF therapy. When treatment is not 
possible or after this in order to boost and maximize the visual recovery, ophthal-
mologist can recur to visual rehabilitation strategies. These can count into two 
main categories of tools: visual stimulation and visual aids. Acoustic biofeedback 
is one of the most effective techniques in order to stimulate visual system. First 
of all, it is mandatory to analyze the characteristics of the visual field defects 
that are affecting the patient. Two types of defects can occur in such patients: 
central scotomas (of various shape, size, and depth) and peripheral defects. The 
two can also occur simultaneously in various combinations. Then, in case of a 
central defect, after analyzing patient’s retinal sensitivity and fixation stability 
with a microperimetry, if the patient has already developed a preferred retinal 
locus (PRL or pseudofovea) by itself, it is possible to stimulate this one if it is in a 
favorable position in order to boost fixation stability or to choose a new point to 
relocate the PRL in a position that the physician considers more favorable for the 
patient because of a better residual retinal sensitivity. A PRL is a point that the 
patient with a central scotoma uses to fixate object, as a “substitute” of the natural 
impaired fovea. This point is chosen considering patient’s expectations, attitudes, 
activities and the residual sensitivity microperimetric map of the patient and 
the distance that the point candidate to be stimulated from the natural fovea. It 
means that for a better outcome it would be better to choose a point with the best 
residual retinal sensitivity not too far from the natural fovea if possible. Acoustic 
biofeedback is a technique that trains the patient relocating the PRL to a more 
useful position; when a point to become the new PRL is chosen by the examiner, 
during the acoustic biofeedback session, a beep is produced by the machine 
(microperimeter), and it becomes more continuous as the point to be stimulated 
gets closer to the center of the fixation target on the machine, hence training the 
patient to use the point set by the ophthalmologist. This one guides the patient 
during the whole session, giving him instructions where to move his gaze to match 
the trained PRL and the center of the fixation point of the machine. A typical 
acoustic biofeedback rehabilitation protocol is composed of 10 sessions of 10 min 
each, typically one session per week. However, it can be repeated if necessary. In 
case of a peripheral defect alone, acoustic biofeedback can be useful if an unstable 
fixation is present in order to stimulate the fixation point and make it more stable. 
Visual aid use can also benefit of a more stable fixation; they are available for 
distance and intermediate-near vision. For distance vision, the most popular 
devices are telescopes, Galilean, and Keplerian ones. They ideally “approach” far 
items to the observer by magnifying them. They can be monocular or binocular, 
clip-on, spectacle mounted, and handheld. For near vision, microscopic systems 
are available; they are high dioptric positive power lens that work by reducing 
focal length. There are many solutions that use this technology: handheld magni-
fiers, bar magnifiers, positive overcorrection of near prescription, visolettes, 
and prismatic hypercorrective are available in various spherical powers and so in 
various magnification power. Electronic aids for near vision are available, with 
portable and fixed CCTV being the mainstay of the category. Other solutions are 
also available such as braille systems (displays, printers, note takers), household, 
personal and other independent living products (for example, braille and talk-
ing watches, talking blood pressure and glucose meters, etc.), OCR systems, and 
audiobooks. Many recent apps for aided mobility, OCR, etc., have been placed on 
the market. In patients with peripheral visual field defects, field enhancement 
systems are very useful. Reversed telescopes and field expanding channel lens 
represent the mainstay of this category.
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Abstract
Myopia is a significant worldwide public health concern, and its prevalence is 
drastically increasing in recent years. It was once viewed as a benign refractive error, 
but is now one of the leading causes of blindness and is associated with numerous 
ocular diseases, which makes it crucial to develop viable treatment options to ade-
quately correct the refractive error and to halt the disease progression. The treatment 
of myopia can be classified into three groups: optical, pharmacological, and surgical 
management, which are aimed at adjusting to the refractive error and reducing the 
axial elongation. The conventional treatment modalities for myopia, such as single 
vision glasses, correct the refractive error and improve visual quality of life, but do not 
affect myopia progression or axial elongation. The newer and various myopic inter-
ventions including spectacle corrections, contact lens corrections, pharmacological 
treatments and surgical corrections, hold great potential for adequate disease control 
to improve the quality of life, reduce myopia burden, and preserve the ocular health.
Keywords: myopia, refractive error, axial elongation, single vision lenses,  
multifocal lenses, rigid gas permeable contact lenses, soft bifocal contact lens, 
orthokeratology, atropine, pirenzepine, anti-hypoxic drugs
1. Introduction
Myopia is a refractive condition of the eye that has globally affected 1.89 billion 
people worldwide, and projected to affect 2.56 billion people by the year 2020 [1]. 
Over the past few decades, the prevalence of myopia in Asia has increased dramati-
cally affecting as much as 80–90% of the pediatric Asian population, and 25–50% 
of the American and European population [2].
Refractive development in early ocular growth is an intricate and continuous 
process. At birth, there is a high prevalence of large refractive errors in newborn 
infants due to mismatch between the axial length and the focal length of its optics 
[3–5]. As the newborn matures, the eye develops in size and refracting power in a 
rapid fashion to attain an ideal refractive state in early childhood. This physiological 
process is known as emmetropization [5–7]. Coordination between axial length and 
optical components will allow for the images of distal objects to focus on the retina, 
rather than in front or behind it [5]. Interruption of this homeostatic process of 
ocular growth results in the development of refractive error. The disorder manifests 
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1. Introduction
Myopia is a refractive condition of the eye that has globally affected 1.89 billion 
people worldwide, and projected to affect 2.56 billion people by the year 2020 [1]. 
Over the past few decades, the prevalence of myopia in Asia has increased dramati-
cally affecting as much as 80–90% of the pediatric Asian population, and 25–50% 
of the American and European population [2].
Refractive development in early ocular growth is an intricate and continuous 
process. At birth, there is a high prevalence of large refractive errors in newborn 
infants due to mismatch between the axial length and the focal length of its optics 
[3–5]. As the newborn matures, the eye develops in size and refracting power in a 
rapid fashion to attain an ideal refractive state in early childhood. This physiological 
process is known as emmetropization [5–7]. Coordination between axial length and 
optical components will allow for the images of distal objects to focus on the retina, 
rather than in front or behind it [5]. Interruption of this homeostatic process of 
ocular growth results in the development of refractive error. The disorder manifests 




It was once considered a mere refractive error, but myopia is now often associ-
ated with a multitude of ocular diseases such as retinal detachment, glaucoma, 
cataract and chorioretinal abnormalities [11]. Therefore, in recent years, the focus 
of myopia research has been on halting the progression to decrease the risk of 
associated future ocular diseases.
This chapter focuses on the mechanics of the various treatment methods includ-
ing optical, pharmacological and surgical strategies, for precise control of myopia. 
The goal of such treatment methods is to reduce both personal and societal burden, 
as well as prevent disease progression such as worsening refractions, axial length 
and overall ocular health.
2. Treatment of myopia
2.1 Optical management
2.1.1 Spectacle correction
While potential optical strategies are investigated for adequate myopia control, 
the visual outcomes of Single Vision Lenses (SVLs) are used as control for efficacy 
comparison. Single vision lenses (SVLs) have universally been utilized by oph-
thalmologists and optometrists for correction of refractive error. With periodic 
monitoring, the spectacle prescription is often adjusted to correct the increasing 
refractive error. The growth of the eye is regulated by visual signals, which are 
manipulated and controlled by the power of the spectacle lens [5]. By regulating 
the refractive error of the cornea and the axial length of the eye, SVLs emulate the 
eye’s innate process of emmetropization by allowing the eye to focus the rays on the 
retina [5, 12].
While visual outcomes are improved, SVLs do not interrupt the myopia 
progression or axial length elongation. Though clinically insignificant, evidence 
from animal studies suggest compensatory eye growth in spectacle induced 
emmetropization [13, 14]. Since SVLs alter the refractive error but does not reduce 
progression or axial elongation, studies have investigated on alternate optical cor-
rection methods, such as under-correction of refractive error.
Animal studies have postulated that under-correction of the refractive error 
reduces the mean change in refractive error, in comparison to fully-corrected SVLs. 
Hence, some clinicians advocate for under-corrected SVLs in an attempt to reduce 
the axial growth and prevent further myopia progression. It is theorized that mod-
est under-correction of SVLs by 0.5–0.75D reduces the accommodative stimulus 
and consequently the blur drive for near work accommodation [15, 16]. However, 
studies have demonstrated contradicting results.
The pilot randomized study performed by Chung et al. compared the effects of 
under correction versus full correction on Hong Kong Chinese children. The study 
demonstrated that myopia progression was slightly greater in patients with under-
correction in comparison to full correction, with 0.5 and 0.35D, respectively [17]. 
Similar results were obtained by study conducted by Adler et al., which showed 
0.66 versus 0.55D for patients with under-correction and full correction, respec-
tively [18]. Both studies concluded that myopic defocus through under-correction 
slightly increased the rate of myopia progression. While SVLs attend to the refrac-
tive error and vision complaints of the child, it does not have a protective role on the 
health and growth of the eye.
As an alternative to SVLs, multifocal lenses have gained popularity for use in 
slowing or halting the progression of myopia and axial elongation of the eye. It 
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is believed that these lenses decrease the rate of myopia progression by reducing 
accommodation effort and hyperopic defocus. A relatively newer version of the 
multifocal lenses is Progressive Addition Lenses (PALs). The Correction of Myopia 
Evaluation Trial (COMET) study is the largest double randomized, double masked 
clinical trial that evaluates the effect of PALs versus SVLs on the progression of 
myopia in children. Although clinically insignificant, the study revealed decreased 
mean increase of myopia in children treated with PALs, compared to children with 
SVLs [13, 19].
A similar study conducted by Hasebe et al. investigated the effects of PALs 
versus SVLs on slowing the progression of myopia using a crossover design, which 
switches the spectacle type at the half of the study. At the end of this 3-year study 
period, progression was less in the group wearing PALs first than the group with 
SVLs first. The study concludes that early intervention with PALs is more effective 
that SVLs in controlling myopia, slowing progression and halting axial elongation 
of the eye [20]. Several other statistically significant, but clinically insignificant, 
studies have explored the use of PALs compared to SVLs for slowing the progression 
of myopia [21–23]. With more large population and long duration studies, the stud-
ies can achieve statistical and clinical significance in preventing myopia progression 
and axial elongation.
Myovision lenses appear similar to SVLs, but they are a newer design of spec-
tacles that correct central and side vision that are experimented on many myopic 
Asian pediatric populations. The mechanism of these spectacles is to reduce the 
peripheral hyperopia and prevent myopia progression. These lenses resemble SVLs 
in appearance, are comfortable to wear and easy to adapt to the young population 
[24]. Similar studies with MyoVision lenses on Japanese children, which reveal an 
insignificant difference between the effect of MyoVision lenses and SVL wearers on 
spherical equivalent refraction and axial elongation of the eye [25].
At this early stage of exploration, the efficacy of MyoVision lenses are not yet 
fully understood or proven. With additional studies that can reduce peripheral 
hyperopic defocus more effectively, there is more potential for reduction of myopia 
progression and axial elongation.
2.1.2 Contact lens correction
Majority of the myopic population advocate for contact lenses are from the adult 
population, as it produces cosmetic benefits in addition to functional improvement 
of the vision and their quality of life. However, contact lenses, such as rigid gas 
permeable contact lens, have also been utilized in the pediatric population to retard 
myopia progression and decrease axial elongation.
Rigid gas permeable contact lenses have been shown to retard myopia progres-
sion in studies such as, The Contact Lens and Myopia Progression (CLAMP), which 
explored the progression of myopia in rigid gas permeable contact lens wearers 
versus soft lens controls. The CLAMP study reported that in 2 years the myopia 
progression was less in rigid gas permeable wearers (−1.56 ± 0.95D) than in soft 
contact lens wearers (−2.19 ± 0.89D) [11, 26]. Numerous other studies have demon-
strated that the provisional decrease in myopia progression in rigid gas permeable 
contact lens wearers in comparison to other treatment groups, was a consequence of 
flattening of the cornea, and not the axial length of the eye [26–28].
Soft bifocal contact lens has demonstrated slowing of myopia progression by 
reducing the accommodation effort and halting axial elongation [29]. These lenses 
are designed with power for distance in the center and additional power in the 
periphery, or inversely, which corrects central myopia and reduces relative periph-
eral hyperopia. A study conducted by Walline et al. compared the effects of soft 
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It was once considered a mere refractive error, but myopia is now often associ-
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2. Treatment of myopia
2.1 Optical management
2.1.1 Spectacle correction
While potential optical strategies are investigated for adequate myopia control, 
the visual outcomes of Single Vision Lenses (SVLs) are used as control for efficacy 
comparison. Single vision lenses (SVLs) have universally been utilized by oph-
thalmologists and optometrists for correction of refractive error. With periodic 
monitoring, the spectacle prescription is often adjusted to correct the increasing 
refractive error. The growth of the eye is regulated by visual signals, which are 
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eye’s innate process of emmetropization by allowing the eye to focus the rays on the 
retina [5, 12].
While visual outcomes are improved, SVLs do not interrupt the myopia 
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emmetropization [13, 14]. Since SVLs alter the refractive error but does not reduce 
progression or axial elongation, studies have investigated on alternate optical cor-
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Animal studies have postulated that under-correction of the refractive error 
reduces the mean change in refractive error, in comparison to fully-corrected SVLs. 
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the axial growth and prevent further myopia progression. It is theorized that mod-
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slightly increased the rate of myopia progression. While SVLs attend to the refrac-
tive error and vision complaints of the child, it does not have a protective role on the 
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As an alternative to SVLs, multifocal lenses have gained popularity for use in 
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is believed that these lenses decrease the rate of myopia progression by reducing 
accommodation effort and hyperopic defocus. A relatively newer version of the 
multifocal lenses is Progressive Addition Lenses (PALs). The Correction of Myopia 
Evaluation Trial (COMET) study is the largest double randomized, double masked 
clinical trial that evaluates the effect of PALs versus SVLs on the progression of 
myopia in children. Although clinically insignificant, the study revealed decreased 
mean increase of myopia in children treated with PALs, compared to children with 
SVLs [13, 19].
A similar study conducted by Hasebe et al. investigated the effects of PALs 
versus SVLs on slowing the progression of myopia using a crossover design, which 
switches the spectacle type at the half of the study. At the end of this 3-year study 
period, progression was less in the group wearing PALs first than the group with 
SVLs first. The study concludes that early intervention with PALs is more effective 
that SVLs in controlling myopia, slowing progression and halting axial elongation 
of the eye [20]. Several other statistically significant, but clinically insignificant, 
studies have explored the use of PALs compared to SVLs for slowing the progression 
of myopia [21–23]. With more large population and long duration studies, the stud-
ies can achieve statistical and clinical significance in preventing myopia progression 
and axial elongation.
Myovision lenses appear similar to SVLs, but they are a newer design of spec-
tacles that correct central and side vision that are experimented on many myopic 
Asian pediatric populations. The mechanism of these spectacles is to reduce the 
peripheral hyperopia and prevent myopia progression. These lenses resemble SVLs 
in appearance, are comfortable to wear and easy to adapt to the young population 
[24]. Similar studies with MyoVision lenses on Japanese children, which reveal an 
insignificant difference between the effect of MyoVision lenses and SVL wearers on 
spherical equivalent refraction and axial elongation of the eye [25].
At this early stage of exploration, the efficacy of MyoVision lenses are not yet 
fully understood or proven. With additional studies that can reduce peripheral 
hyperopic defocus more effectively, there is more potential for reduction of myopia 
progression and axial elongation.
2.1.2 Contact lens correction
Majority of the myopic population advocate for contact lenses are from the adult 
population, as it produces cosmetic benefits in addition to functional improvement 
of the vision and their quality of life. However, contact lenses, such as rigid gas 
permeable contact lens, have also been utilized in the pediatric population to retard 
myopia progression and decrease axial elongation.
Rigid gas permeable contact lenses have been shown to retard myopia progres-
sion in studies such as, The Contact Lens and Myopia Progression (CLAMP), which 
explored the progression of myopia in rigid gas permeable contact lens wearers 
versus soft lens controls. The CLAMP study reported that in 2 years the myopia 
progression was less in rigid gas permeable wearers (−1.56 ± 0.95D) than in soft 
contact lens wearers (−2.19 ± 0.89D) [11, 26]. Numerous other studies have demon-
strated that the provisional decrease in myopia progression in rigid gas permeable 
contact lens wearers in comparison to other treatment groups, was a consequence of 
flattening of the cornea, and not the axial length of the eye [26–28].
Soft bifocal contact lens has demonstrated slowing of myopia progression by 
reducing the accommodation effort and halting axial elongation [29]. These lenses 
are designed with power for distance in the center and additional power in the 
periphery, or inversely, which corrects central myopia and reduces relative periph-
eral hyperopia. A study conducted by Walline et al. compared the effects of soft 
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multifocal contact lenses with single vision lenses, and reported that the average 
myopic progression at 2 years was 0.41 ± 0.03D for the single-vision contact lens 
wearers and 0.29 ± 0.03D for the soft multifocal contact lens wearers [29]. While 
the study produced statistically significant results, it was clinically insignificant.
Using a contralateral eye study design, Anstice et al. demonstrated that the 
eye wearing soft bifocal contact lens have a slower axial elongation in comparison 
to the eye wearing soft single vision contact lens. However, this was not clinically 
 significant [30].
There is much potential for soft bifocal contact lenses to reduce myopic progres-
sion and axial elongation, which can be achieved with future large-scale studies that 
explore the mechanism of myopic control through reduced accommodation effort 
and studies that compare the effectiveness of soft bifocal contact lens with other 
modes of optical control of myopia.
Orthokeratology is a technique used in the reduction of myopia by flattening the 
cornea by the rigid orthokeratology contact lenses. The pattern of lens wear in this 
correction technique allows for the correction of myopia for short periods of time. 
The lenses are worn overnight to temporarily alter the corneal shape by corneal 
thinning, are removed during the day when the visual acuity would be improved 
temporarily [31]. The Berkeley Orthokeratology study demonstrated a significantly 
greater reduction of myopia in orthokeratology contact lens wearers, in comparison 
to a control group. However, the study was not clinically significant [9, 32].
The Longitudinal Orthokeratology Research in Children study was explored 
the effects of Orthokeratology contact lenses worn for 2 years on children in Hong 
Kong. At the study end, the there was a significant difference in the axial length 
between the lens wearers and the control group, 0.29 and 0.54 mm, respectively. 
The study was not clinically significant, represents the need for large scale studies to 
achieve clinical and statistical significance [31, 33].
With additional studies that can reduce peripheral hyperopic defocus more 




Atropine is a non-selective muscarinic antagonist that has been the most effec-
tive in slowing the progression of myopia. One theory for the mechanism of atro-
pine is the role of scleral remodeling in myopia and axial elongation. The expression 
of the muscarinic receptors (mAChRs) results in the proliferation of fibroblasts in 
the scleral collagenous matrix, which promotes scleral remodeling and ultimately 
axial elongation [34]. Some axial elongation induced morphological scleral changes 
include lamellar arrangement of collagen fibers in myopic eyes rather than the tight 
interwoven collagen fibers in emmetropic eyes, the reduction in fibril diameter, a 
dispersed range of fibril diameters, and an increased number of abnormal fibrils 
represent are representations [35, 36]. It is theorized that atropine receptor block-
age interrupts scleral fibroblast proliferation and consequential axial elongation 
of the eye. Although the mechanism of atropine remains obscure, there are several 
working theories on the action and effect of this drug on myopia progression and 
axial elongation.
The Atropine in the Treatment of Myopia (ATOM) study was conducted from 
1999 to 2004, which explored the effect of atropine 1% instilled nightly in children 
in Singapore for 2 years. The study contained two phases: a 2-year treatment phase 
and a 1-year washout phase. At the end of the 2-year study period, there was a 
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77% reduction in myopia progression with an unaltered axial length, compared to 
the control [37, 38]. The study was originally conducted in Asia but was adopted 
by other countries due to its encouraging results [39–43]. Following a successful 
2-year treatment phase, the patients displayed rebound phenomenon in the 1-year 
washout phase. During this phase, there was an increase in both refractive error and 
axial length [37, 38]. The instillation of topical atropine was generally tolerated with 
some short- and long-term side effects. Short-term side effects are red eyes, photo-
phobia, dilatation, increased intraocular pressure and glaucoma, and long-term side 
effects include retinal vascular diseases and cataract formation [37, 38]. The ATOM 
study was proved highly effective in reducing the rate of axial elongation and 
myopia progression, but was associated with such expected side effects.
Following the ATOM1 study was a 5-year clinical trial, which investigates low-
dose atropine on reducing the progression of myopia, and subsequently decreasing 
the side effects. ATOM2 participants were randomly assigned to receive 0.5, 0.1 
or 0.01% concentration of atropine for 24 months, followed by a 1-year washout 
phase. The results of ATOM2 study reveals that 0.01% is a viable concentration for 
reducing myopia progression and increasing the safety profile [44, 45].
While both ATOM and ATOM2 studies display efficacy in reducing myopia 
progression, both studies reveal a dose-dependent rebound phenomenon during 
the washout period. More recently, The Low-Concentration Atropine for Myopia 
Progression (LAMP) study was conducted to evaluate the efficacy and safety of 
low concentrations of atropine eye drops including 0.05, 0.025 and 0.01% com-
pared to a placebo. The LAMP study revealed that all three low concentrations of 
atropine reduce myopia without a discernable adverse effect on the visual quality 
of life, and 0.05% was the most effective in controlling the spherical equivalent 
progression and the axial elongation over the 1-year study period [46]. Numerous 
studies have compared the effect of atropine to other optical strategies, such as 
single vision lenses, multifocal lenses, rigid gas permeable contact lenses, and 
orthokeratology [47–49].
Combination studies have explored the effects of atropine and an optical cor-
rection for greater myopia control. Shih et al. demonstrated that multifocal lens 
wearers treated with 0.5% atropine have a greater reduction of axial elongation and 
myopia progression, compared to placebo group [50]. Atropine eye drops for the 
treatment of myopia control has gained wide popularity in Asian countries, and 
more recently it has been adopted by the Western countries as well. With further 
investigation and modification to the treatment regimen that evades rebound phe-
nomenon, atropine has the potential to be the conventional treatment of myopia.
2.2.2 Pirenzepine
Pirenzepine is a selective M1 muscarinic receptor antagonist with a similar 
mechanism as atropine in halting myopia progression and axial elongation. A 
study conducted by Siatkowski et al. developed a 2% pirenzepine gel that displayed 
great efficacy in reduction of refractive error compared to the placebo group. 
Additionally, the average axial length increase at 1 year was 0.19 mm for patients in 
pirenzepine treatment group compared to 0.23 mm for those in the placebo group. 
While the results are statistically significant, they are clinically insignificant [51]. 
The adverse events in patients treated with pirenzepine were mild to moderately 
severe and included mydriasis, erythema of eyelids and ocular itching [9, 51, 52]. 
Overall, the study displayed good safety and efficacy for use in myopia control. 
Future studies are warranted to compare the efficacy and safety of pirenzepine 
and atropine in slowing the progression of myopia and axial elongation. Atropine 
eye drops for the treatment of myopia control has gained wide popularity in Asian 
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multifocal contact lenses with single vision lenses, and reported that the average 
myopic progression at 2 years was 0.41 ± 0.03D for the single-vision contact lens 
wearers and 0.29 ± 0.03D for the soft multifocal contact lens wearers [29]. While 
the study produced statistically significant results, it was clinically insignificant.
Using a contralateral eye study design, Anstice et al. demonstrated that the 
eye wearing soft bifocal contact lens have a slower axial elongation in comparison 
to the eye wearing soft single vision contact lens. However, this was not clinically 
 significant [30].
There is much potential for soft bifocal contact lenses to reduce myopic progres-
sion and axial elongation, which can be achieved with future large-scale studies that 
explore the mechanism of myopic control through reduced accommodation effort 
and studies that compare the effectiveness of soft bifocal contact lens with other 
modes of optical control of myopia.
Orthokeratology is a technique used in the reduction of myopia by flattening the 
cornea by the rigid orthokeratology contact lenses. The pattern of lens wear in this 
correction technique allows for the correction of myopia for short periods of time. 
The lenses are worn overnight to temporarily alter the corneal shape by corneal 
thinning, are removed during the day when the visual acuity would be improved 
temporarily [31]. The Berkeley Orthokeratology study demonstrated a significantly 
greater reduction of myopia in orthokeratology contact lens wearers, in comparison 
to a control group. However, the study was not clinically significant [9, 32].
The Longitudinal Orthokeratology Research in Children study was explored 
the effects of Orthokeratology contact lenses worn for 2 years on children in Hong 
Kong. At the study end, the there was a significant difference in the axial length 
between the lens wearers and the control group, 0.29 and 0.54 mm, respectively. 
The study was not clinically significant, represents the need for large scale studies to 
achieve clinical and statistical significance [31, 33].
With additional studies that can reduce peripheral hyperopic defocus more 
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dispersed range of fibril diameters, and an increased number of abnormal fibrils 
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age interrupts scleral fibroblast proliferation and consequential axial elongation 
of the eye. Although the mechanism of atropine remains obscure, there are several 
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77% reduction in myopia progression with an unaltered axial length, compared to 
the control [37, 38]. The study was originally conducted in Asia but was adopted 
by other countries due to its encouraging results [39–43]. Following a successful 
2-year treatment phase, the patients displayed rebound phenomenon in the 1-year 
washout phase. During this phase, there was an increase in both refractive error and 
axial length [37, 38]. The instillation of topical atropine was generally tolerated with 
some short- and long-term side effects. Short-term side effects are red eyes, photo-
phobia, dilatation, increased intraocular pressure and glaucoma, and long-term side 
effects include retinal vascular diseases and cataract formation [37, 38]. The ATOM 
study was proved highly effective in reducing the rate of axial elongation and 
myopia progression, but was associated with such expected side effects.
Following the ATOM1 study was a 5-year clinical trial, which investigates low-
dose atropine on reducing the progression of myopia, and subsequently decreasing 
the side effects. ATOM2 participants were randomly assigned to receive 0.5, 0.1 
or 0.01% concentration of atropine for 24 months, followed by a 1-year washout 
phase. The results of ATOM2 study reveals that 0.01% is a viable concentration for 
reducing myopia progression and increasing the safety profile [44, 45].
While both ATOM and ATOM2 studies display efficacy in reducing myopia 
progression, both studies reveal a dose-dependent rebound phenomenon during 
the washout period. More recently, The Low-Concentration Atropine for Myopia 
Progression (LAMP) study was conducted to evaluate the efficacy and safety of 
low concentrations of atropine eye drops including 0.05, 0.025 and 0.01% com-
pared to a placebo. The LAMP study revealed that all three low concentrations of 
atropine reduce myopia without a discernable adverse effect on the visual quality 
of life, and 0.05% was the most effective in controlling the spherical equivalent 
progression and the axial elongation over the 1-year study period [46]. Numerous 
studies have compared the effect of atropine to other optical strategies, such as 
single vision lenses, multifocal lenses, rigid gas permeable contact lenses, and 
orthokeratology [47–49].
Combination studies have explored the effects of atropine and an optical cor-
rection for greater myopia control. Shih et al. demonstrated that multifocal lens 
wearers treated with 0.5% atropine have a greater reduction of axial elongation and 
myopia progression, compared to placebo group [50]. Atropine eye drops for the 
treatment of myopia control has gained wide popularity in Asian countries, and 
more recently it has been adopted by the Western countries as well. With further 
investigation and modification to the treatment regimen that evades rebound phe-
nomenon, atropine has the potential to be the conventional treatment of myopia.
2.2.2 Pirenzepine
Pirenzepine is a selective M1 muscarinic receptor antagonist with a similar 
mechanism as atropine in halting myopia progression and axial elongation. A 
study conducted by Siatkowski et al. developed a 2% pirenzepine gel that displayed 
great efficacy in reduction of refractive error compared to the placebo group. 
Additionally, the average axial length increase at 1 year was 0.19 mm for patients in 
pirenzepine treatment group compared to 0.23 mm for those in the placebo group. 
While the results are statistically significant, they are clinically insignificant [51]. 
The adverse events in patients treated with pirenzepine were mild to moderately 
severe and included mydriasis, erythema of eyelids and ocular itching [9, 51, 52]. 
Overall, the study displayed good safety and efficacy for use in myopia control. 
Future studies are warranted to compare the efficacy and safety of pirenzepine 
and atropine in slowing the progression of myopia and axial elongation. Atropine 
eye drops for the treatment of myopia control has gained wide popularity in Asian 
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countries, and more recently it has been adopted by the Western countries as well. 
With further investigation and modification to the treatment regimen that evades 
rebound phenomenon, atropine has the potential to be the conventional treatment 
of myopia.
2.2.3 Anti-hypoxic drugs
Anti-hypoxic drugs such as salidroside and formononetin have shown anti-
hypoxic effects to treat scleral hypoxia in myopia [53, 54]. Scleral hypoxia, which 
is induced by Hypoxia-Inducible Factor-1α (HIF-1), triggers a signaling cascade 
for myofibroblast trans-differentiation leading to scleral extracellular collagenous 
matrix remodeling in progressing myopia [55]. Formononetin is known decrease 
HIF-1α, vascular endothelial growth factor (VEGF) and prolyl hydroxylase 
domain-2 (PHD-2), which are protective in hypoxia-induced retinal neovascular-
ization [54]. Salidroside is protective against for hypoxia-induced cardiac apoptosis 
and pulmonary hypertension [56, 57].
In animal models with experimentally induced myopia, anti-hypoxic drugs 
down-regulated HIF-1α expression and the phosphorylation levels of eIF2α and 
mTOR to inhibit the development of form deprivation myopia, without affecting 
the normal ocular growth in guinea pigs [55]. Due to encouraging results in animal 
models, the use of anti-hypoxic drugs shows great potential for treatment of myopia 
in human eyes.
2.3 Surgical management
Surgeons have recently advocated for surgical intervention to halt the progres-
sion of myopia, axial elongation and weakening of the posterior sclera. Macular 
buckle surgery or posterior reinforcement (PSR) surgery is proven to be effective 
in reinforcing the weakened posterior sclera. A scleral buckle is used to apply direct 
mechanical force onto the posterior pole, which slows the axial elongation. Shen 
et al. documented significantly higher Best-Corrected Visual Acuity (BCVA) and 
lower refractive error in the group who underwent macular buckle surgery com-
pared to the control group [58]. Additionally, patients who underwent PSR surgery 
have a shorter mean axial length and lower mean refractive error than the control 
group [59, 60].
Macular buckling surgery has also been used myopic macular hole with retinal 
detachment and posterior staphyloma, which displayed high reattachment rates and 
improved visual acuity [61, 62]. Recent studies have experimented with different 
buckle materials, shapes, techniques and other modifications for the best correc-
tion of myopia and its complications [63–65]. With more advanced techniques and 
modifications, the surgical technique can be utilized as conventional treatment of 
myopia to reduce myopia progression and axial elongation.
3. Conclusion
The global prevalence of myopia is in an increasing trend, with estimates of 
myopia and high myopia affecting nearly 5 billion and 1 billion people, respectively, 
in 2050 [1]. As a major public health concern, it is essential to develop interventions 
that sufficiently delay or stop the progression of myopia. Of the above discussed 
treatments, all have shown to reduce the progression of myopia, but atropine has 
been the most popular and effective in reducing progression and axial elonga-
tion. Despite the expected side effects, its rebound phenomenon and its obscure 
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mechanism, atropine has achieved global popularity. With changes in lifestyle, 
health education, government and other health systems, the importance and 
acceptance of myopia control will significantly diminish number of people affected. 
Additionally, the implementation of a conventional, safe and effective intervention 
for myopia control will significantly reduce the personal, societal and economic 
burden, and decrease the disease progression and the risk of future myopia-induced 
ocular complications.
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countries, and more recently it has been adopted by the Western countries as well. 
With further investigation and modification to the treatment regimen that evades 
rebound phenomenon, atropine has the potential to be the conventional treatment 
of myopia.
2.2.3 Anti-hypoxic drugs
Anti-hypoxic drugs such as salidroside and formononetin have shown anti-
hypoxic effects to treat scleral hypoxia in myopia [53, 54]. Scleral hypoxia, which 
is induced by Hypoxia-Inducible Factor-1α (HIF-1), triggers a signaling cascade 
for myofibroblast trans-differentiation leading to scleral extracellular collagenous 
matrix remodeling in progressing myopia [55]. Formononetin is known decrease 
HIF-1α, vascular endothelial growth factor (VEGF) and prolyl hydroxylase 
domain-2 (PHD-2), which are protective in hypoxia-induced retinal neovascular-
ization [54]. Salidroside is protective against for hypoxia-induced cardiac apoptosis 
and pulmonary hypertension [56, 57].
In animal models with experimentally induced myopia, anti-hypoxic drugs 
down-regulated HIF-1α expression and the phosphorylation levels of eIF2α and 
mTOR to inhibit the development of form deprivation myopia, without affecting 
the normal ocular growth in guinea pigs [55]. Due to encouraging results in animal 
models, the use of anti-hypoxic drugs shows great potential for treatment of myopia 
in human eyes.
2.3 Surgical management
Surgeons have recently advocated for surgical intervention to halt the progres-
sion of myopia, axial elongation and weakening of the posterior sclera. Macular 
buckle surgery or posterior reinforcement (PSR) surgery is proven to be effective 
in reinforcing the weakened posterior sclera. A scleral buckle is used to apply direct 
mechanical force onto the posterior pole, which slows the axial elongation. Shen 
et al. documented significantly higher Best-Corrected Visual Acuity (BCVA) and 
lower refractive error in the group who underwent macular buckle surgery com-
pared to the control group [58]. Additionally, patients who underwent PSR surgery 
have a shorter mean axial length and lower mean refractive error than the control 
group [59, 60].
Macular buckling surgery has also been used myopic macular hole with retinal 
detachment and posterior staphyloma, which displayed high reattachment rates and 
improved visual acuity [61, 62]. Recent studies have experimented with different 
buckle materials, shapes, techniques and other modifications for the best correc-
tion of myopia and its complications [63–65]. With more advanced techniques and 
modifications, the surgical technique can be utilized as conventional treatment of 
myopia to reduce myopia progression and axial elongation.
3. Conclusion
The global prevalence of myopia is in an increasing trend, with estimates of 
myopia and high myopia affecting nearly 5 billion and 1 billion people, respectively, 
in 2050 [1]. As a major public health concern, it is essential to develop interventions 
that sufficiently delay or stop the progression of myopia. Of the above discussed 
treatments, all have shown to reduce the progression of myopia, but atropine has 
been the most popular and effective in reducing progression and axial elonga-
tion. Despite the expected side effects, its rebound phenomenon and its obscure 
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mechanism, atropine has achieved global popularity. With changes in lifestyle, 
health education, government and other health systems, the importance and 
acceptance of myopia control will significantly diminish number of people affected. 
Additionally, the implementation of a conventional, safe and effective intervention 
for myopia control will significantly reduce the personal, societal and economic 
burden, and decrease the disease progression and the risk of future myopia-induced 
ocular complications.
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Abstract
Myopia is the most prevalent refractive error in the world and its incidence is 
increasing. Together with conservative methods of treatment, various surgical 
methods have been proposed. Corneal refractive surgery is probably the most 
accepted one. Laser in situ keratomileusis (LASIK), photorefractive keratectomy 
(PRK), and small incision lenticule extraction (SMILE) are suitable for treatment of 
myopia up to −8.00 D in the younger age group. For patients not suitable for corneal 
refractive surgery, lens-based procedures are available. Phakic intraocular lenses are 
suitable for patients younger than 45 years of age with high myopia or some other 
contraindications for corneal refractive surgery. For older patients, refractive lens 
exchange (RLE) with implantation of multifocal or monofocal intraocular lenses is 
gaining popularity.
Keywords: myopia, LASIK, PRK, SMILE, phakic intraocular lenses,  
refractive lens exchange
1. Introduction
Myopia is a common refractive error in the population. It is defined as an optical 
aberration in which parallel light rays from a distant image are getting focused on 
a point anterior to the retina. Hereditary and environmental factors both play an 
important role in the development of myopia. Myopia typically appears between the 
age of 6 and 12, and the mean rate of progression is considered to be approximately 
0.50 D per year, based on studies of mostly Caucasian children. One of the studies 
showed that progression of myopia can vary by ethnicity, as well as by age of the 
child. For instance, in ethnic Chinese children, the progression rate is higher [1].
A recent report in Nature, entitled “The Myopia Boom,” demonstrated, and it is 
now widely accepted, that there is an epidemic of myopia in the developed countries 
of East and Southeast Asia, paralleled by an epidemic of high myopia [2]. Recent 
meta-analyses have suggested that close to half of the world’s population may be myo-
pic by 2050, with as much as 10% highly myopic [3]. Correction of refractive error 
can be achieved conservatively with glasses or contact lenses which is the treatment of 
choice in the childhood. However, despite the long-standing use of glasses and contact 
lenses, there are some disadvantages in both forms of optical correction. Increased 
light scatter, image magnification/minification, discomfort, and inconvenience are 
some of the issues with glasses, while contact lenses may irritate the ocular surface 
with increased risk of corneal scratches and infections. After the age of 21, vari-
ous surgical treatments can be considered. The best surgical option depends on the 
amount of refractive error and the patient’s cornea, lens, and age. Available options 
include various laser vision corrections which are aimed on the cornea, implantation 
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of phakic intraocular lenses (pIOLs), and refractive lens exchange (RLE) with 
implantation of multifocal and monofocal intraocular lenses (IOLs). It is important 
to perform a detailed examination of each patient and assess their needs, wishes, and 
expectations. Doctors need to explain in as much detail as possible what the expected 
results and risk would be with for the selected surgical method.
2. Corneal refractive surgery
Procedures which involve altering the shape of the cornea with excimer laser 
are collectively referred to as keratorefractive surgery, refractive keratoplasty, laser 
vision correction, or refractive corneal surgery.
2.1 Photorefractive keratectomy
Photorefractive keratectomy (PRK) was the first excimer laser technique for 
the treatment of refractive errors. Seiler performed the first corneal ablation in a 
live patient in 1985, and McDonald treated the first human sighted eye in 1985 after 
extensive preclinical investigation [4]. The PRK procedure involves removal of 
the central corneal epithelium, most commonly performed mechanically (brush, 
crescent knife, or alcohol) or with excimer laser when it is referred as transepithelial 
PRK (T-PRK). The denuded anterior stroma is then reshaped by the excimer laser, 
with either central corneal flattening, steepening, or a torical pattern when treating 
myopia, hyperopia, or astigmatism, respectively. Due to significant postoperative 
pain, relatively slow visual recovery, epithelial defects due to irregular healing, and 
haze development, especially when treating high myopia [5, 6], different techniques 
of epithelial removal were introduced over time to solve these complications [7]. 
Recently the role of surface ablations has been reevaluated due to raised issues of 
potential flap complications, risk of iatrogenic corneal ectasia, and inability to treat 
thin corneas with laser in situ keratomileusis (LASIK) [8]. With surface ablation 
techniques, there is no flap involved, and more cornea tissue is preserved, and 
by some it is still considered the overall safest procedure for treatment of low to 
moderate myopia [9]. It is performed, especially in corneas with superficial scar-
ring, epithelial dystrophies, or recurrent erosions, in thin corneas, after penetrating 
keratoplasty and for keratorefractive retreatments. The introduction of mitomycin 
C and modern surface ablation techniques has also increased the range of treatment 
and lowered the risk of haze and regression after PRK [10]. Therefore today surface 
ablation includes several sub-techniques such as epithelial LASIK (epi-LASIK), 
laser-assisted subepithelial keratectomy (LASEK), and T-PRK [11].
2.2 Laser in situ keratomileusis
The term LASIK was first used in 1990 by Pallikaris [4]. The procedure is per-
formed in two steps. The first step involves the formation of a front corneal flap and 
the lifting of the flap for the purpose of exposing the corneal stroma. The hinged flap 
consists of the corneal epithelium, the Bowman membrane, and superficial stroma. 
The second step is the application of the excimer laser on the stromal bed. Once the 
ablation with the excimer laser is finished, the flap is returned into its original position.
LASIK has now become the most common elective surgical procedure in the 
world, presumably because it is almost painless with fast visual recovery, as compared 
to PRK [4]. Nowadays, there are two techniques available for the formation of the 
flap—mechanical microkeratomes and femtosecond lasers. The use of femtosecond 
laser-assisted laser in situ keratomileusis (FsLASIK) offers greater precision in flap 
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creation leading to better morphological stability of the flap compared to earlier bladed 
microkeratome keratomileusis. However, changes in the biomechanical strength of 
the cornea, induction of higher-order aberrations, and flap-related complications can 
still occur [12]. LASIK reduces the tensile strength of the stroma by about 35% when 
the ablation takes place between 10 and 30% of the stromal depth [13]. Regarding the 
available data, and our experience, there is no significant difference in shorter-term 
refractive stability and induction of high-order aberrations between T-PRK and LASIK 
(Figures 1 and 2 and Table 1). However, when higher refractive errors are treated, 
surface ablations pose more risk for haze development and regression [14].
2.3 Small incision lenticule extraction
The femtosecond laser corneal procedure known as small incision lenticule 
extraction (SMILE) was originally described by Sekundo et al. and became clinically 
Figure 1. 
Comparison of change in spherical correction over time between T-PRK and LASIK.
Figure 2. 
Comparison of change in astigmatism correction over time between T-PRK and LASIK.
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Polar diagram showing target and surgically induced astigmatic values for the SMILE group. The concentric 
semicircles reduce in 0.50 D steps from −2.00 DC (outermost semicircle) toward zero (central point) in 0.50 DC 
steps. From right to left, the 0 to 90 to 180° axes are shown in 30° steps. The target and surgically induced 
astigmatism data points are shown as empty circles and filled dots, respectively.
available in 2011 [15]. The procedure does not require the creation of a flap: two pre-
cise intrastromal planar sections are created using a single femtosecond laser to form 
an intrastromal lenticule. The intrastromal lenticule is dissected from the pocket, 
grasped with a forceps, and manually extracted through a small incision. The incision 
is placed at the superior temporal/nasal quadrant, usually angled at 70°, and 2–5 mm 
in length. The removal of the intrastromal lenticule alters the shape of the cornea, 
thereby correcting myopia and astigmatism. Since Bowman’s layer remains intact, the 
procedure offers greater biomechanical stability, especially in the treatment of higher 
levels of myopia [15]. The flapless property of SMILE obviates the risks associated 
with LASIK including adverse events at flap creation and dislocation [16].
The tensile strength of the cornea may reduce by 55% after a SMILE procedure 
when the lenticule is formed and extracted from the anterior half of the stroma. Loss of 
tensile strength is less profound when the lenticule is extracted from deeper regions of 
the stroma. Thus, the exact change in the biomechanical properties of the cornea will 
depend on the amount of ablation and the location where the lenticule is formed [13].
Regarding the available data, and our experience, LASIK and SMILE are com-
parable procedures in terms of visual quality and reduction of myopia; however, in 
treating astigmatism LASIK still offers better precision (Figures 3 and 4).
2.4 Indications and preoperative preparation for refractive surgery
A detailed review of the patient’s condition before surgery and informing the 
patient about the results, benefits, and disadvantages of the procedure are the most 
important steps for a successful outcome of refractive surgery [17].
Table 1. 
Comparison of change in high-order aberrations over time between T-PRK and LASIK.
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The examination should include detailed medical history (systemic status, 
medications intake, allergies, ocular status, information about previous ocular 
surgeries—especially in the case of refractive lens exchange—and information 
about contact lens wear) and reasons/motivations for refractive surgery to iden-
tify patients with unrealistic expectations [18, 19]. It is important for patients to 
understand that refractive surgery primarily serves to reduce spectacle dependence 
and contact lens use, and it is not meant to completely remove all optical aids in all 
situations, for an indefinite time period.
Patients should discontinue contact lens use before the examination (for soft 
contact lenses, at least a week prior to the examination, and for rigid gas permeable 
contact lenses, at least 2–3 weeks prior) since corneal topography and biometry 
measurement can be severely affected by the corneal changes induced by contact 
lens wear. In the case of corneal warpage syndrome (corneal irregularities caused by 
contact lenses), contact lenses should be discontinued for at least 4–6 weeks [20].
The preoperative evaluation must include monocular manifest refraction, 
cycloplegic refraction, uncorrected distance visual acuity (UDVA), corrected 
distance visual acuity (CDVA), pupillometry, tonometry, anterior chamber depth 
(ACD) measurement, corneal topography/tomography, pachymetry, aberrometry, 
tear film quality and quantity, determining the dominant eye, ocular motility, and a 
fundus examination [18, 21]. Cycloplegic refraction is recommended to exclude the 
accommodation effect, while in patients in/or close to presbyopia age near visual 
acuity should be checked also. It is mandatory to check the patient’s refractive sta-
bility during the time, which can most often be obtained by inspecting the patient’s 
eyeglasses or by reviewing the previous ophthalmological documentation [21].
Contraindications for refractive surgery may relate to systemic or ocular disor-
ders. Absolute systemic contraindications are poorly controlled systemic immune 
diseases (e.g., rheumatoid arthritis, systemic lupus erythematosus, polyarteritis 
nodosa), as well as poorly controlled diabetes and AIDS. Such patients have a higher 
risk of complications associated with prolonged inflammation or corneal healing 
after refractive surgery [18, 22–24]. Surgical procedures are not recommended dur-
ing pregnancy and lactation [25].
Ocular absolute contraindications are considered to be poorly controlled or 
untreated eye inflammation (blepharitis, dry eye syndrome, atopy/allergy), 
poorly controlled glaucoma, clinically significant lens opacities, Stevens-Johnson 
syndrome, ocular pemphigoid, and chemical burns of the eye surface [26, 27]. 
Instability of refraction (i.e., a change greater than 0.50 D within a year) is 
Figure 4. 
Polar diagram showing target and surgically induced astigmatic values for the FsLASIK group. The concentric 
semicircles reduce in 0.50 D steps from −2.00 DC (outermost semicircle) toward zero (central point) in 0.50 DC 
steps. From right to left, the 0 to 90 to 180° axes are shown in 30° steps. The target and surgically induced 
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considered as an absolute contraindication, as well as insufficient corneal thickness 
or corneal irregularities suspicious for keratoconus [21, 26, 28, 29]. Precautions are 
also needed in patients with certain systemic therapies (isotretinoin, amiodarone, 
sumatriptan, colchicine) [23, 24, 30]. Caution is also required in functional monoc-
ular patients and in patients with well-controlled glaucoma. Other relative contra-
indications are history of uveitis, herpes simplex, and varicella zoster keratitis. In 
patients with epithelial basal membrane degeneration, LASIK is not recommended, 
but PRK is the procedure to consider [21, 31].
2.5 Limitations and complications of corneal refractive surgery
Complications of corneal refractive surgery are considered rare. They can be divided 
in intraoperative and postoperative complications (which can be early or delayed).
Regarding the intraoperative complications, they are mainly correlated with 
corneal flap creation or excimer laser ablation. During the era of microkeratome, 
flap-related complications were encountered more often and fell within 3%; with 
the introduction of femtosecond lasers, they were almost nullified; however, some 
complications specific to femtosecond lasers appeared [32].
Flap-related complications include free or partial flap creation, incomplete and 
irregular flap creation, thin and perforated flaps, and corneal perforation. Those 
complications were mostly related to corneal anatomy (flat <41.00 D or steep >46.00 
D corneas, small corneal diameter), inadequate suction, mechanical failure—a 
defect in the dissection blade or motor unit—and surgeon experience. Penetration 
into the anterior chamber is extremely rare and may occur during lamellar dissection 
or excimer laser photoablation usually on extremely thin corneas with old scars [33].
Femtosecond-related complications are closely correlated with cavitation 
bubbles and formation of the flap. They are presented in the form of confluent 
cavitation bubbles in the corneal lamellae or anterior chamber which can interfere 
with excimer laser systems and vertical gas breakthrough which is presented in the 
forms of incomplete buttonholes or difficulties in dissecting the flap due to tissue 
bridges [34]. Temporary hypersensitivity to light and rainbow glare are complica-
tions exclusively related to energy and pattern of femtosecond lasers characterized 
with normal visual acuity and photophobia without inflammation or light disper-
sion in low light conditions [35].
Laser-related complications include decentration of excimer laser ablation, 
irregular astigmatism, and formation of central islands. Those complications are 
clinically characterized by poor uncorrected and corrected distance visual acuity 
complaints of glare, “ghosting” around images and haloes, and refractive astigma-
tism in the axis of decentration [33].
Early postoperative complications include flap striae, diffuse lamellar keratitis, 
central toxic keratopathy, pressure-induced steroid keratitis, infectious keratitis, 
and epithelial ingrowth.
Flap striae are caused by misalignment of the flap; peripheral striae usually are 
asymptomatic; however, central location of the striae is associated with loss in cor-
rected distance visual acuity and night vision disturbances [33, 36].
Diffuse lamellar keratitis (Sands of Sahara syndrome) is a sterile inflammation 
probably caused by the introduction of toxins in the flap interface [37, 38]. It is 
graded in four stages, with stage one and two being mild and visually unthreaten-
ing, while stage four can lead to corneal melting and permanent changes [33, 39]. 
In comparison to diffuse lamellar keratitis, central toxic keratopathy is a rare 
noninflammatory central corneal opacification linked to enzymatic degradation of 
keratocytes with spontaneous resolution and mild central opacification which often 
causes refractory hyperopic shift [40].
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Pressure-induced stromal keratitis is also easily mistaken with diffuse lamel-
lar keratitis but is caused by postoperative steroid use which leads to increase in 
intraocular pressure and represents as cystoid lamellar edema [41].
Infectious keratitis after LASIK is extremely rare but can be quite serious since 
invading organisms are already implanted into the deep corneal stroma. The most 
often isolated organisms include Streptococcus pneumoniae, Staphylococcus aureus, 
Mycobacterium chelonae, and Nocardia asteroides [33, 42].
Epithelial ingrowth under the LASIK flap is reported to occur in merely 1–2% 
of patients and is caused by migration of epithelial cells under the flap. It is usually 
insignificant, but if epithelial cells continue to grow, it can cause flap distortion and 
melting causing visual disturbances [43].
Late postoperative complications include dry eye, night vision problems, corneal 
haze, regression of refractive error, and iatrogenic corneal ectasia.
Dry eye syndrome is caused by denervation and cutting of nerve fibers during 
the formation of the flap, removal of corneal tissue by excimer laser, and changes in 
the shape of the cornea. Dry eye syndrome is usually transient and symptoms fade 
away after healing period. It causes discomfort, fluctuation in vision quality, slower 
healing, and epithelial damage and may lead to regression of refractive error and 
reduced vision quality [44].
Symptoms of impaired visual quality are usually more expressed during the 
night due to physiological pupil dilatation. The main causes of nighttime issues 
are the increase in spherical aberrations at the centrally flatted cornea, decentered 
ablations, too small optical zones, newly emerging lens opacities, and induced 
astigmatism [45].
Corneal haze reduces corneal transparency at variable degrees and is more 
common after PRK and correction of high myopia (>−6.00 D). Besides the abla-
tion depth, it is correlated with an excessive ocular UV-B radiation, duration of the 
epithelial defect, postoperative steroid treatment, male sex, and certain population 
with brown iris [46].
Regression of refractive error is defined as return of part of the primary refrac-
tive error and is associated with increase in thickness and curvature of the cornea. 
Potential mechanisms include nuclear sclerosis, stromal synthesis (wound healing), 
compensatory epithelial hyperplasia, and iatrogenic keratectasia [47].
Postoperative ectasia is linked to biomechanical weakening of the cornea and is 
characterized with progressive corneal steepening, either centrally or inferiorly, result-
ing in severe progressive irregular astigmatism and decrease of both uncorrected and 
best-corrected visual acuity. The incidence of ectasia after LASIK has been estimated 
between 0.04 and 0.9% [48]. Risk factors include abnormal topographic findings, thin 
cornea, and high myopia together with young age at the time of surgery [49].
Intraoperative complications of SMILE procedure are usually not sight threaten-
ing, and the procedure usually can be continued [13, 15, 50]. The most common 
complications are incision or cap tears, suction loss, cap perforation, black spots, 
and opaque bubble layer which lead to cap lenticular adhesions and retained 
lenticule. Regarding the postoperative complications of SMILE procedure, they 
are similar to all laser refractive procedures and include epithelial ingrowth, dry 
eye, diffuse lamellar keratitis, corneal haze, irregular astigmatism, minor interface 
infiltrates, increased aberrations, and iatrogenic ectasia [50, 51].
3. Intraocular correction of myopia
Two basic intraocular procedures exist: phakic intraocular lens (pIOL) implanta-
tion and refractive lens exchange (RLE) with posterior chamber IOL implantation.
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considered as an absolute contraindication, as well as insufficient corneal thickness 
or corneal irregularities suspicious for keratoconus [21, 26, 28, 29]. Precautions are 
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sumatriptan, colchicine) [23, 24, 30]. Caution is also required in functional monoc-
ular patients and in patients with well-controlled glaucoma. Other relative contra-
indications are history of uveitis, herpes simplex, and varicella zoster keratitis. In 
patients with epithelial basal membrane degeneration, LASIK is not recommended, 
but PRK is the procedure to consider [21, 31].
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the introduction of femtosecond lasers, they were almost nullified; however, some 
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D corneas, small corneal diameter), inadequate suction, mechanical failure—a 
defect in the dissection blade or motor unit—and surgeon experience. Penetration 
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Femtosecond-related complications are closely correlated with cavitation 
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Early postoperative complications include flap striae, diffuse lamellar keratitis, 
central toxic keratopathy, pressure-induced steroid keratitis, infectious keratitis, 
and epithelial ingrowth.
Flap striae are caused by misalignment of the flap; peripheral striae usually are 
asymptomatic; however, central location of the striae is associated with loss in cor-
rected distance visual acuity and night vision disturbances [33, 36].
Diffuse lamellar keratitis (Sands of Sahara syndrome) is a sterile inflammation 
probably caused by the introduction of toxins in the flap interface [37, 38]. It is 
graded in four stages, with stage one and two being mild and visually unthreaten-
ing, while stage four can lead to corneal melting and permanent changes [33, 39]. 
In comparison to diffuse lamellar keratitis, central toxic keratopathy is a rare 
noninflammatory central corneal opacification linked to enzymatic degradation of 
keratocytes with spontaneous resolution and mild central opacification which often 
causes refractory hyperopic shift [40].
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3.1 Phakic intraocular lenses
Phakic intraocular lenses (pIOL) provide a safe and effective alternative for 
young patients with moderate to high refractive errors who may not be suitable 
candidates for excimer laser procedures or who prefer a reversible form of vision 
correction with efficacy comparable to results of LASIK [52]. It has been established 
that attempted corrections of high myopia with excimer laser procedures induce 
more higher-order aberrations, affecting vision quality and creating problems 
such as glare, halos, and ghost imaging [53]. Additional advantages of intraocular 
procedures are a broader range of treatable ametropia, faster visual recovery, more 
stable refraction, and better visual quality. In addition, the pIOL implantation does 
not affect accommodation, and the procedure is reversible [52, 54].
Currently, there are two types of phakic intraocular lenses approved for cor-
recting refractive errors: anterior chamber—iris fixated—and posterior chamber. 
Verisyse and Veriflex lenses are iris-fixated intraocular lenses. More than 160,000 of 
these lenses have been safely implanted worldwide [55]. The Verisyse pIOL is made 
from rigid, ultraviolet-absorbing polymethyl methacrylate (PMMA). This lens 
requires a 5.5–6.5-mm incision, depending on the optic size of the lens, whereas the 
Veriflex pIOL requires a 3.2-mm incision. The Verisyse pIOL is available for myopia, 
hypermetropia, and astigmatism. For myopia, the pIOL is available in powers from 
−1.00 to −23.50 D in 0.50 D steps with two optic diameters of 5.0 or 6.0 mm. The 
Veriflex pIOL is a foldable implant with 6.0 mm flexible optic made of hydrophobic 
polysiloxane and features a PMMA haptic. It is available only for myopia in powers 
ranging from −2.00 to −14.50 D in 0.50 D steps.
The Visian Implantable Collamer Lens (ICL) is a posterior chamber phakic intra-
ocular lens resting in the ciliary sulcus. ICL is made from soft advanced collamer 
material and requires 3.2 mm incision. It is available for myopia, hypermetropia, 
and astigmatism. For myopia, the pIOL is available in powers from −0.50 to −18.00 
D in 0.50 D steps with four lens diameters (12.1, 12.6, 13.2, 13.6 mm) and optical 
zone up to 6.1 mm.
3.1.1  Preoperative examination and indications for phakic intraocular lens implantation
The preoperative evaluation of a patient for pIOL is the same as for any kind 
of refractive procedure. Inclusion criteria are more than 21 years of age, refractive 
stability (<0.50 D of change) for at least 1 year, ACD ≥ 3.0 mm measured from 
endothelium, endothelial cell count >2300 cells/mm2 (>2500 cell/mm2 if <40 years 
of age, > 2000 cells/mm2 if >40 years of age), irido-corneal angle ≥30° (at least 
grade II by gonioscopy examination), mesopic pupil size <6.00 mm, no anomaly of 
iris or pupil function, no evolving retinal pathology, absence of uveitis or any kind 
of ocular inflammation, and absence of glaucoma or any systemic immunological 
disorder [56, 57].
3.1.2 Intraocular lens power calculation and diameter selection
pIOL optic power is calculated with the software provided by the manufacturer. 
The calculation is based on the formula developed by van der Heijde [58]. The 
formula uses the patient’s refraction at the 12-mm spectacle plane or the vertex 
refraction, the corneal keratometry dioptric power at its apex, and central ACD [59]. 
For Verisyse and Veriflex lenses, only one lens diameter is available, while for the ICL 
overall diameter depends on the ciliary sulcus diameter and should provide perfect 
stability with no excess of compression forces to the sulcus and allow correct vaulting. 
The ICL’s diameter should be oversized 0.5–1.0 mm from the white-to-white (WTW) 
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measurements in myopic eyes and the same length or oversized 0.5 mm in hyperopic 
eyes. The internal diameter of the ciliary sulcus can be measured by ultrasound biom-
etry (UBM) or can be approximated by horizontal WTW measurement obtained 
manually using a caliper or automatically by topographic or biometric devices [60].
3.1.3 Limitations and possible complications of phakic intraocular lenses
The complications relating to pIOLs can, at times, be more disabling than those 
from keratorefractive surgery. Night vision problems, corneal decompensation, 
glaucoma, cataract formation, dyscoria, uveitis, and endophthalmitis are potential 
complications after pIOL implantation. Night vision problems such as glare, halos, 
and diplopia are related to decentration of the pIOL and/or an optic diameter that is 
too small relative to the pupil size [61].
Surgically induced astigmatism is an issue primarily correlated with rigid Verisyse 
lenses and incision diameter. However, some investigators reported that the resulting 
surgically induced astigmatism (SIA) was less than expected [62, 63]. However, when 
compared with the Veriflex pIOL and ICL, the SIA was significantly higher [64].
Implantation of a pIOL, whether iris fixated or positioned in the posterior cham-
ber, is associated with an accelerated decrease in endothelial cell density (ECD) 
[60]. Damage to the corneal endothelium may be due to the direct contact between 
pIOL and the inner surface of the cornea during implantation, from postoperative 
changes in pIOL position, or from subclinical inflammation, and direct toxicity to 
the endothelium. The magnitude of ECD loss after phakic intraocular lens implan-
tation surpasses the expected natural annual decrease of 0.6% as reported in a 1997 
benchmark study based on 42 adults [65]. Following implantation of an iris-claw 
phakic intraocular lens, the loss of ECD is highest during the first year varying 
between 0.75 and 7.2% [66]. Thereafter, the ECD loss continues without following 
an obvious pattern, to about 8.9% after 10 years. However, with an ICL the impact 
on the endothelium is claimed to be lower because the implant is placed in the 
posterior chamber further away from the endothelium itself. For the ICL the ECD 
loss is about 1.7% after 2 years [60] increasing to 6.2% after 8 years [54] and up to 
19.75% after 12 years [67].
In our experience after ICL implantation, there is a linear decrease in ECD over 
a 3-year period, without any signs of exponential EC loss or reaching a plateau or 
stable ECD during this time (Figure 5).
With modern pIOL designs, increased intraocular pressure (IOP) seems to be 
relatively uncommon after 3 months postoperatively and is typically thought to be 
related to corticosteroid response [68]. Posterior chamber pIOLs cause narrowing 
of anterior chamber angle due to its position in ciliary sulcus, and its sizing (too 
long lenses which cause excessive vaulting >750 μm) is closely correlated with 
possible angle-closure glaucoma, pupillary block glaucoma, or pigmentary disper-
sion glaucoma [69, 70]. Given the risk of pupillary block, peripheral iridectomy 
or iridotomy is carried out as a preventative measure in anterior pIOL procedures, 
while in newer models of ICL with aquaport, technology is not needed.
Pupil ovalization/iris retraction is mainly correlated with iris-fixated pIOL and 
can occur if fixation of the pIOL haptics is performed asymmetrically [61, 68, 71]. 
No progressive pupil ovalization has been reported.
Formation of cataract due to the iris-claw pIOL is unlikely because the pIOL 
is inserted over a miotic pupil without contact with the crystalline lens [61]. The 
incidence of cataract formation was 1.1% for the iris-fixated pIOL. The overall 
incidence of cataract formation for posterior chamber pIOLs was 9.60%, which is 
significantly higher in comparison to iris-fixated pIOLs [72]. With various genera-
tions of the ICL, appearance of cataract formation is different. The less vaulted 
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model V3 caused a higher incidence of cataract formation than the newer V4 and 
V5 models [73]. With the V4 model, the recently published FDA study showed an 
incidence of 2.1% anterior subcapsular opacities, which is the most common type 
of cataract after pIOL [59]. Possible reasons are operative trauma, continuous or 
intermittent contact of the posterior chamber pIOL with the crystalline lens, insuf-
ficient nutrition through anterior chamber flow between the posterior chamber 
pIOL and the crystalline lens, and chronic subclinical inflammation with disruption 
of the blood-aqueous barrier due to friction between the pIOL and posterior iris or 
the haptic on the ciliary sulcus [74–76].
The risk of uveitis is a concern given the proximity of pIOLs to the iris, but it 
does not seem to be a significant long-term complication with modern designs. With 
iris-fixated pIOLs, a difficulty with enclavation of the iris can lead to iris atrophy 
and decentration of the implant [52]. Retinal detachment seems to be uncommon 
and lower than in clear lens extraction cases [68, 77]. A few cases of endophthal-
mitis have been reported after pIOL implantation, but it seems less common after 
pIOL implantation and then after cataract surgery [78, 79].
3.2 Refractive lens exchange
Refractive lens exchange (RLE) is by definition used to indicate the replacement of 
the cataractous/clear crystalline lens with an intraocular lens (IOL) to achieve emme-
tropia/near emmetropia. The improved efficacy, predictability, and safety of modern-
day phacoemulsification have resulted in a resurgence of lens extraction as a modality 
for correction of high myopia. Increased numbers of RLE are being performed 
worldwide, especially in patients not suitable for LASIK or pIOL or with early lens 
changes in the presbyopia age group [80, 81]. Optics of the IOL confer better quality 
of vision as compared with LASIK, and this optical quality does not degrade with time 
except in the presence of a posterior capsular opacification. The refractive results are 
predictable and stable with a larger range of refractive correction possible than with 
either LASIK or pIOL. RLE addresses refractive error and cataract and with the use of 
modern multifocal IOLs results in a significant degree of spectacle independence for 
the patient. Visual recovery is faster, and it is more cost-effective, as the higher cost of 
pIOLs and future cataract surgery is eliminated. The principles of surgery are in the 
domain of most cataract/anterior segment surgeons [82].
Overall, patient satisfaction scores after implantation of multifocal IOLs are 
high. For example, using a 0–10 self-recording analogue scale, you can expect 
Figure 5. 
Mean endothelial cell density during the 3-year follow-up (28 eyes); ± SD error bars are included indicating the 
variance in the data.
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typical average satisfaction scores of 8.8 (Zeiss bifocal IOL, n = 48, range 2–10) and 
9.00 (Zeiss trifocal IOL, n = 52, range 4–10). On closer examination satisfaction 
scores are closely linked to post-op uncorrected distance and intermediate, visual 
acuity as demonstrated in Figure 6.
Advanced technology multifocal IOLs tend to be less forgiving with respect 
to the surgical technique, multifocal IOL power selection, ocular comorbidities, 
and patient selection. Comorbidities such as dry eye, vitreomacular pathology, or 
implant decentration may be tolerated in patients after a monofocal IOL implanta-
tion. However, these are much less tolerated by the multifocal IOL patients [83, 84].
Presbyopia-correcting intraocular lenses should provide post-op emmetropia 
for the best visual outcome, as small amounts of residual refractive errors can limit 
visual performance and jeopardize the result [85].
3.2.1 Preoperative examination and indications for refractive lens exchange
In evaluating the highly myopic patient, several aspects apart from the routine 
cataract/refractive surgery assessment should be noted. A detailed past ocular history 
is important, as previous refractive surgery or phakic intraocular lens implants or 
retinal problems (e.g., vitrectomy for previous retinal detachment) will affect lens 
formula choices and their final prognosis. Preoperative assessment should also 
include a detailed clinical examination of their lens status (e.g., cataract density and 
any zonular weakness) and refraction status of both eyes, as well as a dilated exami-
nation of the fovea and periphery for any retina disorder (e.g., myopic choroidal neo-
vascular membrane, macular schisis, retinal tears, or detachment). Other issues for 
discussion include the potential use of toric or multifocal IOLs. Ideally, a larger haptic 
platform toric lens should be used in high myopes to reduce the risk of postoperative 
lens rotation, as the capsular bag is often large and floppy. In some cases, the use of a 
capsular tension ring to stretch the capsular bag may be required to prevent rotations. 
Multifocal IOLs should only be used in an eye with no retinal disorder [86].
Inclusion criteria are more than 40 years of age with myopia not amenable to 
conventional laser refractive surgery (e.g., high refractive error, corneal irregulari-
ties, thin cornea) or phakic IOLS (e.g., shallow anterior chamber, poor endothelial 
cell count, early cataract changes), presbyopic myopic patients who want reason-
able independence from glasses for both distance, and near-vision, myopic patients 
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Figure 5. 
Mean endothelial cell density during the 3-year follow-up (28 eyes); ± SD error bars are included indicating the 
variance in the data.
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typical average satisfaction scores of 8.8 (Zeiss bifocal IOL, n = 48, range 2–10) and 
9.00 (Zeiss trifocal IOL, n = 52, range 4–10). On closer examination satisfaction 
scores are closely linked to post-op uncorrected distance and intermediate, visual 
acuity as demonstrated in Figure 6.
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and patient selection. Comorbidities such as dry eye, vitreomacular pathology, or 
implant decentration may be tolerated in patients after a monofocal IOL implanta-
tion. However, these are much less tolerated by the multifocal IOL patients [83, 84].
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visual performance and jeopardize the result [85].
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cataract/refractive surgery assessment should be noted. A detailed past ocular history 
is important, as previous refractive surgery or phakic intraocular lens implants or 
retinal problems (e.g., vitrectomy for previous retinal detachment) will affect lens 
formula choices and their final prognosis. Preoperative assessment should also 
include a detailed clinical examination of their lens status (e.g., cataract density and 
any zonular weakness) and refraction status of both eyes, as well as a dilated exami-
nation of the fovea and periphery for any retina disorder (e.g., myopic choroidal neo-
vascular membrane, macular schisis, retinal tears, or detachment). Other issues for 
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3.2.2 Limitations and possible complications of refractive lens exchange
The commonest disadvantage is the loss of accommodation with the need for 
near-vision glasses in the cases of monofocal IOL and the inherent risk associated 
with intraocular surgery, especially in high myopes [80]. The risk for endophthal-
mitis in general cataract surgery with implantation of a posterior chamber IOL is 
0.1–0.7% with an optimal antiseptic perioperative treatment regimen [87]. Lens 
surgery is significantly more challenging in a highly myopic eye for several reasons. 
The issues that we take for granted in an eye of normal length (22–25 mm) such as 
the accuracy of axial length measurements and the choice of lens formula become 
a significant issue in the highly myopic eye as the predicted refractive outcomes 
are not achieved consistently. Axial length measurement error has been largely 
overcome by the use of optical interferometry. Despite this, consistent hyperopic 
errors are still reported. Improved predictive results are obtained with the Barrett 
Universal II (software constants), Haigis (ULIB), SRK/T, Holladay 2 (software con-
stants), and Olsen (software constants) formulas in eyes with axial lengths greater 
than 26.0 mm and IOL powers greater than 6.0 D. In the eyes with axial lengths 
greater than 26.0 mm and IOL less than 6.00 D, the Barrett Universal II formula 
(software constants) and the Haigis (axial length adjusted) and Holladay 1 formulas 
(axial length adjusted) should be used [88, 89].
Intraoperatively, a highly myopic eye is surgically more challenging as the 
anterior chamber is deeper, with a floppy and large capsular bag and occasionally 
zonular weakness [90]. The anterior chamber is often unstable, and it is even less 
stable in a previously vitrectomized high myopic patient. There is also a concern 
that with elongated axial lengths, there is a higher risk of bag instability that can 
cause impaired vision, and the more complicated the IOL design is, the more 
sensitive the IOL is to final centration. A study by Soda et al. found that in uncom-
plicated cataract surgery with an IOL in the bag, the maximum decentration can be 
0.3 mm for a satisfying result [91]. In addition, it is reported that myopic patients 
may exhibit worse results with more reported subjective symptoms and measur-
able aberrations like coma and glare in mesopic and scotopic lighting conditions 
compared to non-myopic controls, after multifocal IOL implantation with approxi-
mately the same amount of decentration [91]. RLE may increase the risk for retinal 
detachment and is generally not considered in myopic pre-presbyopic patients who 
can still accommodate.
The incidence of retinal detachment is especially high among younger age 
groups (<50 years) and in the eyes with long axial length > 26 mm. The reported 
incidence of retinal detachment after RLE ranges from 2 to 8%. Meticulous sur-
gery with minimal intraoperative vitreous disturbance and a regular follow-up 
postoperatively until the occurrence of posterior vitreous detachment can reduce 
the risk of retinal detachment further. With the higher risk of retinal detachment 
in younger patients, it is prudent to defer RLE in patients younger than 40 years if 
possible [92].
Other possible causes of unfavorable visual outcome after uncomplicated 
phacoemulsification are cystoid macular edema (CME) and choroidal neovascular 
membrane (CNVM). Overall incidence of subclinical CME diagnosed with optical 
coherence tomography (OCT) is 5%, and incidence of clinical CME is 3%; however, 
high myopia does not increase the risk of CME [93]. Reported incidence of CNVM 
after RLE for myopia is 12.5% [94]; however, whether this was related to the higher 
degree of myopia with preexisting lacquer crack that was missed or due to some 
inflammatory mediators and free radicals released after surgery cannot be conclu-
sively proved. Because the reported incidence of CNVM after uncomplicated phaco-
emulsification is not high, we assume that it is secondary to the degree of myopia, 
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and it is prudent to perform OCT preoperatively in all RLE patients, especially those 
with more than 10 D of myopia. The presence of a myopic CNVM in the fellow eye is 
also considered as a risk factor for developing CNVM in the operated eye [80, 94].
4. Conclusions
Surgical treatment of myopia is a viable, safe, efficient, and predictable method 
for treating patients with myopia. There are several options of surgical treatment; 
we as doctors must always use our best judgment and available data to make sure we 
recommend the best method for each patient and their respective needs while tak-
ing into account any possible risk and contraindications. Among elective procedures 
in medicine, myopia treatment is one of the most commonly performed surgeries 
because of the positive effect it brings the patients’ quality of life.
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Secondary intraocular lens (IOL) implantation has evolved over the past few 
decades. Several new techniques, lens options, and materials now exist. Careful 
patient selection is important to determine the optimal secondary IOL technique. 
Intraocular lens placement in the capsular bag is the most ideal followed by sulcus 
placement. However, the best option when no capsular support exists in an aphakic 
patient remains unclear. Surgeons should be aware of contraindications for each 
technique; however, there are several situations where anterior chamber intraocular 
lens (ACIOL), scleral-fixated intraocular lens (SFIOL), and iris fixation can all 
be used. In those cases, surgeon familiarity and comfort with the secondary IOL 
technique can determine the type of surgery performed.
Keywords: secondary intraocular lens, aphakia, scleral fixated, iris fixated,  
anterior chamber intraocular lens
1. Introduction
Secondary intraocular lens implantation is defined as implantation of an 
intraocular lens following an initial surgery that resulted in aphakia or a defi-
cient intraocular lens. The indications for secondary intraocular lens insertion 
have evolved with improved surgical outcomes of modern cataract surgery. 
Newer surgical techniques and lenses has also advanced the field of secondary 
intraocular lenses. The first wave of secondary intraocular lenses to be implanted 
was the anterior chamber intraocular lens (ACIOL) [1]. Secondary intraocular 
lenses can now be implanted in a variety of anatomic locations with different 
techniques used to support the lens (sutured, iris claw, etc.). Specifically, sutured 
IOL and intrascleral fixation techniques have been gaining popularity. Szigiato 
et al. found a 538% increase in secondary sutured IOL techniques from 2000 to 
2013 [2]. However, with the advent of several new techniques there is no clear 
guidance for the best technique for secondary IOL placement. This chapter aims 
to discuss the variety of secondary intraocular lenses, the indications for use, 
and surgical considerations.
2. Indications
Modern cataract surgery has evolved the role of secondary intraocular lens 
implantation since there is now less incidence of surgical aphakia after cataract 
surgery [2]. With current technology and improved cataract surgery technique, the 
most common reason for secondary lens implantation is IOL exchange. The rates 
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most common reason for secondary lens implantation is IOL exchange. The rates 
of IOL exchange also have declined over the years with recent studies showing 
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rates of 0.34–0.77% [2–4]. ACIOL explantation is most commonly due to corneal 
decompensation and inflammation [5, 6]. PCIOL explantation is most commonly 
due to IOL decentration and dislocation [7]. IOL dislocation can be due to zonular 
dehiscence from trauma, previous complicated surgery, or conditions predisposing 
to zonular instability such as pseudoexfoliation syndrome and Marfan’s syndrome.
Uveitis-hyphema-glaucoma (UGH) syndrome is a complication of iris chafing of an 
IOL. Most commonly this is due to a single-piece IOL with a haptic outside of the cap-
sular bag that comes in contact with posterior iris tissue. IOL chafing of iris tissue leads 
to iris transillumination defects, pigment dispersion, microhyphema/hyphema, and 
glaucoma. Treatment of UGH often requires IOL removal with placement of a second-
ary IOL although in some cases the haptic in the sulcus alone can be cut and removed.
In recent years, advancements in IOL calculations, cataract surgery technology 
and technique have improved refractive outcomes. Patient visual expectations after 
cataract surgery have increased and now, in some cases, IOL exchanges are per-
formed for unexpected refractive outcomes, dissatisfaction with multifocal lenses, 
and dysphotopsias following cataract surgery. The rates of IOL exchange due to 
patient dissatisfaction in one study showed an increase from 7.8% in 2005 to 21% in 
2014 [3]. In 2005, no patients underwent IOL exchange for unsatisfactory refractive 
outcomes in the absence of optical aberrations but in 2014, 42% of IOL exchanges 
were due to unsatisfactory refractive outcomes alone.
3. Preoperative evaluation
Prior to consideration of secondary intraocular lens implantation, a thorough 
pre-operative history is required. In particular, details of the prior cataract removal 
including intraoperative complications, type of IOL implanted, location of the IOL 
implant and the presence of other ocular hardware including glaucoma drainage 
devices are important pieces of information to gather before secondary IOL surgery. 
To this end, review of prior operative reports and medical records is a critical ele-
ment of every preoperative evaluation.
A thorough examination of the anterior and posterior segment is required 
to plan for a secondary IOL implantation. The conjunctiva and scleral should be 
examined to identify any prior incisional glaucoma surgery or devices. Corneal 
health should be evaluated to determine if an ACIOL is a viable option. Specular 
microscopy or pachymetry can be obtained as needed to assess corneal endothelial 
health. Anterior chamber depth should be evaluated as a narrow/shallow chamber 
might preclude safe ACIOL placement. The presence of vitreous prolapse in the 
anterior chamber should be noted as well as the integrity of the iris and capsule. 
Of note, high frequency ultrasound has shown to be better than slit lamp exami-
nation in assessing capsular support for sulcus IOL implantation [8]. If there is 
an intraocular lens in place, the type of lens and degree of dislocation should be 
assessed. The optic nerve and retina should be thoroughly examined to evaluate for 
any other ocular comorbidities that can limit vision potential or require treatment 
at the time of secondary IOL implantation. Finally, vision potential with a reliable 
manifest refraction is important to gauge the potential benefit of secondary IOL 
implantation.
4. Contact lens and aphakic glasses
Aphakic spectacles are a non-invasive option for bilateral aphakia although 




Aniseikonia is a significant difference in the perceived size of images between the 
two eyes. This difference in image sizes can be as large as 30% which makes fusion 
impossible [9]. Other drawbacks of aphakic spectacles are that they are heavy and 
have poor cosmesis since the lenses are thick centrally with significant magnifica-
tion. Also, patients wearing aphakic lenses may notice a ring scotoma and have to 
cope with objects jumping in and out of their visual field.
Extended-wear contact lenses can be an adequate option for managing binocular 
and monocular aphakia. Properly fitted contact lenses can be well-tolerated by 
patients and secondary IOL implantation can be avoided in patients who are happy 
with contact lens use. Some physicians argue that a trial of aphakic contact lenses 
should be required prior to secondary IOL implantation, especially in eyes with 
questionable functional visual potential.
5. Determination of anatomic location of secondary IOL
Choosing the best location and technique for secondary IOL implantation can 
be a difficult one. No clear guidelines are established for secondary IOL implanta-
tion. In 2003, Wagoner et al. reviewed the literature on secondary IOL implantation 
[10]. In this paper, the authors found no evidence to claim superiority of any one 
technique or anatomic location for fixation. Since 2003, secondary IOL surgery has 
continued to evolve dramatically and still no clear evidence exists to guide surgeons. 
As Wagoner’s paper noted, the most important factor often is the surgeon’s comfort 
with a secondary IOL technique.
There are however, some recommendations in ruling out certain anatomic 
locations for IOL fixation. For example, poor corneal endothelial status and/or 
abnormal angle/iris anatomy should discourage anterior chamber IOL implanta-
tion. Lack of adequate iris support would rule out other iris-fixated approaches 
(sutured or iris-claw). Lack of posterior capsular support or a fibrosed anterior/
posterior capsule would rule out in-the-bag PCIOL placement. Sulcus intraocular 
lens implantation requires adequate anterior capsular support. Scleral abnor-
malities (i.e., Marfan’s, scleral thinning, etc.) would rule out scleral fixation 
techniques.
In-the-bag posterior chamber intraocular lens implantation remains the best 
anatomic location for an intraocular lens. However, even if during secondary 
IOL implantation the aphakic eye has an intact posterior capsule, the anterior/
posterior capsule is typically fibrosed, preventing IOL implantation inside the 
capsular bag. Brunin et al. evaluated the complication rates, visual acuity and 
refractive outcomes of different intraocular lens implantation techniques [11]. 
Their study noted that capsular bag implantation had the best refractive out-
comes followed by sulcus IOL with optic capture and sulcus IOL without optic 
capture. There was no difference between transscleral-sutured IOL, iris-fixated 
IOLs, and ACIOLs.
If possible, in-the-bag implantation has the best outcomes given its closest 
proximity to normal anatomy. This requires a stable and intact capsular bag. 
If no posterior capsular exists but there is adequate anterior capsular support, 
sulcus IOL implantation can be performed, preferably with optic capture. 
However, if no capsular support exists, the guidelines for secondary IOL implan-
tation remain controversial [12]. If a viable 3-piece IOL has been dislocated, the 
preference might be to reposition the lens with an iris-sutured or scleral fixation 
technique. Other options include ACIOL implantation, iris-fixation techniques, 
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There are however, some recommendations in ruling out certain anatomic 
locations for IOL fixation. For example, poor corneal endothelial status and/or 
abnormal angle/iris anatomy should discourage anterior chamber IOL implanta-
tion. Lack of adequate iris support would rule out other iris-fixated approaches 
(sutured or iris-claw). Lack of posterior capsular support or a fibrosed anterior/
posterior capsule would rule out in-the-bag PCIOL placement. Sulcus intraocular 
lens implantation requires adequate anterior capsular support. Scleral abnor-
malities (i.e., Marfan’s, scleral thinning, etc.) would rule out scleral fixation 
techniques.
In-the-bag posterior chamber intraocular lens implantation remains the best 
anatomic location for an intraocular lens. However, even if during secondary 
IOL implantation the aphakic eye has an intact posterior capsule, the anterior/
posterior capsule is typically fibrosed, preventing IOL implantation inside the 
capsular bag. Brunin et al. evaluated the complication rates, visual acuity and 
refractive outcomes of different intraocular lens implantation techniques [11]. 
Their study noted that capsular bag implantation had the best refractive out-
comes followed by sulcus IOL with optic capture and sulcus IOL without optic 
capture. There was no difference between transscleral-sutured IOL, iris-fixated 
IOLs, and ACIOLs.
If possible, in-the-bag implantation has the best outcomes given its closest 
proximity to normal anatomy. This requires a stable and intact capsular bag. 
If no posterior capsular exists but there is adequate anterior capsular support, 
sulcus IOL implantation can be performed, preferably with optic capture. 
However, if no capsular support exists, the guidelines for secondary IOL implan-
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technique. Other options include ACIOL implantation, iris-fixation techniques, 





Secondary intraocular lens implantation into the capsular bag can only be 
performed in the early post-operative period before the formation of anterior–
posterior capsular adhesions. Typically, this procedure is performed in the early 
post-cataract surgery period due to incorrect intraocular lens power or patient 
dissatisfaction with an IOL (i.e., dysphotopsia from a multifocal IOL). Despite 
advances in IOL power formulas, some of which take into account the effects of 
prior refractive surgery, patients can still end up with large IOL power errors that 
may necessitate IOL exchange. Even with small errors, premium lens patients can 
demand IOL removal due to higher patient expectations in this population. IOL 
explantation in these cases should ideally be performed within 4–6 weeks of the 
initial cataract surgery although in-the-bag IOL exchange months to years following 
cataract surgery has been reported. A needle or cannula with viscoelastic is used to 
dissect the anterior capsular off the lens with care to avoid damaging zonular fibers 
and the posterior capsule. Once the lens is mobilized and removed, the capsular 
stability is assessed. If good anterior and posterior capsular support is noted the 
capsular bag is inflated with viscoelastic and a new lens can then be placed into the 
capsular bag.
7. Sulcus intraocular lens
Sulcus intraocular lens implantation is the second-best option if the anterior 
capsule is intact and in-the-bag implantation cannot be performed. In cases with a 
single-piece IOL dislocation, the IOL must be removed and replaced with a 3-piece 
IOL in the sulcus. In cases of 3-piece IOL dislocation, the IOL can be retrieved and 
repositioned into the ciliary sulcus. If the capsulorhexis is intact, the optic can then 
be captured by pushing the optic posteriorly through capsulorhexis with the lens 
haptics remaining in the sulcus. Of note, most three-piece IOLs have an overall 
haptic to haptic diameter of 13 mm or less, which can be too short especially in long 
eyes. This can lead to lens decentration and tilt. Three-piece intraocular lenses with 
larger haptics can fit better in the sulcus and decrease chances of decentration/
tilt. With optic capture, the IOL calculations remain the same as the in-the-bag 
 calculations [10].
Single-piece acrylic IOLs should not be placed in the sulcus [13–15]. Single-piece 
IOLs have haptics that are as thick as the optic and can chronically chafe the poste-
rior iris causing uveitis-glaucoma-hyphema (UGH) syndrome. Unlike three-piece 
IOLs, which are posteriorly vaulted, single-piece IOLs are planar in configuration, 
increasing the potential contact between the optic and the iris. Furthermore, single 
piece IOLs are shorter in overall length than 3-piece IOLs and thus are not well sup-
ported in the sulcus leading to high rates of decentration and tilt.
7.1 Technique
Viscoelastic is used to create space between the iris and anterior capsular bag. 
The capsular bag should be evaluated to identify areas with optimal support. Iris 
mobilization with a Kuglen iris manipulator or expansion with iris hooks may be 
necessary for adequate visualization of the capsule. The haptics should be placed in 
areas where the anterior capsular support is greatest. The corneal incision should 
be planned along the axis where IOL haptic placement is desired. The lens is then 




underneath the iris. However, if the corneal incision is not in the axis of desired 
haptic placement the lens can be inserted with the haptics on top of the iris. The lens 
is than rotated to the desired axis on top of the iris. Once in the desired axis the hap-
tics are then placed into the sulcus. The trailing haptic is then rotated into the sulcus 
with a second instrument. The intraocular lens is then checked for stability and 
centration. If possible, the optic can be captured into the anterior capsule. There is 
no indication for peripheral iridotomy with sulcus intraocular lens implantation.
8. Iris-fixated intraocular lens
A secondary IOL can be fixated to iris tissue by suture or iris-claw enclavation. 
Iris-fixated secondary IOLs have the benefit of sparing scleral/conjunctival surgery 
in case future glaucoma surgery is needed, however normal iris anatomy is required. 
Iris fixation can cause iris chafing leading to inflammation and cystoid macular 
edema. As with all secondary IOL techniques, patient selection and counseling are 
key for surgical success.
A three-piece IOL can also be sutured to the iris via a variety of techniques. In 
one technique, the IOL is inserted into the anterior chamber such that the optic is 
captured by the iris with the haptics located behind the iris. A 10-0 prolene suture 
on a long-curved needle is used to suture the haptic to the iris with as small a bite as 
possible and placed as peripherally as possible. Peripheral placement avoids creating 
an oval iris. The suture is then tied in place and the ends trimmed. A smaller corneal 
incision can be used as the IOLs for this technique are foldable.
Iris-claw lenses are the most commonly used iris-fixation technique outside 
of the United States. Several studies have shown the safety and efficacy of this 
technique [16, 17]. A peripheral iridectomy is required to decrease the risk of 
pupillary block. Iris-claw lenses need to be carefully centered during enclavation. 
Studies have shown that if the iris-claw lens undergoes deenclavation, the haptics 
are irreversibly damaged, and the lens requires explanation [18]. These lenses can 
be fixated anterior or posterior to the iris. A 5-year follow-up showed no differences 
in astigmatism, complications or post-operative corneal endothelial cell density 
between anterior or posterior placement [19]. However, some prefer posterior 
placement with the theory that deenclavation posteriorly has less risk of corneal 
endothelial decompensation compared to the anterior approach [20].
9. Scleral-fixated intraocular lens
Scleral-fixated intraocular lenses have gained popularity for secondary IOL 
implantation in patients with aphakia. They are indicated in patients who do 
not wish to remain aphakic and have no capsular or iris support. However, some 
surgeons prefer SFIOLs even if there is iris support. In patients where an ACIOL 
might not be a good option such as in patients with corneal endothelial disease or 
glaucoma, SFIOLs or IFIOLs are both viable options.
Scleral-sutured intraocular lens implantation started in the 1980s with ab-
interno and ab-externo approaches. Ab-interno approaches utilized suture passes 
from inside to outside the eye in a blind maneuver. This led to complications with 
retinal detachment, vitreous hemorrhage, and unpredictable haptic placement. 
Ab-externo approaches were found to be more promising with sutures passed 
from outside to inside the eye. This led to more reliable suture placement. Lewis 
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capsular bag is inflated with viscoelastic and a new lens can then be placed into the 
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single-piece IOL dislocation, the IOL must be removed and replaced with a 3-piece 
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be captured by pushing the optic posteriorly through capsulorhexis with the lens 
haptics remaining in the sulcus. Of note, most three-piece IOLs have an overall 
haptic to haptic diameter of 13 mm or less, which can be too short especially in long 
eyes. This can lead to lens decentration and tilt. Three-piece intraocular lenses with 
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increasing the potential contact between the optic and the iris. Furthermore, single 
piece IOLs are shorter in overall length than 3-piece IOLs and thus are not well sup-
ported in the sulcus leading to high rates of decentration and tilt.
7.1 Technique
Viscoelastic is used to create space between the iris and anterior capsular bag. 
The capsular bag should be evaluated to identify areas with optimal support. Iris 
mobilization with a Kuglen iris manipulator or expansion with iris hooks may be 
necessary for adequate visualization of the capsule. The haptics should be placed in 
areas where the anterior capsular support is greatest. The corneal incision should 
be planned along the axis where IOL haptic placement is desired. The lens is then 




underneath the iris. However, if the corneal incision is not in the axis of desired 
haptic placement the lens can be inserted with the haptics on top of the iris. The lens 
is than rotated to the desired axis on top of the iris. Once in the desired axis the hap-
tics are then placed into the sulcus. The trailing haptic is then rotated into the sulcus 
with a second instrument. The intraocular lens is then checked for stability and 
centration. If possible, the optic can be captured into the anterior capsule. There is 
no indication for peripheral iridotomy with sulcus intraocular lens implantation.
8. Iris-fixated intraocular lens
A secondary IOL can be fixated to iris tissue by suture or iris-claw enclavation. 
Iris-fixated secondary IOLs have the benefit of sparing scleral/conjunctival surgery 
in case future glaucoma surgery is needed, however normal iris anatomy is required. 
Iris fixation can cause iris chafing leading to inflammation and cystoid macular 
edema. As with all secondary IOL techniques, patient selection and counseling are 
key for surgical success.
A three-piece IOL can also be sutured to the iris via a variety of techniques. In 
one technique, the IOL is inserted into the anterior chamber such that the optic is 
captured by the iris with the haptics located behind the iris. A 10-0 prolene suture 
on a long-curved needle is used to suture the haptic to the iris with as small a bite as 
possible and placed as peripherally as possible. Peripheral placement avoids creating 
an oval iris. The suture is then tied in place and the ends trimmed. A smaller corneal 
incision can be used as the IOLs for this technique are foldable.
Iris-claw lenses are the most commonly used iris-fixation technique outside 
of the United States. Several studies have shown the safety and efficacy of this 
technique [16, 17]. A peripheral iridectomy is required to decrease the risk of 
pupillary block. Iris-claw lenses need to be carefully centered during enclavation. 
Studies have shown that if the iris-claw lens undergoes deenclavation, the haptics 
are irreversibly damaged, and the lens requires explanation [18]. These lenses can 
be fixated anterior or posterior to the iris. A 5-year follow-up showed no differences 
in astigmatism, complications or post-operative corneal endothelial cell density 
between anterior or posterior placement [19]. However, some prefer posterior 
placement with the theory that deenclavation posteriorly has less risk of corneal 
endothelial decompensation compared to the anterior approach [20].
9. Scleral-fixated intraocular lens
Scleral-fixated intraocular lenses have gained popularity for secondary IOL 
implantation in patients with aphakia. They are indicated in patients who do 
not wish to remain aphakic and have no capsular or iris support. However, some 
surgeons prefer SFIOLs even if there is iris support. In patients where an ACIOL 
might not be a good option such as in patients with corneal endothelial disease or 
glaucoma, SFIOLs or IFIOLs are both viable options.
Scleral-sutured intraocular lens implantation started in the 1980s with ab-
interno and ab-externo approaches. Ab-interno approaches utilized suture passes 
from inside to outside the eye in a blind maneuver. This led to complications with 
retinal detachment, vitreous hemorrhage, and unpredictable haptic placement. 
Ab-externo approaches were found to be more promising with sutures passed 
from outside to inside the eye. This led to more reliable suture placement. Lewis 
 popularized an ab-externo technique in 1991 [21] whereby 10-0 polypropylene 
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suture was placed 2 mm posterior to the limbus and then “docked” into a 28-gauge 
straight needle 180 degrees away to externalize the needle. The suture that remained 
inside the eye was brought out through the corneal incision and cut. The suture 
ends were then tied to the IOL haptics and the IOL was inserted into the eye for 
sulcus placement. The external sutures were then tied down to the adjacent sclera. 
Ten-year follow-up of thirteen eyes showed only two eyes had minimal decentration 
although it did not affect final visual acuity [22].
Since Lewis described his technique, newer lenses and sutures have further 
improved ab-externo techniques. Lenses such as the CZ70BD (Alcon, Fort Worth, 
TX), enVista MX60 and the Akreos AO60 (Bausch and Lomb, Rochester, NY) have 
eyelets for suture fixation, which improve lens stability. Most prior scleral suture-
fixed techniques used 10-0 polypropylene. However, several studies have described 
10-0 polypropylene late suture breakage [23–25]. These reports show late break-
age of 10-0 polypropylene suture up to 8 years post-placement. Gore-tex sutures 
have been used outside the eye with notable long-term stability. Studies with up to 
3 years follow-up have shown Gore-tex suture durability within the eye. Similarly, 
9-0 polypropylene has been shown to have improved suture stability compared 
to 10-0 polypropylene but with only short-term follow-up. Long-term studies are 
needed to further evaluate if these sutures continue to avoid suture breakage.
Bausch & Lomb Akreos AO60 hydrophilic acrylic lens contains 4 eyelets allow-
ing 4 point fixation. However, these lenses undergo calcification and opacify when 
in contact with intraocular gas or air [26]. Given that aphakic patients often have 
coincident retinal pathology and might be at increased risk for retinal detachment 
repair this might be an important consideration when deciding on the optimal lens 
and fixation technique. The Bausch & Lomb enVista Mx60 IOL is made of hydro-
phobic acrylic and does not opacify when in contact with gas or air. However, it has 
only 2 eyelets for fixation at the haptic-optic junction.
9.1 Scleral fixation of IOL with Gore-tex suture technique
Typically, conjunctival peritomies are performed where the sclerotomy sites 
are planned, 180 degrees apart. Sclerotomy placement at horizontal, oblique and 
vertical orientations are all acceptable. A toric lens marker is used to mark the axis 
of the lens within the peritomy. Sclerotomy sites are marked, 3 mm posterior to the 
limbus and 4–5 mm apart from each other in each scleral bed. One of the suture 
sclerotomy sites can be used for the vitrectomy trocar. The trocar sclerotomy should 
be made perpendicularly without tunneling to facilitate suture knot insertion. The 
lens is pre-threaded with a suture on each side and inserted into the eye. The sutures 
are then externalized using forceps through the sclerotomies taking care not to 
tangle the sutures. To avoid suture tangling and disorganization, the sutures can be 
inserted into the eye and externalized prior to lens insertion. The sutures are then 
tied down permanently with care taken to make sure the suture tension allows the 
lens to be appropriately centered. The knot is then buried into the sclerotomies to 
avoid knot erosion through the conjunctiva. The conjunctiva is sewn in place over 
the sclerotomies and sutured. Long term follow-up results are yet to be determined. 
Two-year results have shown good lens and suture stability with the Gore-tex 
suture. Complications include hypotony (up to 10%) with and without serous cho-
roidal detachment. This is thought to occur from leakage from the sclerotomy sites. 
Vitreous hemorrhage and hyphema have also been reported. Published studies have 
not reported persistent post-operative inflammation, endophthalmitis or suture 
erosion/breakage at 2 years [27]. With in-the-bag calculations for the IOL, a recent 




outcome than 3 mm sclerotomies [28]. Other studies have shown acceptable refrac-
tive outcomes with this technique and 3 mm from the limbus sclerotomies with 
in-the-bag IOL calculations [29].
9.2 Sutureless scleral fixation intraocular lens implantation
Sutureless techniques have also been developed to avoid potential complications 
that can rise from suture fixation including knot erosion, endophthalmitis, and 
suture breakage. Agarwal described scleral fixation with glued haptic fixation [30]. 
Scleral flaps are created 180 degrees apart and a sclerotomy is made within the flap. 
The haptics of a 3-piece IOL are then externalized via the sclerotomy and glued into 
place with the flap closing over the haptic. Several complications can occur with the 
haptic including extrusion, dislocation, and breakage. Haptic-related complications 
seen include haptic extrusion, haptic dislodgement, broken haptic and subconjunc-
tival haptic. Most of the haptic-related complications are due to improper scleral 
tucking [31].
Yamane et al. described a technique whereby three-piece IOL haptics are passed 
through a 27 gauge needle which guides the haptic through a tunneled sclerotomy 
[32]. The externalized haptic is than cauterized to create a bulb at the tip of the hap-
tic to allow for improved stability within the scleral tunnel. Short-term outcomes 
from Yamane’s initial study reported no IOL dislocation at 1.5 years. Reported 
complications include optic capture of the iris (8%), vitreous hemorrhage (5%) 
and cystoid macular edema (1%). It is important to note that the Yamane technique 
utilizes the EC-3 PAL three-piece intraocular lens, which has more durable and mal-
leable haptics compared to the 3-piece IOLs commonly used in the United States. 
Higher rates of IOL dislocation have been reported with the Yamane technique 
when non-EC-3 PAL 3-piece IOLs are used. Several modified Yamane techniques 
have been since described including the use of 27 gauge trocars instead of a needle 
to externalize the haptics. Long-term follow-up has yet to be presented since these 
techniques have only been introduced in the past decade.
10. Anterior chamber intraocular lens
Baron was the first to implant an anterior chamber IOL in 1952 [33]. Several 
other ACIOLs followed during the 1950s but were limited by their design and 
anterior vault that led to high rates of corneal decompensation. Closed loop ACIOLs 
gained popularity in the 1970s due to their various flexible designs that were 
thought to alleviate problems with sizing. However, the sharp edges of the closed-
loop ACIOL haptic eroded uveal tissue, released inflammatory mediators, and led 
to multiple complications including uveitis-glaucoma-hyphema syndrome, corneal 
decompensation, and cystoid macular edema [34–37]. Open-loop ACIOL designs 
were introduced in the 1980s and their design continued to be improved with its use 
peaking in the 1990s. These modern open-loop ACIOL designs appear to have less 
associated complications.
A peripheral iridectomy is required as ACIOLs can cause pupillary block glau-
coma. Compared to other IOL techniques, the ACIOL requires a larger six-millime-
ter incision. Typically, a scleral tunnel is formed in order to minimize astigmatism 
from a clear corneal incision. Contraindications for anterior chamber intraocular 
lens include corneal decompensation, angle abnormalities with or without glau-
coma, and lack of iris support. Complications associated with ACIOL implantation 
include endothelial failure with corneal edema, chronic intraocular inflammation, 
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outcome than 3 mm sclerotomies [28]. Other studies have shown acceptable refrac-
tive outcomes with this technique and 3 mm from the limbus sclerotomies with 
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seen include haptic extrusion, haptic dislodgement, broken haptic and subconjunc-
tival haptic. Most of the haptic-related complications are due to improper scleral 
tucking [31].
Yamane et al. described a technique whereby three-piece IOL haptics are passed 
through a 27 gauge needle which guides the haptic through a tunneled sclerotomy 
[32]. The externalized haptic is than cauterized to create a bulb at the tip of the hap-
tic to allow for improved stability within the scleral tunnel. Short-term outcomes 
from Yamane’s initial study reported no IOL dislocation at 1.5 years. Reported 
complications include optic capture of the iris (8%), vitreous hemorrhage (5%) 
and cystoid macular edema (1%). It is important to note that the Yamane technique 
utilizes the EC-3 PAL three-piece intraocular lens, which has more durable and mal-
leable haptics compared to the 3-piece IOLs commonly used in the United States. 
Higher rates of IOL dislocation have been reported with the Yamane technique 
when non-EC-3 PAL 3-piece IOLs are used. Several modified Yamane techniques 
have been since described including the use of 27 gauge trocars instead of a needle 
to externalize the haptics. Long-term follow-up has yet to be presented since these 
techniques have only been introduced in the past decade.
10. Anterior chamber intraocular lens
Baron was the first to implant an anterior chamber IOL in 1952 [33]. Several 
other ACIOLs followed during the 1950s but were limited by their design and 
anterior vault that led to high rates of corneal decompensation. Closed loop ACIOLs 
gained popularity in the 1970s due to their various flexible designs that were 
thought to alleviate problems with sizing. However, the sharp edges of the closed-
loop ACIOL haptic eroded uveal tissue, released inflammatory mediators, and led 
to multiple complications including uveitis-glaucoma-hyphema syndrome, corneal 
decompensation, and cystoid macular edema [34–37]. Open-loop ACIOL designs 
were introduced in the 1980s and their design continued to be improved with its use 
peaking in the 1990s. These modern open-loop ACIOL designs appear to have less 
associated complications.
A peripheral iridectomy is required as ACIOLs can cause pupillary block glau-
coma. Compared to other IOL techniques, the ACIOL requires a larger six-millime-
ter incision. Typically, a scleral tunnel is formed in order to minimize astigmatism 
from a clear corneal incision. Contraindications for anterior chamber intraocular 
lens include corneal decompensation, angle abnormalities with or without glau-
coma, and lack of iris support. Complications associated with ACIOL implantation 
include endothelial failure with corneal edema, chronic intraocular inflammation, 
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and/or uveitis glaucoma hyphema. The angle to angle measurement measured by 
a UBM or OCT is the most accurate option for fitting an ACIOL. More commonly 
however the white-to-white distance is measured intraoperatively with calipers 
and 1 mm is added to size the ACIOL. The white-to-white distance is not always a 
reliable equivalent to the actual angle to angle distance.
Many of the complications of ACIOL implantation can be prevented with an 
appropriately-sized lens, however, limited sizes are available. An overly small 
lens can be mobile and cause damage to the corneal endothelium leading to cor-
neal decompensation. A small lens can also cause trauma to iris tissue leading to 
inflammation and cystoid macular edema. Similarly, an overly large lens can cause 
inflammation, cystoid macular edema and corneal endothelial failure. A large lens 
can be noted if the iris is distorted or ovalized during placement. This is due to the 
footplates not being seated well in the angle. Since the vertical and horizontal angle 
to angle dimensions are different the lens can be rotated to see if it fits better at a 
different meridian.
10.1 Anterior chamber intraocular lens implantation technique
A scleral tunnel is created in either a frown or linear configuration. This can be 
placed temporally or superiorly based on surgeon preference. A corneal incision 
is avoided to minimize astigmatism however can be used if needed. The benefits 
of a corneal incision include preserving conjunctiva/sclera for potential glaucoma 
interventions. Miosis is induced and viscoelastic is then injected. The ACIOL is then 
inserted with or without a use of a lens glide. The purpose of the lens glide to secure 
placement of the ACIOL across the pupil so as not to get the lens or haptic caught 
on the iris at the pupillary margin. The ACIOL is then positioned such that the 
footplates of the IOL are well-seated in the angle and the pupillary margin is round. 
Gonioscopy can be performed to confirm appropriate placement of the ACIOL 
footplates. Once the ACIOL is positioned, a peripheral iridectomy is created and the 
scleral or corneal incision is closed.
11. Conclusion
Ophthalmology has seen an evolution in secondary intraocular lens implanta-
tion. Particularly, in the past decade, the implantation of scleral-fixated intraocular 
lenses has gained popularity along with ACIOL implantation [36]. Careful patient 
selection is critical to determine the optimal secondary IOL technique. When pos-
sible, placement of the secondary intraocular lens in the capsular bag is preferred, 
followed by placement in the sulcus with optic capture. When capsular support 
is absent, ACIOL implantation, iris fixation and scleral fixation of a secondary 
intraocular lens can be considered. The variety of surgical options with respect to 
secondary IOL implantation illustrates the lack of an optimal consensus technique. 
Indeed, several studies have compared these techniques with no clear favorite 
[38–41]. In most cases, patient ophthalmic history and anatomic considerations in 
addition to surgeon familiarity and comfort with the secondary IOL technique may 
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sible, placement of the secondary intraocular lens in the capsular bag is preferred, 
followed by placement in the sulcus with optic capture. When capsular support 
is absent, ACIOL implantation, iris fixation and scleral fixation of a secondary 
intraocular lens can be considered. The variety of surgical options with respect to 
secondary IOL implantation illustrates the lack of an optimal consensus technique. 
Indeed, several studies have compared these techniques with no clear favorite 
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Currently, ideal cataract surgery should end with the placement of an intra-
ocular lens (IOLs) in the bag. However, in the clinical setting we have to manage 
cases without enough capsular support to allow the physiological IOL placement. 
Progress has been made in terms of IOL designs and implantation techniques. 
The options should be analyzed not only in accordance with surgeon’s experi-
ence but also with patient’s age, local, and systemic comorbidities. Thus, in the 
absence of an appropriate capsule, IOL can be placed in the anterior chamber, 
fixated to the iris or to the sclera wall. In this paper, the personal experience 
of one surgeon with ab externo scleral-fixated IOLs is presented, with the aim 
to outline the place of this surgical technique in the correction of aphakia. A 
retrospective study was carried out, including 57 patients in which an IOL was 
fixated to the sclera, throughout January 2015–April 2019. The causes of aphakia, 
preoperative and postoperative best-corrected visual acuities (BCVA), and intra- 
and postoperative complications are analyzed. Statistical tests were applied in 
order to draw significance. In most instances, BCVA has remained stable, with 
no significant complications, making sclera fixation IOL a viable solution in the 
correction of aphakia.
Keywords: scleral-fixated IOL, aphakia, cataract surgery, eye trauma,  
lens dislocation
1. Introduction
Ideal correction of aphakia means the placement of the intraocular lens (IOLs) 
in the bag which relies on good capsular support [1–3]. In these circumstances, IOL 
is well centered to the pupillary axis, maximizing the chances of optimal surgical 
and refractive outcomes [2].
In the absence of adequate posterior capsular support, like in complicated 
cataract surgery with disruption of the posterior capsule, it is often possible to place 
the IOL in the sulcus with excellent visual outcome [1, 3].
However, in the clinical practice there are situations like trauma, diseases, 
and complicated cataract surgery that result in inadequate anterior and posterior 
capsular support, making the conventional in-the-bag or in the sulcus placement of 
the IOL impossible.
Addressing this situation can be managed in several ways, like anterior chamber 
(ACIOLs), iris-fixated (IFIOLs), and scleral-fixated (SFIOLs) [2, 3]. Choosing the 
best technique in the absence of capsular support can be challenging, although all 
these variants proved to have similar benefits and risks [2, 3].
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Currently, ideal cataract surgery should end with the placement of an intra-
ocular lens (IOLs) in the bag. However, in the clinical setting we have to manage 
cases without enough capsular support to allow the physiological IOL placement. 
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retrospective study was carried out, including 57 patients in which an IOL was 
fixated to the sclera, throughout January 2015–April 2019. The causes of aphakia, 
preoperative and postoperative best-corrected visual acuities (BCVA), and intra- 
and postoperative complications are analyzed. Statistical tests were applied in 
order to draw significance. In most instances, BCVA has remained stable, with 
no significant complications, making sclera fixation IOL a viable solution in the 
correction of aphakia.
Keywords: scleral-fixated IOL, aphakia, cataract surgery, eye trauma,  
lens dislocation
1. Introduction
Ideal correction of aphakia means the placement of the intraocular lens (IOLs) 
in the bag which relies on good capsular support [1–3]. In these circumstances, IOL 
is well centered to the pupillary axis, maximizing the chances of optimal surgical 
and refractive outcomes [2].
In the absence of adequate posterior capsular support, like in complicated 
cataract surgery with disruption of the posterior capsule, it is often possible to place 
the IOL in the sulcus with excellent visual outcome [1, 3].
However, in the clinical practice there are situations like trauma, diseases, 
and complicated cataract surgery that result in inadequate anterior and posterior 
capsular support, making the conventional in-the-bag or in the sulcus placement of 
the IOL impossible.
Addressing this situation can be managed in several ways, like anterior chamber 
(ACIOLs), iris-fixated (IFIOLs), and scleral-fixated (SFIOLs) [2, 3]. Choosing the 
best technique in the absence of capsular support can be challenging, although all 
these variants proved to have similar benefits and risks [2, 3].
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A vitreoretinal surgeon is relatively frequently confronted with the situation to 
place an IOL in an eye without capsular support following the various conditions: 
trauma, complicated cataract surgery, and different ocular diseases. Trauma is of 
special interest, since it affects younger patients and is frequently followed by other 
changes in eye anatomy that add difficulty to the IOL implantation procedure. General 
conditions such as Marfan syndrome and homocystinuria affect young people with 
long life expectancy, so finding the best long-term solution for them is mandatory.
After an overview on the possibilities to correct aphakia in the absence of 
capsular support, with focus on the SFIOLs, personal experience with SFIOLs will 
be presented.
2. Correction of aphakia in the absence of capsular support: Overview
When facing an aphakic eye with no capsular support, the IOL can be placed in the 
anterior chamber, fixated to the iris (in its extreme or mid-periphery) or fixated to the 
sclera. The surgical techniques in all of these approaches have improved considerably 
over the last decades with subsequent optimization of visual and ocular outcomes [3].
2.1 ACIOLs
Placement of an IOL in the AC requires a healthy endothelium and a normal 
depth of the AC [2]. This technique has the advantages of being simple and quick. 
Modern designs of ACIOLs with flexible open-loop haptics and anteriorly vaulted 
optics make them beneficial for many patients [2]. However, they are not suitable 
for patients with glaucoma, endothelial compromise, significant iris trauma, or 
diabetic retinopathy.
Complications related to ACIOLs, even if rarer now, are still cited: uveitis-
glaucoma-hyphema (UGH) syndrome and cystoid macular edema [2]. The general 
idea is that ACIOLs are in decline, as their placement requires bigger incisions, more 
astigmatism with suturing, and slower visual recovery [2].
2.2 IFIOLs
Some surgeons’ experience reveals that IFIOLs are more efficient than ACIOLs 
and even developed an ideal patient profile benefiting from them: older, with 
average-sized anterior segments, especially if they have some remnants of capsule 
and vitreous that help stabilize the lens. The haptics have to be fixated to the iris as 
peripherally as possible. The complications associated with this type of implant are 
intra- and postoperative hyphema, cystoid macular edema, uveitis, and glaucoma. 
Even if the IFIOL is properly fixated, there is a certain degree of IOL mobility, 
with subsequent mechanical trauma from pseudophacodonesis, which is why most 
surgeons do not indicate them in younger patients [2]. Another reason of concern is 
suture longevity, requiring another surgery down the road [2].
The sutureless iris-claw IOLs are inserted through a 5-mm incision and are 
attached to the mid-peripheral iris with the help of an inclavation needle that grabs 
iris tissue between claws on either side of the lens while the pupil is kept miotic. 
A study of 2 years follow-up showed good visual functional recovery and lack of 
complications related to this technique [2].
2.3 SFIOLs
An IOL can be fixated at the sclera in several ways: with sutures, with no sutures 
by tunneling of the haptics, and with fibrin glue.
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Suturing an IOL to the sclera is the most technically demanding procedure among 
the others discussed here, but it has two major advantages: durability and security.
When dealing with a dislocated IOL, several factors have to be considered: IOL 
type, extent of dislocation, and status of the capsular bag. If a one-piece in the bag 
IOL is partially dislocated, trans-scleral suture fixation is preferred. If a one-piece 
IOL is completely dislocated, it is recommended to be replaced with a three-piece IOL 
which is sutured to the sclera. If retinal pathology is associated, it is preferable to 
leave the eye aphakic to quiet down and perform the implantation in a second step. 
For example, once the retinal detachment is fixed and stable, a scleral-fixated three-
piece IOL is carried out.
SFIOLs have drawbacks too. The patient is left with a subconjunctival suture, so 
in case of conjunctival erosion, the suture is exposed and makes way for bacteria 
to enter the eye and cause endophthalmitis. Therefore, it is desirable to bury the 
sutures. In order to prevent conjunctival erosion, Lewis imagined a method to bury 
the knot under a triangular scleral flap performed before entering the eye and the 
covering of the knot with the hinged scleral tissue at the end of surgery [3].
To avoid the use of sutures, tunneling of IOL haptics was imagined [2].
Another method to secure the IOL at the sclera is with fibrin glue. The pioneer 
of this technique advocates that it inhibits pseudophacodonesis better than the 
other variants. IOL movement inside the eye generates inflammation which is at the 
origin of cystoid macular edema [2].
An issue related to IOL fixation at the sclera comes from the fact that surgery is 
performed at pars plana, which is a region where anterior segment surgeon does not 
feel very comfortable. This is why this technique is preferred mostly by vitreoretinal 
surgeons.
All of the abovementioned alternatives to fixate an IOL inside an aphakic eye 
without capsular support produce good visual outcomes. Decision-making process 
relies on several factors: eye anatomy, other pathologies, patient’s age, visual poten-
tial, and surgeon’s comfort. It is equally important to know when a certain technique 
is contraindicated. Ideally, ophthalmic surgeon should master several techniques 
and be able to adjust plans during surgery [2].
3.  Scleral-fixated intraocular lens: Indications and results: Personal 
experience
3.1 Aim
In this paper, the personal experience of one surgeon with ab interno scleral-
fixated IOLs is presented, with the aim to outline the place of this surgical technique 
in the correction of aphakia.
3.2 Methods
This is a retrospective study that includes 57 aphakic eyes belonging to 57 patients 
who underwent ab interno scleral fixation of IOL during January 2015 to April 2019 
at our tertiary care Ophthalmological Department, Emergency County Hospital 
from Cluj-Napoca, Romania. The patients were in the 10–89 years age group.
The detailed history was taken from each patient regarding any systemic or 
ocular condition. A written informed consent was taken from each patient before 
procedure.
Ophthalmological examination included grading of the visual acuity (VA) with 
the decimal system, followed by slit lamp examination of the anterior and posterior 
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A vitreoretinal surgeon is relatively frequently confronted with the situation to 
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After an overview on the possibilities to correct aphakia in the absence of 
capsular support, with focus on the SFIOLs, personal experience with SFIOLs will 
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in case of conjunctival erosion, the suture is exposed and makes way for bacteria 
to enter the eye and cause endophthalmitis. Therefore, it is desirable to bury the 
sutures. In order to prevent conjunctival erosion, Lewis imagined a method to bury 
the knot under a triangular scleral flap performed before entering the eye and the 
covering of the knot with the hinged scleral tissue at the end of surgery [3].
To avoid the use of sutures, tunneling of IOL haptics was imagined [2].
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feel very comfortable. This is why this technique is preferred mostly by vitreoretinal 
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without capsular support produce good visual outcomes. Decision-making process 
relies on several factors: eye anatomy, other pathologies, patient’s age, visual poten-
tial, and surgeon’s comfort. It is equally important to know when a certain technique 
is contraindicated. Ideally, ophthalmic surgeon should master several techniques 
and be able to adjust plans during surgery [2].
3.  Scleral-fixated intraocular lens: Indications and results: Personal 
experience
3.1 Aim
In this paper, the personal experience of one surgeon with ab interno scleral-
fixated IOLs is presented, with the aim to outline the place of this surgical technique 
in the correction of aphakia.
3.2 Methods
This is a retrospective study that includes 57 aphakic eyes belonging to 57 patients 
who underwent ab interno scleral fixation of IOL during January 2015 to April 2019 
at our tertiary care Ophthalmological Department, Emergency County Hospital 
from Cluj-Napoca, Romania. The patients were in the 10–89 years age group.
The detailed history was taken from each patient regarding any systemic or 
ocular condition. A written informed consent was taken from each patient before 
procedure.
Ophthalmological examination included grading of the visual acuity (VA) with 
the decimal system, followed by slit lamp examination of the anterior and posterior 
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segment, examination of retinal periphery, and measurement of intraocular pres-
sure by applanation tonometry. B-scan and OCT were performed whenever neces-
sary. A-scan biometry was carried out before the procedure in all cases to find the 
value of the IOL to be implanted.
The data were analyzed statistically with the Program SPSS 21.0. Chi-square 
test was used to find statistical significance. A p-value ˂ 0.05 was considered 
significant.
This study was approved by the Ethics Committee belonging to the “Iuliu 
Hatieganu” University of Medicine and Pharmacy, and it is performed in accor-
dance with the Declaration of Helsinki regarding the clinical studies involving 
human subjects.
3.3 Surgical procedure
All patients were operated by the same surgeon in local anesthesia, with the 
exception of one 10-year-old child with Marfan syndrome.
Pars plana vitrectomy (PPV) was performed in all cases to remove the lens/
nucleus/IOL from the vitreous. The three subluxated lenses were removed by pars 
plana approach (lensectomy).
Conjunctival peritomies were created superiorly, then at horizontal merid-
ians. Triangular partial-thickness (about 1/3 of the scleral thickness) limbal-
based scleral flaps were dissected at horizontal meridians (9 o’clock and 3 o’clock 
position).
Intraocular pressure (IOP) was maintained with pars plana scleral infusion 
throughout surgery.
A 6-mm sclerocorneal tunnel incision was created superiorly, at 12 o’clock 
position, and anterior chamber (AC) was entered with a 2.2-mm knife. All vitreous 
was removed from the anterior chamber, if present, with the posterior vitrector. In 
the meantime, the two sutures (10–0 PC9 polypropylene) had been fixed to the IOL 
haptics of the specially designed IOL (Figure 1).
The long-curved needle carrying the 10–0 PC9 suture entered the AC and then 
exteriorized through the sclera, at 9 o’clock meridian, about 1–2 mm posterior from 
the posterior surgical limbus. The procedure was repeated similarly with the second 
needle (Figure 2).
The IOL was inserted in the sulcus, while the sutures were pulled, in order to 
center it. The haptics were secured at the sclera with knots that were buried under 
the previously fashioned scleral flaps (Figure 3).
Corneoscleral incision was sutured with 10–0 polypropylene sutures and the 
conjunctiva, with 8–0 vicryl sutures (Figure 4).
Figure 1. 
IOL for scleral fixation - model CZ 70 BD (Alcon).
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All patients were examined the next day after surgery, followed 1 week and then 
every month, for 3 months. At each visit, best-corrected visual acuity (BCVA) was 
noted and slit lamp examination, indirect ophthalmoscopy, and IOP measurement 
were performed. Wherever necessary, ultrasound and OCT examination were 
carried out.
In all cases, CZ70BD (Alcon, Fort Worth, TX) has been used. It incorporates 
eyelets on each haptic through which sutures can be passed that help to prevent 
suture slippage and subsequent IOL dislocation. Since this IOL has only two eyelets, 
two-point fixation technique has been used in all cases. The suture of choice was 
10–0 polypropylene with PC9 needles.
Figure 2. 
Ab interno IOL implantation by suturing it to the sclera. Scleral flaps are visible at the horizontal meridian.
Figure 3. 
IOL is pushed behind the iris, whereas the 2 sutures are pulled in order to center it.
Figure 4. 
IOL is well centered, the conjunctiva is sutured, the 3 ports of PPV are visible.
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Fifty-seven patients were included in this study, with a mean age of 64.22 years. 
Minimum age in our series was 10 years, whereas maximum age was 89 years. Age 
distribution of patients is presented in Table 1.
Out of 57 patients, 40 were males (70.17%) and 17 were females (29.82%).
The cause that led to aphakia requiring scleral fixation of the IOL was rep-
resented by trauma in 30 patients (52.63%), complicated cataract surgery in 24 
patients (42.10%), and subluxated lens in 3 patients (5.26%).
Medium age within the three groups was 61.10 years within the trauma group, 
65.20 years within the postcataract surgery group, and 37 years within the sublux-
ated lens group. These data are summarized in Table 2.
Within the trauma group, 24 patients were males (80%) and 6 patients were 
females (20%). Within the complicated cataract surgery group, 15 patients were 
males (62.50%) and 9 were females (37.50%). Within the subluxated lens group, 
one patient was male (33.33%) and two were females (66.66%).
T-test found a p-value ˂0.05 when comparing gender distribution between the 
first two groups: there was significantly more men than women within the trauma 
group as opposed to the postcataract surgery group.
Preoperative BCVA ranged between hand motion (HM) and 5/10, and it is 
illustrated in Table 3.
Preoperative BCVA according to the cause is illustrated in Table 4.
In nine cases (15.78%), there was a history of retinal detachment (RD) prior to 
IOL suture: five within the group of patients with complicated cataract surgery and 
four within the trauma group. In these circumstances, the strategy was to operate 
first RD, and if the retina was stable after tamponade agent removal, scleral fixation 
of the IOL was performed.
In five cases from the trauma group, an IOL was luxated into the vitreous cavity. 
In all situations we replaced it with an IOL specially designed for scleral fixation: 
CZ70BD (Alcon, Fort Worth, TX).
In six cases from the trauma group, an intraocular foreign body had been 
removed by PPV several months prior to IOL fixation.







Age distribution of patients with scleral-fixated IOL.
Cause Number of cases % Medium age (years)
Trauma 30 52.63 61.10
Postcataract 24 42.10 65.20
Surgery Subluxated lens 3 5.26 37
Table 2. 
Causes of aphakia and medium age according to it.
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In two cases we noted breaking of sutures during surgery which was solved by 
replacing it. Breakage of one IOL haptic was encountered in one case, and it was 
solved by IOL replacement.
Intraoperatively soft eye was encountered in 11 cases (19.29%), and it was solved 
by adjusting the infusion pressure.
The most common complication during surgery was hemorrhage: 20/57 cases 
(35.08%). It was mild/moderate, and self-limiting, and it happened during punc-
turing the sclera with the PC9 needle in all cases. The blood was washed out with 
the PPV infusion system.
In the postoperative period, vitreous hemorrhage persisted in 10 cases (17.54%) 
and resolved spontaneously in 9 of them. PPV was performed in the remaining 
case, 4 weeks after IOL fixation, with good outcome: BCVA 5/10.
In three cases (5.26%), mild corneal edema was noted, with complete resolution 
under medical treatment.
Postoperative anterior uveitis was noted in seven patients (12.28%) who 
responded positively to medical treatment. In one of them, uveitis was present 
before IOL fixation; therefore we consider that our procedure reactivated it, rather 
than produced it.
Cystoid macular edema (CME) was identified in three cases (5.26%).
In one case, we had to reposition the IOL, due to high astigmatism (−6D) caused 
by IOL tilt, with good final outcome: BCVA 7/10.
Chronic glaucoma requiring long-term topical treatment was diagnosed in three 
patients in our series (5.26%), all within the trauma group.
We report no chronic corneal edema, no retinal detachment, and no suture 
break with subsequent IOL dislocation in the postoperative period in this series.
Uncorrected visual acuity improved in all cases within this series. BCVA of 5/10 
or better was noted in 22 cases (38.59%). Table 3 shows BCVA at the last control 
visit (3 months after surgery).
3.5 Discussion
Recovery of the visual function in an aphakic patient is challenging. Aphakic 
glasses are not an option, because of their high magnification and subsequent 
aniseikonia [4]. Contact lenses are difficult to handle, especially in older patients 
BCVA Before surgery (%) Last visit after surgery (%)
˂1/50 7 (12.28) 4 (7.01)
≥1/50 ˂ 1/10 32 (56.14) 28 (56.14)
≥1/10 18 (31.57) 25 (43.85)
Table 3. 
BCVA before and at the last visit after surgery.
Cause/BCVA ˂1/50 ≥1/50 ˂1/10 ≥1/10
Trauma 4 13 13
Previous cataract 3 16 5
Surgery subluxated lens — 3 —
Table 4. 
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In two cases we noted breaking of sutures during surgery which was solved by 
replacing it. Breakage of one IOL haptic was encountered in one case, and it was 
solved by IOL replacement.
Intraoperatively soft eye was encountered in 11 cases (19.29%), and it was solved 
by adjusting the infusion pressure.
The most common complication during surgery was hemorrhage: 20/57 cases 
(35.08%). It was mild/moderate, and self-limiting, and it happened during punc-
turing the sclera with the PC9 needle in all cases. The blood was washed out with 
the PPV infusion system.
In the postoperative period, vitreous hemorrhage persisted in 10 cases (17.54%) 
and resolved spontaneously in 9 of them. PPV was performed in the remaining 
case, 4 weeks after IOL fixation, with good outcome: BCVA 5/10.
In three cases (5.26%), mild corneal edema was noted, with complete resolution 
under medical treatment.
Postoperative anterior uveitis was noted in seven patients (12.28%) who 
responded positively to medical treatment. In one of them, uveitis was present 
before IOL fixation; therefore we consider that our procedure reactivated it, rather 
than produced it.
Cystoid macular edema (CME) was identified in three cases (5.26%).
In one case, we had to reposition the IOL, due to high astigmatism (−6D) caused 
by IOL tilt, with good final outcome: BCVA 7/10.
Chronic glaucoma requiring long-term topical treatment was diagnosed in three 
patients in our series (5.26%), all within the trauma group.
We report no chronic corneal edema, no retinal detachment, and no suture 
break with subsequent IOL dislocation in the postoperative period in this series.
Uncorrected visual acuity improved in all cases within this series. BCVA of 5/10 
or better was noted in 22 cases (38.59%). Table 3 shows BCVA at the last control 
visit (3 months after surgery).
3.5 Discussion
Recovery of the visual function in an aphakic patient is challenging. Aphakic 
glasses are not an option, because of their high magnification and subsequent 
aniseikonia [4]. Contact lenses are difficult to handle, especially in older patients 
BCVA Before surgery (%) Last visit after surgery (%)
˂1/50 7 (12.28) 4 (7.01)
≥1/50 ˂ 1/10 32 (56.14) 28 (56.14)
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Preoperative BCVA according to the cause.
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(medium age in our group was 64.22 years) who have never worn them before. 
Therefore, the only viable option in these cases is to place an IOL inside the eye. 
Since the capsular support is not adequate for IOL placement in the bag or in the 
sulcus, the available placement possibilities are anterior chamber, iris fixation (in its 
extreme or mid-periphery), or suture at the sclera.
Scleral fixation of an IOL is a safe option, and therefore it is the most used one 
in our practice. This preference is also explained by the fact that a vitreoretinal feels 
more comfortable working around pars plana and behind the iris plane, as com-
pared to the AC.
The medium age of our patients (64.22 years) is higher as reported in the litera-
ture [4]. This might be partially explained by the high number of cases with previ-
ous complicated cataract surgeries (42.10%), since we are a referral center in the 
area. However, the medium age within the group with complicated cataract surgery 
is not significantly higher than within the trauma group: 65.20 years vs. 61.10 years, 
respectively. One observation is that five patients with posttraumatic IOL disloca-
tion in the vitreous cavity were included in the trauma group, contributing to the 
increase of the medium age in this group.
As expected, men accounted for the majority of trauma cases: 24/30 (80%). In 
the group with complicated cataract surgery, male predominance, even if not so 
obvious, was still identified: 15/24 (62.50%).
3.5.1 Comments related to the IOL
In all cases we used the IOL model CZ70BD (Alcon, Fort Worth, Texas) (Figure 1). 
This is a rigid PMMA IOL. Foldable IOLs designed for sclera fixation were not available.
Since this IOL has only two eyelets, two-point fixation technique has been used 
in all cases. Therefore, it is more susceptible to IOL tilt which leads to higher-order 
aberrations that cannot be corrected with eyeglasses. In our series, in one single 
case we had to reposition a tilted IOL that determined high astigmatism (6D). Final 
outcome, after repositioning the IOL, was favorable, with BCVA 7/10.
Studies comparing the tilt concluded that it was significantly higher in SFIOL 
patients than in the ones with IOL in-the-bag [5].
Another IOL designed for being sutured at the sclera, Akreos AO 60 (Bausch & 
Lomb, Rochester, NY), has four haptics, each with its own eyelet for suture passage. 
The four-point fixation is theoretically associated with a lesser risk of tilt and dislo-
cation, though there is no study comparing the differences in tilt between CZ70BD 
and Akreos AO 60 so far [6, 7]. Another major difference between the two implants 
is that Akreos AO 60 is hydrophilic and therefore susceptible to optic opacification 
by calcium salt deposition in case of air or gas filling of the eye [8]. Since the prob-
ability of future PPVs followed by internal tamponade in these complex cases is not 
negligible, Akreos AO 60 is not the optimal choice for these patients.
IOL dislocation following suture breakage is one serious complication, and it 
determines sudden visual drop. Since the last reported control visit in our patients 
is 3 months, the risk of this complication is still present, especially as most studies 
report it between 2 and 5 years after surgery [9]. The 10–0 polypropylene sutures 
that we used in all our patients are designated for sewing and ligation soft tissues 
in cardiovascular, neurological, and ophthalmic surgeries. Even if these sutures are 
firm and durable, there are reports indicating that they might not be a long-term 
solution to fixate an IOL [9]. Therefore, some surgeons recommend the use of 9–0 
polypropylene sutures in these circumstances. Nevertheless, suture breakage was 
reported even with this type of sutures, especially in young adults and children 
[9]. An issue of concern related to the 9–0 polypropylene suture is related to the 
size of the knot. A bigger knot is associated with a higher risk of sclera atrophy, 
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erosion, and resultant endophthalmitis [9]. This drawback is overcome by creating 
the sclera flaps covering the knots or by using an intrascleral Z suture instead of 
the knot [4].
When evaluating a surgical procedure in ophthalmology, there are two impor-
tant interferingly elements to discuss: its impact on visual acuity and the complica-
tions related to it.
3.5.2 Visual acuity
In our series, BCVA of 5/10 or better was noted in 22 cases (38.59%). This is 
lower than reported by other authors [4, 10, 11], but the difference is that we did 
not exclude from our study the patients with associated lesions: RD, IOFB, and 
ruptured globe. In these circumstances, the final functional prognosis is influenced 
not only by IOL implantation technique but mainly by the consequences of other 
major ocular injuries.
The main advantage of surgery was that uncorrected visual acuity improved in 
every case in our series.
3.5.3 Complications
Since we used the infusion line of the PPV system, we were able to manage 
intraoperatively soft eye which may have had serious implications on functional 
recovery. Also, AC opening was performed cautiously, avoiding its sudden decom-
pression which might have favored choroidal bleeding and detachment. The pars 
plana-placed infusion line allowed the maintenance of a relatively constant IOP 
throughout surgery.
We fashioned the sclera flaps before opening the AC, because the eye was more 
stable. Creating these flaps, even if laborious, is a very important step, aimed to 
increase the postoperative comfort of the patient and decrease the risk of endo-
phthalmitis by burying the knots under them, which we did in all cases. Therefore, 
we report no case of postoperative endophthalmitis in this series.
Hemorrhage during surgery occurred in 20/57 cases (35.08%), and it was mild/
moderate and self-limiting. It was produced during puncturing the sclera with the 
PC9 needle in all cases. This maneuver is performed “blindly” without actually 
seeing the tip of the needle but rather “feeling” it in its way through the sclera.
In the postoperative period, hemorrhage persisted in 10 cases (17.54%) but 
resolved spontaneously in 9 of them. In one case we had to reoperate the patient by 
PPV, 4 weeks after IOL suturing, since the hemorrhage had no tendency to clear. 
Final outcome was positive, with visual acuity of 5/10.
Postoperative astigmatism varied between −1.00D. cyl and -6D. cyl. The causes 
of astigmatism are corneal incision which is larger than in circumstances in which 
foldable IOLs are used, tight sutures, and IOL misalignment or tilt [3]. As previ-
ously mentioned, the high astigmatism due to IOL tilt forced us to reposition the 
IOL in only one situation that resolved positively, with final VA 7/10. Astigmatism 
could be significantly reduced by using foldable lenses for scleral fixation that can 
be inserted through smaller incisions.
Iris manipulation when fixating an IOL to the sclera is definitely more intense 
than when placing a foldable IOL in the bag; therefore an inherent complication 
is anterior uveitis, which we encountered in seven cases in our series (12.28%), a 
lower percentage than we found in the literature [3, 9]. Anterior uveitis responded 
promptly to medical therapy and resolved within 2–4 weeks after surgery.
CME was identified in three cases (5.26%) and prevented the increase of visual 
acuity. One possible explanation for it might be IOL instability inside the eye [2].
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resolved spontaneously in 9 of them. In one case we had to reoperate the patient by 
PPV, 4 weeks after IOL suturing, since the hemorrhage had no tendency to clear. 
Final outcome was positive, with visual acuity of 5/10.
Postoperative astigmatism varied between −1.00D. cyl and -6D. cyl. The causes 
of astigmatism are corneal incision which is larger than in circumstances in which 
foldable IOLs are used, tight sutures, and IOL misalignment or tilt [3]. As previ-
ously mentioned, the high astigmatism due to IOL tilt forced us to reposition the 
IOL in only one situation that resolved positively, with final VA 7/10. Astigmatism 
could be significantly reduced by using foldable lenses for scleral fixation that can 
be inserted through smaller incisions.
Iris manipulation when fixating an IOL to the sclera is definitely more intense 
than when placing a foldable IOL in the bag; therefore an inherent complication 
is anterior uveitis, which we encountered in seven cases in our series (12.28%), a 
lower percentage than we found in the literature [3, 9]. Anterior uveitis responded 
promptly to medical therapy and resolved within 2–4 weeks after surgery.
CME was identified in three cases (5.26%) and prevented the increase of visual 
acuity. One possible explanation for it might be IOL instability inside the eye [2].
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3.5.4 Advantages of scleral-fixated IOLs
One major advantage of scleral-fixated IOL, especially for a vitreoretinal 
surgeon, is that any future vitreoretinal surgery procedure can be performed with 
no risk of IOL dislocation, as may happen in anterior placed IOLs [12]. Moreover, 
these complicated cases in which secondary IOLs are indicated are at risk to develop 
posterior segment complications that require proper examination and even surgical 
treatment. Pupil dilatation and examination of the retina and vitreous are much 
easier in an eye with scleral-fixated IOL than in one with ACIOL or iris-fixated IOL 
[12]. Besides, PPV which is usually performed before suturing IOL at the sclera 
considerably decreases the risk of future posterior segment complications in these 
patients.
In all our cases, prior to suturing IOL at the sclera, PPV has been performed. 
This contributed to visual function improvement by eliminating all the debris, 
blood, and inflammatory cells from the vitreous cavity which are specific for the 
posttraumatic and complicated postcataract surgery settings [12].
Scleral-fixated IOL should be the preferred technique to correct aphakia 
also because it is more physiological than anterior segment IOL placement, 
which may be associated with the risk of corneal touch and loss of  endothelium, 
anterior uveitis, and glaucoma in the long run [5]. Chronic glaucoma  requiring 
long-term topical treatment was diagnosed in three patients in our series 
(5.26%), all in the trauma group, which allows us to speculate that posttrau-
matic injuries, rather than the surgical technique itself, were more likely to 
cause it.
Some surgeons advocate that in experienced hands, fixating an IOL to the 
sclera offers a visual prognosis which is good enough to favor this procedure as the 
standard of care for correcting aphakia in patients with insufficient capsular sup-
port [12]. With its limitations and lack of long-term follow-up, our study supports 
this idea. Larger sample and longer-term follow-up are necessary to establish the 
safety and complications associated with scleral-fixated IOLs. Also, there is room 
for innovating IOL designs and surgical techniques, like sutureless glueless scleral 
fixation IOL [13].
4. Conclusions
Ab interno scleral fixation of a rigid IOL was a safe and viable technique to cor-
rect aphakia in patients with inappropriate capsular support in this series.
During surgery, the most frequent complication was mild vitreous hemorrhage 
which was self-limiting and did not prevent the recovery of visual acuity.
The complications noted in the postoperative period were few and did not influ-
ence the overall visual prognosis.
The limitations of this study are the relatively small sample of patients and the 
short-term follow-up.
Studies on higher number of patients and with longer follow-up are mandatory 
in order to outline the status of scleral-fixated IOL as the standard of care for cor-
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